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Abstract 
Intermediate filaments are together with actin filaments and microtubules major components of 
the metazoan cytoskeleton. In epithelial and epithelium-derived cancer cells intermediate 
filaments are composed of type I and type II keratin polypeptides. The keratin network is 
anchored to desmosomes, which connect cells to each other, and to hemidesmosomes, which 
attach epithelial cells to the extracellular matrix. The keratin cytoskeleton protects cells against 
various types of stress and is involved in fundamental cellular processes including signalling, 
differentiation and organelle trafficking. Time-lapse fluorescence microscopy of cultured 
epithelial cells producing fluorescently-tagged keratins has shown that the keratin network is in 
continuous motion and undergoes cycles of assembly and disassembly. From these data a 
complex cycle of keratin turnover was proposed consisting of peripheral nucleation of keratin 
particles next to focal adhesions, followed by elongation of these particles and their integration 
into the peripheral network with subsequent bundling of keratin filaments. The assembling 
keratins are transported to the cell interior in an actin filament- and microtubule-dependent 
fashion. Perinuclear filaments either mature into a stable perinuclear cage or disassemble into 
soluble subunits that rapidly diffuse and are re-utilised for another round of assembly in the cell 
periphery. 
The aim of this work was to develop tools and conditions to measure the keratin cycle in order to 
identify regulators of keratin dynamics. 
Experiments were performed in different epithelial cell lines producing fluorescently-tagged 
keratins alone and in combination with other fluorescent proteins of interest and specific 
shRNAs. Motion, bulk flow, and branching of keratins were calculated from time lapse 
recordings in different cell lines under defined and highly standardised conditions using novel 
tools that were developed in cooperation with the “Institute of Imaging & Computer Vision” of 
RWTH Aachen University. The results were compared to and validated by conventional methods 
such as fluorescence recovery after photobleaching and manual tracking. The results were 
complemented by immunoblot analyses and immunocytochemistry. 
Using these tools motion and turnover of keratins was quantified at subcellular resolution 
providing strong support for the proposed keratin cycle. The analyses presented overwhelming 
and objective evidence that keratin assembly takes place primarily in the cell periphery occurring 
even in the highly elongated retraction fibres of migrating cells and that disassembly occurs 
predominantly in the central, perinuclear part of the cells. I could show that keratin motion and 
turnover decreased with increasing times after plating. The decrease was further enhanced when 
cells were cultivated under conditions favouring the formation of hemidesmosomal structures. In 
accordance, downregulation of the cytoskeletal cross linker plectin, which is involved in 
hemidesmosomal anchorage of keratins, perturbed keratin network organisation through 
disruption of hemidesmosomal attachment, but did not otherwise affect keratin dynamics and led 
only to a slight but significant decrease in keratin network branching. On the other hand, 
epidermal growth factor (EGF) reversed the sessile phenotype of epithelial cells increasing 
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keratin filament formation, keratin filament movement, and keratin filament disassembly. 
Unexpectedly, inactivation of focal adhesion kinase had no short term influence on keratin 
dynamics. Instead, Src was identified as a possible candidate for regulation of keratin dynamics.  
This work shows for the first time that keratin dynamics are regulated by specific culture 
conditions and signalling pathways. The identification of EGF as a positive modulator of keratin 
turnover and the newly developed tools simplify the search for molecular mechanisms that are 
involved in keratin assembly and disassembly downstream of the EGFR. 
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1. Introduction 
 
Cytoskeleton 
Nikolai Koltzoff proposed in 1903 that the cell shape is defined by a skeleton composed from a 
net of filaments, or fibres, which he called ‘cytoskeleton’ (Koltzoff, 1903). Today it is known 
that the eukaryotic cytoskeleton is composed of actin filaments, microtubules, and different types 
of intermediate filaments. In cells of vertebrates the cytoskeleton is essential for cell shape, 
signalling processes, and mechanical stability. Cytoskeleton-associated motor proteins are 
responsible for organelle trafficking, cell motility, cell division, and differentiation. Unlike the 
name suggests, the cytoskeleton can be highly dynamic, and undergo fast morphologic changes 
as is the case during cell migration and division. The three main parts of cytoskeleton in 
epithelial cells are shown in Fig. 1-1. 
 
Fig. 1-1 : Cytoskeleton. 
The images show the complete cytoskeleton inside the same A431 cells. The cells were cultivated for 48 hours 
without serum on laminin-332-rich matrix. Actin was detected with phalloidin, pan-keratin with guinea pig 
antibodies, microtubules with α-tubulin antibodies, and DNA was stained with Höchst-33343. The images are 
maximum intensity projections from confocal sectioning of complete cells. Scale bar is 10 µm. 
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1.1. Actin 
Actin is expressed in the cytoplasm of nearly all eukaryotic cells. It can remain in the monomeric 
form (G-actin), or polymerize into microfilaments (F-actin). These microfilaments are organised 
into higher-order structures that form three-dimensional networks. The actin polymerisation 
generates mechanical force that can be used for migration of eukaryotic cells by lamellipodia 
extensions. Lamellipodia are highly dynamic structures (up to 1 µm s-1) forming leading 
lamellae, growth cones, and ruffles. Otherwise, actin polymerisation is used to drive the 
centripetal flow (≤ 0.8 µm s-1) and to form a cortex that is responsible for cell shape. F-actin is 
furthermore involved in endocytosis, trafficking, muscle contraction, and cell contraction during 
cell division [for review see (Pollard et al., 2000; Stricker et al., 2010)]. 
On the structural level F-actin microfilaments are ≈ 6 nm thick. They can be bundled into thicker 
filaments by actin-bundling proteins, for example fascin (Edwards and Bryan, 1995; Kane, 
1975), fimbrin (Glenney et al., 1981), villin (Bretscher and Weber, 1980), filamin (Stossel et al., 
2001), and α-actinin (Jockusch and Isenberg, 1981). F-actin filaments have two different ends. 
The rapidly growing “barbed end” is responsible for membrane protrusions. In contrast the 
“pointed end” is less preferred for actin polymerisation (Tilney et al., 1981). In vitro such ends 
can be attached to other actin filaments, at an angle of 70 ± 7°, creating branching that is similar 
to actin networks in living cells (Mullins et al., 1998). In response to extracellular stimuli cells 
can regulate actin polymerisation within seconds (Gerisch, 1982) by formins or Arp2/3 complex. 
Formins are actin nucleation factors (Sagot et al., 2002), that unlike Arp2/3 associates with 
barbed ends. They are responsible for the nucleation of linear and unbranched filaments that are 
found in actin cables, filopodia, stress fibers, and actin-rich cell adhesions. Formins are also 
involved in the regulation of microtubule-dependent processes [for review see (Goode and Eck, 
2007)]. The Arp2/3 complex induces the polymerisation of actin filaments, at an angle of ≈ 70°, 
at pointed ends (Ma et al., 1998; Welch et al., 1997; Winter et al., 1997). Arp2/3 is regulated by 
WASp, Scar/WAVE (Machesky et al., 1999), and other WASP-like proteins (Rohatgi et al., 
1999; Winter et al., 1999). Without nucleation factors the polymerisation of actin is unfavourable 
due to the instability of small actin oligomers (Sept and McCammon, 2001). Once started, at 
barbed ends, the actin polymerisation is stopped by capping proteins [for review see (Cooper and 
Sept, 2008)]. On thermo dynamical level actin polymerisation is not dependent on ATP-bound 
actin (De La Cruz et al., 2000), but ATP increases the stability of formed filaments (Pantaloni et 
al., 2001; Pollard, 1986). The half-live of ATP bound to F-actin before hydrolysis is ≈ 2 seconds 
(Blanchoin and Pollard, 2002). 
In signal transduction, actin polymerisation is induced by activation of WASp and N-WASP, in a 
phosphatidylinositol-4,5-bis-phosphate (PIP2)-dependent way, by Rho-family GTPases Cdc42 
and Rho (Rohatgi et al., 1999; Yarar et al., 1999). Actin polymerisation can also be induced by 
focal adhesion kinase (FAK), which is essential for the formation of nascent lamellipodia 
(Serrels et al., 2007). In vitro the polymerisation rate of actin is 100-1000 subunits s-1, which 
corresponds to ≈ 0.3-3 µm s-1. In vivo these values are presumably lower. In mature filaments 
actin tends automatically toward depolymerisation, which can occur intrinsically, or can be 
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enhanced by ADF/cofilin that severe ADP-bound F-actin (Pollard et al., 2000). The mechanism 
of F-actin polymerisation based on dendritic nucleation hypothesis is summarised in Fig. 1-2. 
 
 
Fig. 1-2: Assembly of actin filaments at the leading edge of a motile cell. 
This figure shows the “dendritic nucleation hypothesis” model for actin based on (Pollard, 2007; Pollard et al., 
2000). In the shown example Rho-family GTPases are activated by extracellular stimuli. In consequence WASp and 
Scar/WAVE induce actin polymerisation by Arp2/3 on one side of an actin filament. The new created branch grows 
at 70° angle, until it is capped at the barbed end by a capping protein. ATP bound to aged F-actin becomes 
hydrolysed to ADP with the consequence that ADF/cofilin depolymerizes the filaments to monomers. Finally, 
profilin catalyses the exchange of actin-bound ADP to ATP, which is more favourable for polymerisation of new F-
actin. Note that actin nucleation induced by formin mechanism is not shown in this schema. 
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1.2. Microtubules 
Microtubules (MTs) are rod-like structural components of the cytoskeleton that are hollow 
inside, and have a diameter of 24-25 nm. They position the nucleus and organelles, and are the 
main structural elements of flagella and cilia. During cell 
division MTs form the mitotic spindle, which is essential 
for chromosome segregation. Together with actin and 
intermediate filaments, MTs are responsible for the 
mechanical stability of the cell [for review see (Desai and 
Mitchison, 1997; Inoue and Sato, 1967)]. MTs are 
composed of non-covalently bound ≈ 50 kDa α- and β-
tubulin heterodimers (Weisenberg et al., 1968) that share 
an amino acid homology of about 46-63% depending on 
the alignment method used (Burns, 1991)(160 species 
were compared). The ends of MTs are discerned in plus 
ends that are terminated by β-subunits, and minus ends 
that are capped by α-subunits (Mitchison, 1993). MTs 
have predominantly 13-14 protofilaments (in vitro) 
depending on the tissue they were purified from (Evans et 
al., 1985; Mandelkow et al., 1986). Other combinations between 10-15 protofilaments are also 
found in vitro [for review see (Conde and Caceres, 2009)]. The formed MT-tubes have a B-type 
lattice in which neighbouring monomers at the 3-start are either α or β (Kikkawa et al., 1994; 
Mandelkow et al., 1986; Song and Mandelkow, 1993). The overall microtubule structure is 
helical as shown in Fig. 1-3. MTs can grow fast by polymerisation at the plus ends and slower on 
the minus ends. This process is GTP dependent but can also occur by ATP hydrolysis at higher 
concentrations (Walker et al., 1988; Weisenberg et al., 1976).  Alternatively, different ends can 
switch between polymerisation and depolymerisation. In this process depolymerised subunits 
from other MTs can be used for polymerisation (Mitchison and Kirschner, 1984). The 
polymerisation can result in pushing force, and the process of depolymerisation in pulling force 
(Inoue and Salmon, 1995). The polar nature of MTs is important for kinesin motors that move 
toward plus ends (Vale et al., 1994), and dynein motors that move toward minus ends. MTs have 
different half-life times inside cells, for example 5-10 minutes during interphase and 0.5-1 
minutes during mitosis [for review see (McNally, 1996)]. The dynamics of MTs are regulated by 
different nucleation and depolymerisation factors, for example by γ-tubulin in the formation of 
centrosomes (Oakley and Oakley, 1989). 
MTs can be imaged in vivo using differential interference contrast microscopy (DIC) in thin 
regions of cells (Cassimeris et al., 1988), and by fluorescence microscopy inside whole cells 
(Sammak and Borisy, 1988; Schulze and Kirschner, 1988; Stearns, 1995). In live cell 
microscopy MTs can interact dynamically with focal contacts (Kaverina et al., 1999). There is 
also growing evidence that MTs are involved in turnover of focal adhesions. One possibility 
could be by Rho family pathways that control actomyosin-based contractility [for review see 
(Stehbens and Wittmann, 2012)]. 
Fig. 1-3: Microtubule structure. 
The shown microtubule is laterally 
composed of 13 protofilaments. Based on 
(Conde and Caceres, 2009; Litjens et al., 
2006). 
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1.3. Intermediate filaments 
 
1.3.1. Structure 
Intermediate filaments (IFs) have a diameter of 8-12 nm which is intermediate between actin and 
microtubules. In mammals approximately 70 intermediate filament proteins are expressed in a 
tissue- and differentiation-specific manner. They are subdivided in type I-V as summarised in 
Tab. 1-1 (Hesse et al., 2001; Kim and Coulombe, 2007). Only specific combinations of these 
proteins can form IFs, for example vimentin can form polymers with vimentin or desmin, but 
never with keratins (Franke et al., 1983). 
Tab. 1-1: Nomenclature of intermediate filament proteins corresponding to (Kim and Coulombe, 2007). 
IF name Type Cell and tissue distribution 
Keratins I (n=28) K9-K28 (epithelia); K31-K40 (hair/nail) 
Keratins II (n=26) K1-K8, K71-K74 (epithelia); K81-K86 (hair) 
Vimentin III mesenchymal 
Desmin III muscle 
GFAP III astrocytes/glia 
Peripherin III peripheral neurons 
Neurofilaments IV CNS neurons 
α-Internexin IV CNS neurons 
Nestin IV neuroepithelial 
Syncoilin IV muscle 
Synemin IV muscle 
Lamins B1, B2 V nuclear lamina 
Lamins A/C V nuclear lamina 
Phakinin (CP49) unknown lens 
Filensin unknown lens 
Although, intermediate proteins have rather different primary structures, they share all a 
common domain structure. In the central part a ≈ 310 residue-long α-helical rod domain (≈ 350 
for nuclear intermediate filaments) is located. This domain is subdivided in four regions (coils 
1A, 1B, 2A, 2B), which are flanked by non-helical head and tail domains as shown in Fig. 1-4 A. 
The variable head and tail domains determine the specific functions of the different isoforms. 
The rod domain mediates coiled-coil dimer formation with other intermediate proteins. The 
dimers associate then to tetramers, which form in an antiparallel manner protofilaments as 
described in Fig. 1-4 B. These protofilaments are apolar and have equivalent ends. In 
consequence, IFs are apolar unlike microtubules and actin filaments [for review see (Fuchs and 
Weber, 1994; Parry and Steinert, 1999)].  
Complete sturctures of polymerised IFs are not available at atomic-resolution yet because IFs are 
difficult to crystallize. Only parts of the vimentin “rod” were described by X-ray crystollography 
(Chernyatina et al., 2012; Nicolet et al., 2010; Strelkov et al., 2002). Cryotransmission electron 
microscopy of stratum corneum keratin shows several subfibrils inside mature IFs (Norlen and 
Al-Amoudi, 2004), and electron microscopy preparations of in vitro IFs show an axial repeat 
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inside mature polymers, indicating that coiled-coiled dimers are staggered within (Aebi et al., 
1988). 
 
Fig. 1-4: Structure and formation of intermediate filaments. 
In A the domain structure of an intermediate filament monomer is shown. The conserved rod domain is flanked by 
variable head and tail domains. In B two of these monomers form a parallel dimer, and in C two of these dimers 
form an antiparallel tetramer that has an apolar organization. The figures are based on (Kim and Coulombe, 2007; 
Tang, 2008). 
 
1.3.2. Localisation 
The most type I-III intermediate filament proteins are present in filamentous networks, that 
extend from a ring/cage surrounding the nucleus to the plasma membrane. Only a small part of 
these proteins is in a nonpolymerised state i.e. as dimers or tetramers. It remains unclear if these 
nonpolymerised molecules are stored in macromolecular complexes. It is known that the amount 
of soluble keratin in cytoplasm is small (Franke et al., 1987). Approximately 5% soluble keratins 
8 and 18 were found in HT29 epithelial cells, which increased during mitosis (Chou et al., 1993). 
For soluble vimentin a value of ≈ 0.4% in cytosol was determined (Soellner et al., 1985). 
 
1.3.3. Transcription and translation 
The transcription of IFs is differentiation-related, and the expression of “wrong” isoforms can 
negatively influence cells (Blessing et al., 1993). Keratins are the largest IF protein group with 
over 50 isoforms (Bragulla and Homberger, 2009). In simple epithelia keratin pair 8/18 is 
expressed. This is different in stratified epithelia, where keratin pair 5/14 is expressed in basal 
cells, and keratin pair 1/10 in suprabasal cells (Fuchs and Weber, 1994). During wound healing 
the transcription of IF changes in wound-proximal cells (DePianto and Coulombe, 2004), 
possibly optimizing migration of regenerating cells into the wound [for review see (Coulombe 
and Wong, 2004)]. In the embryonic ectoderm and in adult skin of mice, keratins 6, 16, and 17 
are such wound-inducible genes (Coulombe and Wong, 2004; Mazzalupo et al., 2003). 
Correspondingly, in keratinocytes six hours after tissue injury the levels of keratins 6 and 16 are 
strongly increased (Paladini et al., 1996). Keratins 5 and 14 can be found in basal keratinocytes, 
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but the mRNA is only present in the suprabasal epidermis layer (Lersch and Fuchs, 1988). In 
keratin 10 deficient mice the expression of keratin 1 is down-regulated, and the expression of 
keratins 5 and 14 are increased (Reichelt et al., 2001). In mouse embryos type II IFs are 
translated prior to their type I assembly partners, and are stored unpolymerised in aggregates 
before filaments appear (Lu et al., 2005).  For type III intermediate filament peripherin it was 
shown that it’s mRNA moves along microtubules, and the translation is initiated when the 
movement is ceased (Chang et al., 2006). 
Epithelial cells that are transformed into cancer cells undergo a process called epithelial-to-
mesenchymal transition (EMT). EMT leads in some cancers to expression of vimentin 
additionally to keratins. Vimentin is also expressed throughout embryogenesis but becomes 
mostly restricted to mesenchymal cells during later development phases. In case of keratins this 
is similar; their expression is restricted after embryogenesis to epithelial cells. 
 
1.3.4. Dynamics 
Intermediate filaments (IFs) are assembled from a pool of non-covalently bound homodimers, 
or/and heterodimers depending on their biophysical properties (Eichner et al., 1986). In case of 
keratins the non-filamentous forms are distributed in cytosol (Kolsch et al., 2010), and are 
protected from spontaneous polymerisation in an unknown way. The amount of nonfilamentous 
keratin changes under different conditions. For example, during mitotic arrest (Chou et al., 1993) 
and heat stress the soluble keratin pool increases (Liao et al., 1995). The different proteins that 
bind to soluble keratins are possibly involved in the stabilisation of the non-filamentous form. 
These are: chaperone Hsc70 that interacts with the head domain of keratin 5 (Planko et al., 
2007), heat shock protein Hsp70 that localises preferentially with soluble keratins 8 and 18 (Liao 
et al., 1995), and 14-3-3 proteins (Liao and Omary, 1996). Furthermore, plectin and 14-3-3 are 
found in granular keratin agregates that do not form recognizable filaments (Strnad et al., 2002). 
Once formed IFs tend to be very stable, but they can reorganize relatively fast within minutes 
during events such as mitosis, or apoptosis. The resulting question is how the polymerisation and 
depolymerisation of IFs occurs. In a recent study it was shown that vimentin- and neurofilament-
subunits can attach at filament ends, sometimes forming rings with the same filament. In 
addition, the formed filaments incorporated filament subunits along their length (Colakoglu and 
Brown, 2009). The first mechanism was proposed previously by (Woll et al., 2005) and the 
second mechanism by (Chang et al., 2006; Miller et al., 1991). 
Keratins and other IFs are possibly formed from unit length filaments (ULFs, 50-60 nm long) 
that were found in vitro (Herrmann et al., 1999; Herrmann et al., 2002). In experiments based on 
standard fluorescence microscopy in vivo it is unclear if the detected keratin precursors are single 
or multiple ULFs because of the resolution limit of conventional microscopes. These particles 
are moving in an actin dependent manner toward the cell interior (Werner et al., 2004; Windoffer 
et al., 2006). In the case of vimentin ULFs can elongate in both directions in vitro (Kirmse et al., 
2007). 
Introduction 
 
  19 
Another feature of IFs is the non-covalent “cross-linking” (bundling) of thinner filaments into 
thicker filament bundles. Modelling experiments show that long-range interactions between 
filaments are necessary for bundle-like structures (Kim et al., 2010). This process can occur 
intrinsically (Lee and Coulombe, 2009), or it can be induced by different factors. For example 
phosphorylation is important for bundling of type IV IFs (Kushkuley et al., 2009). In this context 
shear stress in A549 cells increases the phosphorylation of S73 on keratin 8, and phosphorylation 
of S33 on keratin 18. Simultaneously the soluble keratin pool is drastically decreased, 
corresponding to an increased amount of thicker bundles (Flitney et al., 2009). Otherwise, 
cytolinkers can be involved in filament stability and bundling. For example, during mitosis 
plectin prevents vimentin networks from complete disassembly (Spurny et al., 2008). 
Downregulation of periplakin by siRNA delays wound closure, and inhibits keratin bundle 
formation (Long et al., 2006). Periplakin interacts with plectin 1, 1f and 1k, and downregulation 
of plectin in scratch-wounded MCF-7 cells inhibits keratin re-organisation (Boczonadi et al., 
2007). The repeat 5 domain of plectin inhibits in vitro the formation of vimentin filaments and to 
lower degree of keratin filaments in a dose-dependent manner (Steinbock et al., 2000). Another 
cytolinker that increases keratin bundling and mechanical stability in keratinocytes during wound 
healing is epiplakin (Ishikawa et al., 2010). Keratinocytes lacking plectin show thicker keratin 
filaments which could result from decreased cross-linking (Osmanagic-Myers et al., 2006).  
At present it is unknown in detail how the keratin assembly and dissasembly processes are 
regulated. Potential mechnisms that are likely involved are phosphorylation, ubiquination, 
proteolysis (Ku and Omary, 2000; Loffek et al., 2010), sumoylation (Snider et al., 2011), and 
interaction with other proteins like plectin, or 14-3-3 (Strnad et al., 2002). Correspondingly, 
focal adhesions that are hot spots for signal transduction proteins could be important for 
formation of keratin filaments. In case of vimentin it was shown that assembly of filaments at 
focal adhesions is dependent from plectin 1f. Without this isoform filaments are formed at 
diferent positions with changed kinetics (Burgstaller et al., 2010). In this context it is interesting 
that plectin 1f was shown to bind keratins (Steinbock et al., 2000), and that it is found in talin 
positive focal adhesions at the end of actin stress fibers (Rezniczek et al., 2003). Further focal 
adhesion-proteins that maybe involved in the binding of IFs are: integrin α2β1 (Kreis et al., 
2005), vinculin, metavinculin (Sun et al., 2008a), talin (Sun et al., 2008b), and zyxin (Sun et al., 
2010). 
Inhibition of p38 MAPK, or PKCζ increases keratin network stability, otherwise enhancing the 
activity of these kinases increases keratin turnover (Sivaramakrishnan et al., 2009; Woll et al., 
2007). In response to shear-induced stress keratin networks are ubiquitinated (Jaitovich et al., 
2008; Rogel et al., 2010), this is also probably true for malfunctioning keratins 8/18 in Mallory-
Denk bodies, in diseases of the liver [for review see (Zatloukal et al., 2007)]. In hypoxia the 
mitochondrial complex III-generated reactive oxygen species (ROS) act as second messenger, 
enhancing the degradation of keratin network (Na et al., 2010). Proteolysis of keratins can also 
occur during viral infection by viral proteases, or caspases (Zhang and Schneider, 1994), and was 
described in apoptotic cells (Caulin et al., 1997). The clevage occurs at a conserved motif 
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(VEXD) within the rod domain, but also other potential clevage-sites are known (Chen et al., 
2003; Omary et al., 2004). 
The process of keratin network assembly is mostly independent of protein synthesis, as it was 
shown in cell culture experiments where the keratin networks were recycled for new filaments 
(Kolsch et al., 2010; Windoffer et al., 2004). Interestinglly, the nucleation of keratin filaments 
continues in the presence of microtubule and actin disruptors, but the movement of keratin 
networks is disturbed under these conditions. In more detail, experiments in SW13 cells show 
that actin is important for slow, inward-directed transport of keratin (≈ 0.23 µm min-1), and 
microtubules are important for fast bidirectional transport (≈ 17 µm min-1) in axon-like cell 
extensions (Woll et al., 2005). Similarly, neurofilament subunits and filament polymers are 
transported from the cell body to the axonal periphery (Terada et al., 1996; Yan and Brown, 
2005). In epithelial EpH4 cells it was confirmed that actin is essential for keratin filament 
transport toward cell interior, but microtubules are not (Kolsch et al., 2009). The keratin network 
is further stabilised by desmosomes and hemidesmosomes (Long et al., 2006). Fluorescently-
tagged vimentin filaments show different dynamic and regulation properties, when compared to 
fluorescently-tagged keratins 8 and 18 in PtK2 epithelial cells. Furthermore, vimentin filaments 
move faster than keratins, and have a higher turnover. In contrast to keratin, the movement of 
vimentin is strongly microtubule-dependent (Yoon et al., 2001). 
 
1.3.5. Function and interaction with other proteins 
Keratin IFs are especially important for protection of stratified epithelia against stress. This was  
shown in mice expressing a mutated keratin that disrupted the formation of normal keratin 
filaments. These animals “exhibited abnormalities in epidermal architecture and often died 
prematurely” (Vassar et al., 1991). Transgenic murine embryos lacking keratins survive until day 
9.5 (Vijayaraj et al., 2009). Keratins 8 and 18 deficient epithelial cells (also cancer cells) are ≈ 
100 times more sensitive to TNF-induced cell death, and mice deficient of these genes are more 
sensitive to liver damage induced by concanavalin A (Caulin et al., 2000). Keratins 8 and 18 are 
the only keratins in mouse liver hepatocytes. Without keratin 8 no keratin networks are formed, 
and Fas receptor-mediated apoptosis is enhanced (Gilbert et al., 2001). In this scenario the Fas 
receptor activation leads (in wild type cells) to phosphorylation of keratins 8 and 18 (Ku et al., 
2003). Interestingly, in cell culture cytoplasmic IFs are dispensable for survival unlike 
microtubules and actin (Venetianer et al., 1983). This is possibly the case, because such cells are 
cultivated under gentle conditions. 
In cells, IFs can associate with F-actin, microtubules, and nucleus. These connections are 
meditated by plakins like plectin, whereas in the case of nucleus additionally nesprin-3 is 
involved (Wilhelmsen et al., 2005). Keratin IFs also associate with desmosomes that are cell-cell 
connections, and with hemidesmosomes that connect cells to the extracellular matrix (Green and 
Jones, 1996; Litjens et al., 2006). In a VE-cadherin-mediated way IFs can be anchored in 
endothelial cells to “unique junctional complexes” (Kim et al., 2005; Kowalczyk et al., 1998). 
Introduction 
 
  21 
After skin injury, during wound healing, keratin networks undergo reorganisation in 
keratinocytes at the wound edge. The keratin network is then concentrated around the nucleus in 
opposite direction of cell movement. During this process the expression of keratins 6 and 16 is 
enhanced, which possibly is necessary for reorganisation of the network for cell migration 
(Paladini et al., 1996). Also mouse embryos that do not express keratin 17 show significantly 
delayed wound closure (Mazzalupo et al., 2003). Otherwise, cell lines from EBS patients that 
have keratins with impaired abilities to form networks have increased migration properties 
(Morley et al., 2003). This is in accordance with downregulation of keratin 8 that leads to 
increased migration and wound closure in some cell lines (Long et al., 2006). 
Furthermore, IFs are involved in vesicle transport. In basal layer keratinocytes, keratins impact 
the transport and distribution of melanin granules for skin pigmentation [for review see (Gu and 
Coulombe, 2007)]. Also the localisation of GLUT-1 and GLUT-3 glucose transporters is keratin-
dependent (Vijayaraj et al., 2009). In case of vimentin it was shown that it colocalize with 
integrin αVβ3 positive focal adhesions (Tsuruta and Jones, 2003). CHO cells lacking integrin β3 
show collapsed vimentin networks that are not attached to focal adhesions (Bhattacharya et al., 
2009). Another adhesion complex that binds to vimentin is integrin α2β1 (Kreis et al., 2005). 
Mutations in genes encoding for IFs lead to more than 80 incurable human diseases of muscle, 
heart, skin, and neurological system (Omary, 2009). Interestingly, in cancer vimentin and 
keratins 8 and 18 enhance the migration of cells (Chu et al., 1993; Chu et al., 1996; Gilles et al., 
1999), and novel studies indicate that keratins could be important for metastasis, as was 
proposed for vimentin (Knosel et al., 2006; Ptitsyn et al., 2008). 
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1.4. Extracellular matrix adhesion complexes 
Adhesion of cells to the extracellular matrix (ECM) is essential for tissue formation, cell 
migration, and a variety of signal transduction processes. ECM is composed of extracellular 
molecules secreted by cells. The knowledge about complexes that mediate the adhesion of cells 
to ECM is limited. It is known that hemidesmosomes connect cells and the keratin cytoskeleton 
to the basement membrane. Focal adhesions (FAs) in contrast connect the actin cytoskeleton 
with ECM. 
 
1.4.1. Focal adhesions 
Focal adhesions (FAs) are multifunctional organelles that connect cells mechanically with the 
ECM. They concentrate different cellular molecules at sites of integrin receptor clustering, and 
are therefore involved in force transmission, cytoskeletal regulation, and signalling [for review 
see (Bershadsky et al., 2003; Burridge and Chrzanowska-Wodnicka, 1996; Geiger et al., 2001)]. 
FAs were originally identified in cell culture by electron microscopy (Abercrombie et al., 1971) 
and later by interference reflection microscopy (Abercrombie and Dunn, 1975). Cultured cells 
have tens to hundreds FAs, ranging from one square micron to several square microns. The 
number and distribution of FAs can vary strongly between different cells in the same cell culture 
dish. The morphology of FAs can be affected by different factors, like composition of 
substratum, culture medium, time after plating, and cell density (Zamir et al., 1999). The size of 
FAs is increased by tension that induces their phosphorylation (Bershadsky et al., 1996). On the 
structural level FAs are divided in three different types. Classical focal contacts are found in the 
cell periphery, and have an oval/arrowhead form. They contain integrin αVβ3, paxillin, vinculin, 
low levels of tensin, and are highly tyrosine phosphorylated. Fibrillar adhesions are attached to 
fibronectin fibers, and appear elongated, or dot-like. They contain integrin α5β1, high levels of 
tensin, parvin/actopaxin, and are low tyrosine phosphorylated. Focal complexes are small dot-
like adhesions on the edge of lamellipodia, with a non-uniform molecular structure (Zamir et al., 
1999). 
In the following FA proteins are described that were investigated in this work. The cytolinker 
plectin is found in FAs (Seifert et al., 1992) and its deficiency in fibroblasts increases the 
quantity of FAs (Andra et al., 1998). Plectin 1f isoform is important for the assembly of vimentin 
precursors at fibrillar adhesions influencing the morphology of vimentin networks (Burgstaller et 
al., 2010). Plectin is also described in more detail for hemidesmosomes in chapter 1.4.2.2. The 
non-receptor kinases FAK and Src are involved in cell migration, adhesion, polarisation, and 
therefore in FA-turnover. Their signal transduction-properties are described in chapter 1.6. 
Paxillin belongs to the first proteins that translocate to focal contacts (Laukaitis et al., 2001). The 
protein was identified as a binding partner of the actin cytolinker vinculin (Turner et al., 1990). 
In recent years an impressive number of other paxillin binding targets were identified, for 
example FAK/Pyk2, Ras, integrin β1, and tubulin. Tyrosine phosphorylation of paxillin is 
necessary for cell migration. The phosphorylation is mediated by a wide variety of growth 
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factors, one of them being epidermal growth factor (EGF) [for review see (Brown and Turner, 
2004)]. Paxillin can also be phosphorylated on serine/threonine-residues mediated by integrin 
αVβ5 activation upon cell adhesion (De Nichilo and Yamada, 1996). Interesting for this work 
was also that integrin β5 can be used as a marker for FAs (Katoh et al., 2013; Vial and 
McKeown-Longo, 2008). 
 
1.4.2. Hemidesmosomes 
The name hemidesmosomes (HDs) comes from electron microscopy images, where 
hemidesmosomes look like half desmosomes (desmosomes are cell-cell connections). 
Hemidesmosomes mediate stable attachment of basal epithelial cells to the underlying basement 
membrane. In this process HDs connect the IF 
network to laminin-332, or/and collagen IV. 
In tissues two different types of 
hemidesmosomes are found. Intestinal 
epithelia assemble type II HDs which contain 
the heterodimer integrin α6β4 and the 
cytoskeleton linker plectin. Skin and complex 
epithelia assemble type I HDs that are similar 
to type II, but furthermore contain BP180 
(collagen XVII), tetraspanin CD151, and 
BPAG1e (BP230) as shown in Fig. 1-5 [for 
review see (Borradori and Sonnenberg, 1996; 
Green and Jones, 1996; Tsuruta et al., 2011)]. 
Malfunction of HDs causes several diseases of 
the skin that result in de-adhesion of 
epidermis, and formation of blisters between 
dermis and keratinocytes [for review see 
(Sawamura et al., 2010). 
Keratinocytes in cell culture fail to assembly 
real hemidesmosomes, but they assemble 
similar protein complexes that are called 
“hemidesmosome like complexes” (HD-like 
complexes), or “stable anchoring complexes” 
(Carter et al., 1990). Also some cancer cell 
lines, for example A431 or 804G are able to 
assemble HD-like complexes. These 
complexes are considered as different at the 
ultra-structural level from hemidesmosomes 
assembled in tissues (Tsuruta et al., 2003). 
Older studies describe HD-like structures as stable complexes that are absent in migrating 
Fig. 1-5: Components and structure of type I and II 
hemidesmosomes. 
The scheme shows the interaction between 
hemidesmosomal components and the involved domains 
that are described in 1.4.2.1 and 1.4.2.2. The figure is 
based on (Borradori and Sonnenberg, 1999).  
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keratinocytes (Carter et al., 1990). Newer studies show that these complexes can be dynamic, 
especially in migrating cells (Tsuruta et al., 2003). Otherwise, HD-like complexes can be 
disassembled enhancing cell migration, during wound healing, and in some tumors where 
laminin-332 is cleaved by metalloproteases [for review see (Tsuruta et al., 2011)]. The 
components of HDs are described in more detail in following chapters. 
 
1.4.2.1. Integrin α6β4 
Integrin α6β4 is a transmembrane receptor that mainly binds laminin-332 (old names: 
kalinin/nicein/laminin-5) in the ECM (Burgeson et al., 1994; Niessen et al., 1994). The receptor 
has also a lower affinity to laminin-111 (Lee et al., 1992), and laminin-211/-221 (Spinardi et al., 
1995). The β4-subunit contains an intracellular domain of ≈ 1000 residues with unique sequence 
and length compared to other β integrins. The interaction between integrin β4 and plectin is 
mediated by first two FNIII domains, CS domain (Geerts et al., 1999), the fourth FNIII domain, 
and C-terminal tail of β4 (Koster et al., 2004). BP180 and BP230 bind to the third FNIII domain 
of integrin β4 and to a segment up to the fourth FNIII domain (Koster et al., 2003). 
In cells four different splice-variants of integrin β4 are expressed, but their significance is 
unknown [for review see (de Melker and Sonnenberg, 1999)]. Mutations in the β4-subunit can 
lead to epidermal blistering (Vidal et al., 1995), and absence of the protein leads to death after 
birth (DiPersio et al., 2000). In cell migration the function of integrin α6β4 is controversial, it 
can increase or decrease migration depending on the experimental setup. In mouse keratinocytes 
lacking integrin β4 the migration is increased (Raymond et al., 2005), but otherwise the 
expression of β4 in β4-null human keratinocytes increases migration in an epidermal growth 
factor- (EGF)-dependent manner (Russell et al., 2003). In conditional integrin β4 knockout mice 
differentiation, proliferation and survival is normal, as long as cell adhesion is not disturbed 
(Raymond et al., 2005). The activation of the epidermal growth factor receptor (EGFR) in A431 
cells plated on laminin-111 leads in a PKC-dependent manner to serine phosphorylation of 
integrin β4, and to a translocation of integrin α6β4 to lamellipodia (Rabinovitz et al., 1999). 
Activation of the Ron receptor in keratinocytes plated on laminin-332 leads to similar results, 
mediated by 14-3-3 protein association with the Ron receptor (Santoro et al., 2003). In cells 
expressing integrin β4 the effect of EGF on Rac1 activation is stronger than in cell lines that do 
not express integrin β4 (Russell et al., 2003; Zahir et al., 2003). EGF furthermore leads to 
tyrosine phosphorylation of integrin β4 and disassembly of HD-like structures. In this process 
the kinase Fyn associates with integrin α6β4 (Mariotti et al., 2001). Interestingly, in this study it 
was shown that integrin β4 is already tyrosine phosphorylated in A431 cells and that EGF 
increases the phosphorylation levels. In aggressive carcinomas integrin α6β4 is responsible for 
migration and survival of cancer cells by activation of phosphoinositide-3OH-kinase (PI-3K). 
Important downstream targets of PI3-K in this scenario are Akt, Rac and mTOR [for review see 
(Lipscomb and Mercurio, 2005; Mercurio and Rabinovitz, 2001)]. 
The keratin network is connected in hemidesmosomes to integrin α6β4 by plectin or BPAG1e. 
For further information see: (Lipscomb and Mercurio, 2005; Wilhelmsen et al., 2006). 
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1.4.2.2. Plectin 
Plectin is a multifunctional cytolinker with a molecular weight of ≈ 500 kDa that belongs to the 
plakin family. It was detected first by immunoblot analysis and named HD1 (Hieda et al., 1992).  
Plectin isoforms differ only at their amino termini, which are encoded by at least 11 different 
exons that are spliced directly on to exon 2. The expression of different isoforms is tissue 
dependent and can differ during development (Fuchs et al., 1999). For more detail on localisation 
see Tab. 1-2. 
Tab. 1-2: Cellular localisation of plectin isoforms. 
Isoform Localisation Published in 
1 binds IFs to costameres in skeletal muscle (Hijikata et al., 2008) 
1a major isoform in keratinocytes; colocalizes with 
hemidesmosomes 
(Andra et al., 2003) 
1b links vimentin to mitochondria (Rezniczek et al., 2003) 
1c major isoform in neural cells; epithelia (Andra et al., 2003; Fuchs 
et al., 2009) 
1d links desmin to Z-disks and costameres in muscle (Konieczny et al., 2008) 
1f FA-evolved fibrillar adhesions (FbAs); suprabasal 
epidermal keratinocytes; colocalizes with periplakin; links 
desmin to Z-disks and costameres in muscle 
(Boczonadi et al., 2007; 
Burgstaller et al., 2010; 
Konieczny et al., 2008; 
Rezniczek et al., 2003) 
1h vimentin network (Rezniczek et al., 2003) 
1k suprabasal epidermal keratinocytes; colocalizes with 
periplakin 
(Boczonadi et al., 2007) 
1e, 1g, 1i, 1j unknown (only cDNA was published) (Fuchs et al., 1999) 
The binding of keratin cytoskeleton to integrin α6β4 in hemidesmosomes is mediated by plectin 
1a (Andra et al., 2003). This binding is critical for hemidesmosome formation (Rezniczek et al., 
1998) and stability (Koster et al., 2001). The connection can be disrupted by treatment of cells 
with EGF with the consequence of integrin α6β4 redistribution to cell protrusions (Rabinovitz et 
al., 1999; Santoro et al., 2003). The actin-binding domain (ABD) of plectin can bind to actin, or 
integrin β4, but not to both proteins at once (Geerts et al., 1999). X-ray structures of integrin β4 
show that the binding to plectin induces structural changes that prevent the access to actin-
binding domain in plectin (de Pereda et al., 2009). This is possibly the reason why 
hemidesmosomes only incorporate IFs and not F-actin. The connection of plectin to IFs is 
mediated by plectin’s carboxy-terminal repeat 5 domain (Nikolic et al., 1996). There is also 
some evidence that other domains could be involved (Favre et al., 2011; Nikolic et al., 1996). In 
vitro plectin mutants consisting of repeat 5 domain impair in a dose dependent manner the self-
assembly of keratin 5/14 filaments and of vimentin filaments. These mutants also promote the 
disassembly of vimentin filaments and to a lesser degree of keratin 5/14 filaments (Steinbock et 
al., 2000). In fibroblasts plectin is associated with vimentin during filament assembly and it is 
required for vimentin transport (Spurny et al., 2008). 
Plectin-deficient keratinocytes have keratin networks with greater mesh size and thicker 
filaments. The keratin network in these cells is more susceptible to osmotic-stress and 
hyperphosphorylation induced by okadaic acid (Osmanagic-Myers et al., 2006). These plectin-
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deficient keratinocytes show also increased migratory behaviour in wound healing assays, but 
plectin-deficient fibroblasts do not (Andra et al., 1998). Such increased migratory properties are 
also observed in integrin β4-deficient keratinocytes (Geuijen and Sonnenberg, 2002). 
Plectin can interact with actin, and microtubules, but plectin’s role in these processes is not clear. 
Plectin-deficient cells favour the formation of actin stress fibers, and reduce microtubule 
dynamics (Wiche and Winter, 2011). In signalling plectin can affect the activity of Erk1/2, c-Src, 
and PKCδ (Osmanagic-Myers et al., 2006), Fer (Lunter and Wiche, 2002), and it can also bind to 
RACK1 affecting PKC signalling pathways (Osmanagic-Myers and Wiche, 2004). 
 
1.4.2.3. Other components of hemidesmosomes 
Bullous pemphigoid antigen 1 (BP230, BPAG1e) is a member of the plakin family that is 
capable of binding to keratins by its C-terminal region. The plakin domain of BPAG1e interacts 
with BPAG2 and integrin β4 in hemidesmosomes (Koster et al., 2003). Interestingly, BPAG1 
deficient mice show defects not in epithelia, where hemidesmosomes are found, but in nervous 
system. These animals exhibit furthermore muscle weakness (Brown et al., 1995). At least four 
different isoforms of BPAG1 exist that differ in the N-terminal region and in the ability to bind 
actin and microtubules. BPAG1e is expressed only in epithelia, BPAG1a in neuronal system, and 
BPAG1b in muscle (Jefferson et al., 2006; Lin et al., 2005; Sonnenberg and Liem, 2007). 
Bullous pemphigoid antigen 2 (BP180, BPAG2, type XVII collagen, COL17) is a 
transmembrane protein in type I hemidesmosomes that interacts with BPAG1 (Borradori et al., 
1998), and integrin β4 (Borradori et al., 1997). There is evidence that BP180 binds to laminin-
332 (Reddy et al., 1998; Van den Bergh et al., 2011), and participates in adhesion to collagen IV 
(Qiao et al., 2009). 
CD151 is a member of tetraspanin family of proteins and it binds strongly to integrin α3β1 in 
focal adhesions (Kazarov et al., 2002; Yauch et al., 1998) and weaker to integrin α6β4 in type I 
hemidesmosomes (Sterk et al., 2000). It also interacts with integrin α6β1 and α7β1 (Sterk et al., 
2002). CD151 is involved in cell adhesion (Fitter et al., 1999),  polarization (Yanez-Mo et al., 
2001), and wound healing (Penas et al., 2000). The most studies in recent years have 
concentrated on CD151 role in cancer development [for review see (Sadej et al., 2014)]. 
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1.5. Epidermal growth factor signalling 
 
1.5.1. Epidermal growth factor (EGF) 
The Nobel Prize in Physiology or Medicine 1986 was awarded jointly to Stanley Cohen and Rita 
Levi-Montalcini for their discoveries of growth factors, one of them being epidermal growth 
factor (EGF). EGF itself is a single polypeptide containing 53 amino acids with a molecular 
mass of 6.1 kDa (Taylor et al., 1972). The name EGF refers to its stimulatory effect on epidermal 
proliferation (Cohen and Elliott, 1963), which was also recognised later in cell culture 
(Hollenberg and Cuatrecasas, 1973). Otherwise, EGF induces early responses in cells, which are 
related to changes in cytoskeleton and cell adhesion, and are described in more detail here. 
The most noticeable direct responses of cells to EGF are the formation of ruffles and shape 
changes (Boonstra et al., 1987; Chinkers et al., 1979). Ruffling is caused by actin polymerisation 
(Rijken et al., 1991) in a Ras pathway-dependent manner (Bar-Sagi and Feramisco, 1986), in 
particular by the Rho family of GTPases (Hall, 1992). Furthermore, the binding of PI-3K 
(phosphatidylinositol 3’-kinase) to the PDGF (platelet-derived growth factor) receptor is 
necessary for EGF induced cell ruffling (Wennstrom et al., 1994), and the activation of PI-3K is 
essential for EGF-induced cell migration in breast cancer cells (Price et al., 1999). Exposure of 
MTLn3 adenocarcinoma cells to an EGF gradient leads to extension of lamellipodia toward the 
source of EGF and induces migration in this direction (Condeelis et al., 2001). An exposure of 
cells to EGF without a gradient induces the extension of lamellipodia in different directions, but 
does not lead to directed migration (Lichtner et al., 1993; Segall et al., 1996). The formation of 
lamellipodia at the leading edge during this process is F-actin dependent (Chan et al., 1998), and 
similar to cell ruffling, dependent on PI-3K (Hill et al., 2000). The PI-3K is activated 
downstream of EGFR by p85α (Domchek et al., 1992) or by Ras (Ong et al., 2001). The Rho 
family GTPase Rac is activated in a PI-3K-dependent manner by Ras (Rodriguez-Viciana et al., 
1996). Rac activity induces lamellipodia formation (Allen et al., 1997) by control of actin 
polymerisation through WAVE2, which binds to Arp2/3 (Takenawa and Miki, 2001). 
Another mechanism for the induction of cell migration in response to EGF is the activation of 
ERK/MAPK (extracellular signal-regulated kinase / mitogen-activated protein kinase) signalling 
pathway. This occurs by the cascade: EGF receptor  Ras  Raf-1  MEK-1/2  ERK-1/2 
[for review see (Seger and Krebs, 1995)]. The downstream substrates of ERK signalling, MLCK 
(myosin light chain kinase), protease calpain, and FAK (focal adhesion kinase) are important for 
cell migration (Huang et al., 2004). MLCK activation is involved in focal adhesion turnover and 
protrusion formation at the leading edge of migrating cells (Totsukawa et al., 2004; Webb et al., 
2004). Calpain proteases are responsible for focal adhesion disassembly necessary for cell 
migration (Cuevas et al., 2003; Dourdin et al., 2001; Glading et al., 2004). The family member 
m-calpain is targeted to focal adhesions upon binding to activated FAK in a Src-dependent way 
(Carragher et al., 2003). FAK and paxillin signalling are described in more detail in chapter 
1.6.1. Alternatively, EGFR was described to activate ERK signalling by activation of Src (Ren et 
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al., 2004). The described pathways involved in cell migration are summarised in a simplified 
scheme in Fig. 1-6. 
 
Fig. 1-6: Epidermal growth factor (EGF) mediated signalling involved in cell migration. 
The schema shows selected signal transduction proteins in blue colour, involved in cell migration, that are activated 
in response to EGF binding to EGFR (epidermal growth factor receptor). These signalling proteins induce 
morphological cell shape changes necessary for cell migration as shown in brown colour.  ERK (extracellular 
signal-regulated kinase), FAK (focal adhesion kinase), MLCK (myosin light chain kinase), PI-3K 
(phosphatidylinositol 3’-kinase), and Src (sarcoma kinase). The other abbreviations are commonly used names. 
MEK-1 is also known as MAPK kinase 1, and MEK-2 as Erk kinase 1.  
 
1.5.2. Epidermal growth factor receptor (EGFR) 
The ErbB family of receptor tyrosine kinases include four family members. The most prominent 
member is the EGFR (also known as ErbB1, c-erbB-1, HER, HER-1, or EGF receptor). The 
ErbB receptors, with exception of Erb2, are activated by at least ten specific ligands. In this 
context ligand binding leads to dimerization of the receptors with the same Erb family member 
or other Erb-receptors. The subunit composition of the formed dimer is important for the induced 
signalling pathways (Jones et al., 1999), the variations were also reviewed in (Yarden and 
Sliwkowski, 2001). 
The following summary will concentrate on EGFR (ErbB1) because for its specificity toward 
EGF binding, which is not the main ligand for other ErbB receptors (Jones et al., 1999). Besides 
EGF, the EGFR can be activated by transforming growth factor-α (TGFα), heparin-binding 
EGF-like growth factor (HB-EGF), amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), 
and epigen [for review see (Dreux et al., 2006; Harris et al., 2003)]. EGFR is overexpressed in 
different tumour cell lines, especially in A431 cells where it constitutes nearly 0.15% of the total 
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cell protein (Stoscheck and Carpenter, 1984a) with approximately 2.6 x 106 molecules (Haigler 
et al., 1978). In comparison, in fibroblasts the receptor constitutes approximately 0.0035% of 
total cell protein (Stoscheck and Carpenter, 1984b). EGFR was first purified from A431 cells 
(Cohen et al., 1982). The complete receptor is composed of 1186 amino acid residues and 
approximately 40 kDa N-linked oligosaccharide resulting in a molecular mass of approximately 
170 kDa (Carpenter and Cohen, 1990).  
EGF-induced dimerization of the receptor leads to autophosphorylation of tyrosine residues in 
the c-terminal tail segment which are necessary for binding of SH2 (Src homology 2) or PTB 
(phosphotyrosine-binding) domains of potential substrates in process of signal transduction 
(Ferguson et al., 2003; Schlessinger and Ullrich, 1992; Zhang et al., 2006). Interestingly, the 
activation leads to rapid internalization and inactivation of bound EGF (Carpenter and Cohen, 
1976). In this process the receptor is degraded (Stoscheck and Carpenter, 1984b) or recycled 
back to the plasma membrane (Chi et al., 2011; Gui et al., 2012; Longva et al., 2002; Sorkin et 
al., 1991).  
EGFR can bind to F-actin without additional linkers, but not to actin stress fibres, microtubules 
or intermediate filaments (den Hartigh et al., 1992; van Bergen en Henegouwen et al., 1992).  
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1.6. Src and FAK signalling 
1.6.1. Focal adhesion kinase (FAK) mediated signalling 
The focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that is localised at focal 
adhesions (Schaller et al., 1992). Proline-rich kinase 2 (Pyk2) is the only other member of the 
FAK family. Pyk2 differs in its regulatory properties but is involved in the same pathways as 
FAK, and can be affected by the same inhibitors. 
The phosphorylation of FAK on Y397 is needed for its catalytic activity. It can occur upon 
integrin activation, for example by binding to integrin α5β1 (Shi and Boettiger, 2003) or by 
growth factor signalling as described for EGF in chapter 1.5.1. The phosphorylation of FAK 
Y397 can be performed by Src family of kinases (Calalb et al., 1995; Schaller et al., 1994) or by 
intrinsic autophosphorylation (Leu and Maa, 2002). In general, phosphorylated Y397 is a 
docking site for SH2 domain-containing proteins like Src family kinases (Schaller et al., 1994) or 
PI-3K (Chen and Guan, 1994).  
The knock down of Pyk2 in macrophages leads to impaired polarization, membrane ruffling, and 
chemotaxis (Okigaki et al., 2003). Conditional knock down of FAK in macrophages on the other 
hand leads to increased protrusive activity, altered adhesion dynamics, impaired chemotaxis, and 
inability to form lamellipodia necessary for directed cell movement. Interestingly, additional loss 
of Pyk2 has no further effects on cell migration, indicating that both kinases control migration 
through the same pathways (Owen et al., 2007). FAK-deficient fibroblasts have reduced 
migratory behaviour and form enlarged focal adhesions (Ilic et al., 1995). In fibroblasts with 
downregulated FAK the disassembly of focal adhesion at the trailing-edge is impaired upon 
induction of migration (Iwanicki et al., 2008). This effect can be compensated by Pyk2. 
Otherwise knockdown of Pyk2 and FAK in fibroblasts dramatically impairs tail retraction 
necessary for migration (Lim et al., 2008). In general, FAK coordinates formation of 
lamellipodia (Tilghman et al., 2005) and the assembly and disassembly of focal adhesions during 
migration (Webb et al., 2004). 
The role of FAK and Pyk2 in regulation of Rho signalling, responsible for cell migration, is 
controversial. The absence of FAK in fibroblasts increases activation of Rho (Ren et al., 2000) 
and in macrophages the downstream Rho effector Rac (Owen et al., 2007). The opposite was 
reported for absence of Pyk2 in macrophages where Rho activation in response to chemokines 
was impaired (Okigaki et al., 2003). Interestingly, in osteoclasts the absence of Pyk2 leads to 
increased activity of Rho (Gil-Henn et al., 2007). These findings indicate that the role of Pyk2 in 
control of Rho signalling is cell type- and/or signal-dependent. It is known that different proteins 
are used by FAK and Pyk2 to activate or inhibit Rho signalling [for review see (Schaller, 2010)]. 
One of these proteins downstream of FAK and Src is paxillin kinase linker (PKL/Git2)(Yu et al., 
2009) which targets β-pix to focal adhesions by binding to paxillin (Turner et al., 1999). This is 
of interest because β-pix recruits Rac1 to focal adhesions (Chang et al., 2007) indicating a role 
for migration polarity in response to ERK signalling (Yu et al., 2009). In cancer cells FAK was 
described necessary for recognition of matrix stiffness and invasion into soft matrix by 
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invadopodia formation (Alexander et al., 2008). FAK also plays a role in disassembly of focal 
adhesions in a microtubule-dependent way. The recruitment of Grb2 and dynamin to FAK is 
necessary for this process (Ezratty et al., 2005). Another mechanism of FAK to induce focal 
adhesion disassembly is the recruitment of the protease calpain. This occurs in the ERK/MAPK 
signalling dependent way (Carragher et al., 2003). Furthermore, FAK can directly bind to Arp2/3 
complex that regulates actin polymerisation. When this linkage is prevented, cell spreading and 
lamellipodia formation is reduced. The Arp2/3 complex is released after activation of FAK 
(Serrels et al., 2007). 
 
1.6.2. Src 
Src (c-Src) belongs to the family of Src kinases which is composed of eleven different members 
in Homo sapiens (Manning et al., 2002). Activation of Src is induced by intrinsic 
autophosphorylation of Y418 in humans and Y416 in chicken (Feder and Bishop, 1990). Src is 
activated by EGFR, as described in 1.5.1, which leads to activation of ERK signalling. Another 
mechanism for activation is the binding of Src to FAK that is phosphorylated on Y397. This 
binding leads to full activation of FAK by phosphorylation of Y576 and Y577 within the 
activation loop and Y861 and Y925 within the C-terminal domain [for review see (Mitra and 
Schlaepfer, 2006)]. More activation mechanisms for Src as binding to integrin receptors or 
downstream of growth factor receptors were reviewed by  (Thomas and Brugge, 1997). 
The roles of Src in cell migration are related to activation of FAK signalling described in the 
previous chapter and as downstream effector of EGF signalling described in chapter 1.5.1. 
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1.7. Aim of the thesis 
In previous studies advanced quantitative methods were unavailable to measure the movement, 
turnover, and structural complexity of intermediate filament networks. This made the 
identification of factors responsible for intermediate filament dynamics problematic. The goal of 
this thesis was the development of quantitative methods and assays to measure dynamic 
properties of keratin networks at subcellular resolution in order to gain new insights about 
keratin network regulation. To this end, standardised conditions and microscopic procedures had 
to be established for reliable and reproducible monitoring of keratin filament networks. To 
analyse the resulting data sets, optimised computational image analysis methods had to be 
developed in cooperation with the Lehrstuhl für Bildverarbeitung of RWTH Aachen University. 
As proof-of-principle, these novel tools and methods should be applied for the precise 
quantitative determination of the influence of factors that modulate keratin dynamics. The search 
for suitable paradigms was based on previous hypotheses, namely: 
1. Hemidesmosome-like structures stabilise the keratin network. 
2. The keratin cytoskeleton becomes less dynamic at increased culture times. 
3. Growth factors stimulate keratin dynamics. 
4. Focal adhesions favour keratin filament assembly.  
5. Plectin family of cytolinkers attach keratins to other cytoskeletal filaments and cellular 
structures.
Material and Methods 
 
  33 
2. Materials and methods 
 
2.1. Materials 
2.1.1. Chemicals 
Tab. 2-1: Chemicals (A-K). 
Name Source of supply 
2-Mercaptoethanol Carl Roth, Karlsruhe, Germany 
Accutase PAA Laboratories, Pasching, Austria 
Acetic acid Carl Roth, Karlsruhe, Germany 
Acetone Carl Roth, Karlsruhe, Germany 
Acrylamide/bisacrylamide 40%, mixing ratio 
29:1 Carl Roth, Karlsruhe, Germany 
Agarose, high gelling Sigma-Aldrich, St. Louis, MO, USA 
Ammonium persulfate (APS) Sigma-Aldrich, St. Louis, MO, USA 
Ammonium hydroxide 5N Sigma-Aldrich, St. Louis, MO, USA 
Agar-Agar, Kobe I Carl Roth, Karlsruhe, Germany 
Tryptone Carl Roth, Karlsruhe, Germany 
Boric acid Carl Roth, Karlsruhe, Germany 
Bovine serum albumin - Fraction V (BSA) Sigma-Aldrich, St. Louis, MO, USA 
Bromophenol blue SERVA Electrophoresis GmbH, Heidelberg, Germany 
CaCl2 Merck KGaA, Darmstad, Germany 
Chloroform Carl Roth, Karlsruhe, Germany 
Coomassie Brilliant Blue R-250 SERVA Electrophoresis GmbH, Heidelberg, Germany 
Copper(II) sulfate Merck KGaA, Darmstad, Germany 
Dimethyl sulfoxide (DMSO) Merck KGaA, Darmstad, Germany 
Dithiothreitol (DTT) Merck KGaA, Darmstad, Germany 
DAPI (4',6-diamidino-2-phenylindole) Hoffmann-La Roche, Basel, Switzerland 
Essential amino acids 50X (Gibco®) Life Technologies, Carlsbad, CA, USA 
Ethanol Carl Roth, Karlsruhe, Germany 
Ethidium bromide Carl Roth, Karlsruhe, Germany 
Ethylene glycol tetraacetic acid (EGTA) Sigma-Aldrich, St. Louis, MO, USA 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, St. Louis, MO, USA 
Formaldehyde Carl Roth, Karlsruhe, Germany 
Glycerol (99.5%) Carl Roth, Karlsruhe, Germany 
Glycine Biomol GmbH, Hamburg, Germany 
Hydrochloric acid 1N Carl Roth, Karlsruhe, Germany 
Hydrochloric acid 37% Carl Roth, Karlsruhe, Germany 
Isopropanol Carl Roth, Karlsruhe, Germany 
jetPEI® + NaCl PEQLAB Biotechnologie GmbH, Erlangen, Germany 
KCl SERVA Electrophoresis GmbH, Heidelberg, Germany 
Kodak AL4 (fixer) Eastman Kodak Company, Rochester, NY, USA 
Kodak LX24 (developer) Eastman Kodak Company, Rochester, NY, USA 
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Tab. 2-2: Chemicals (L-Y). 
Name Source of supply 
L-alanyl-L-glutamine 100X (GlutaMAX™) Life Technologies, Carlsbad, CA, USA 
L-glutamine PAA Laboratories, Pasching, Austria 
Lipofectamine 2000 Life Technologies, Carlsbad, CA, USA 
Methanol Carl Roth, Karlsruhe, Germany 
MnCl2 Sigma-Aldrich, St. Louis, MO, USA 
MOPS (3-(N-morpholino)propansulfonic acid) SERVA Electrophoresis GmbH, Heidelberg, Germany 
Mowiol Carl Roth, Karlsruhe, Germany 
N-acetyl-l-cysteine, ≥ 99% (TLC), powder Sigma-Aldrich, St. Louis, MO, USA 
NaCl Carl Roth, Karlsruhe, Germany 
NaOH Carl Roth, Karlsruhe, Germany 
Non-essential amino acids 100X (Gibco®) Life Technologies, Carlsbad, CA, USA 
Nonidet P-40 (NP-40) Sigma-Aldrich, St. Louis, MO, USA 
Phenylmethylsulfonyl fluoride (PMSF) Merck KGaA, Darmstad, Germany 
Polybrene® (hexadimethrine bromide) Sigma-Aldrich, St. Louis, MO, USA 
Ponceau S Sigma-Aldrich, St. Louis, MO, USA 
Powdered milk, blotting grade, low fat Carl Roth, Karlsruhe, Germany 
RbCl2 Sigma-Aldrich, St. Louis, MO, USA 
Roti®-Block Blocking Reagent Carl Roth, Karlsruhe, Germany 
Sodium bicarbonate Carl Roth, Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) SERVA Electrophoresis GmbH, Heidelberg, Germany 
Sucrose Sigma-Aldrich, St. Louis, MO, USA 
Tetramethylethylenediamine (TEMED) Carl Roth, Karlsruhe, Germany 
Tris(hydroxymethyl)aminomethane (Tris base) Biomol GmbH, Hamburg, Germany 
Tris(hydroxymethyl)aminomethane 
hydrochloride (Tris HCl) Life Technologies, Carlsbad, CA, USA 
Triton-X 100 Sigma-Aldrich, St. Louis, MO, USA 
Trypan blue Sigma-Aldrich, St. Louis, MO, USA 
Trypsin, powder 
Biochrom, belongs to Merck KGaA, Darmstad, 
Germany 
Tween-20 Merck KGaA, Darmstad, Germany 
PBS, without Ca2+/Mg2+, powder 
Biochrom, belongs to Merck KGaA, Darmstad, 
Germany 
PBS, without Ca2+/Mg2+ Sigma-Aldrich, St. Louis, MO, USA 
Xylene cyanol Sigma-Aldrich, St. Louis, MO, USA 
Yeast extract Carl Roth, Karlsruhe, Germany 
 
2.1.2. Molecular ladders 
Tab. 2-3: Molecular ladders. 
Name Source of supply 
GeneRuler 1 kb DNA Ladder (SM0311) Thermo Fisher Scientific, Waltham, MA, USA 
MassRuler DNA Ladder Mix (SM0403) Thermo Fisher Scientific, Waltham, MA, USA 
PageRuler Protein Ladder (SM0661) Thermo Fisher Scientific, Waltham, MA, USA 
ProSieve QuadColor Protein Marker Lonza, Basel, Switzerland 
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2.1.3. Kits 
Tab. 2-4: Kits. 
Name Source of supply 
AceGlow™ Chemiluminescence Substrate PEQLAB Biotechnologie GmbH, Erlangen, Germany 
Amersham ECL WB analysis system GE Healthcare, Fairfield, CT, USA 
Quick Start Bradford Protein Assay Bio-Rad, Hercules, CA, USA 
DNA Clean & Concentrato-5 Zymo Research Corporation, Irvina, CA, USA 
Lenti-X™ GoStix™ Clontech Laboratories Inc., Mountain View, CA, USA 
Lenti-X™ HTX Packaging System Clontech Laboratories Inc., Mountain View, CA, USA 
QIAfilter Plasmid Maxi Kit Qiagen, Venlo, Netherlands 
QIAprep Spin Miniprep Kit Qiagen, Venlo, Netherlands 
QIAquick PCR Purification Kit Qiagen, Venlo, Netherlands 
QuickLyse Miniprep Kit Qiagen, Venlo, Netherlands 
Venor®GeM Mycoplasma Detection kit Minerva Biolabs GmbH, Berlin, Germany  
 
2.1.4. Enzymes 
Tab. 2-5: Enzymes. 
Name Source of supply 
Antarctic Phosphatase New England Biolabs, Ipswich, MA, USA 
BamHI New England Biolabs, Ipswich, MA, USA 
BamHI HF New England Biolabs, Ipswich, MA, USA 
DpnI New England Biolabs, Ipswich, MA, USA 
EcoRI  New England Biolabs, Ipswich, MA, USA 
EcoRI HF New England Biolabs, Ipswich, MA, USA 
EcoRV Hoffmann-La Roche, Basel, Switzerland 
EcoRV HF New England Biolabs, Ipswich, MA, USA 
Hind III New England Biolabs, Ipswich, MA, USA 
KpnI New England Biolabs, Ipswich, MA, USA 
NdeI Thermo Fisher Scientific, Waltham, MA, USA 
NdeI New England Biolabs, Ipswich, MA, USA 
NheI Thermo Fisher Scientific, Waltham, MA, USA 
NheI HF New England Biolabs, Ipswich, MA, USA 
PfuUltra II Fusion HS DNA Polymerase Agilent Technologies, Santa Clara, CA, USA 
Phusion® High-Fidelity DNA Polymerase Thermo Fisher Scientific, Waltham, MA, USA 
PNK Thermo Fisher Scientific, Waltham, MA, USA 
SacI Thermo Fisher Scientific, Waltham, MA, USA 
SalI Thermo Fisher Scientific, Waltham, MA, USA 
SalI Hoffmann-La Roche, Basel, Switzerland 
T4 DNA Ligase Thermo Fisher Scientific, Waltham, MA, USA 
XbaI New England Biolabs, Ipswich, MA, USA 
XhoI Thermo Fisher Scientific, Waltham, MA, USA 
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2.1.5. Inhibitors and growth factors 
Tab. 2-6: Inhibitors and growth factors. 
Name Source of supply 
Cetuximab Merck Serono GmbH, Darmstadt, Germany 
Epidermal growth factor (EGF) Sigma-Aldrich, St. Louis, MO, USA 
FAK Inhibitor 14 (FAK-14) Tocris Bioscience, Bristol, UK 
Fetal Calf Serum (FCS) Invitrogen GmbH, Karlsruhe, Germany 
Fetal Calf Serum (FCS) Gold 
PAA Laboratories, belongs to General Electric, 
Fairfield, CT, USA 
Mitomycin C Carl Roth, Karlsruhe, Germany 
PF-431,396 Tocris Bioscience, Bristol, UK 
PF-562,271 Pfizer Inc., New York City, NY, USA 
PF-573,228  Tocris Bioscience, Bristol, UK 
SKI-606 (Bosutinib) Tocris Bioscience, Bristol, UK 
 
2.1.6. Cell culture media, matrix proteins, and antibiotics 
Tab. 2-7: Cell culture media, matrix proteins, and antibiotics. 
Name Source of supply 
Ampicillin sodium salt Carl Roth, Karlsruhe, Germany 
Antibody Stabilizer, based on PBS CANDOR Bioscience GmbH, Wangen, Germany 
Aqua B. Braun (distilled H2O) B. Braun Melsungen AG, Melsungen, Germany 
Collagen I, bovine BD Biosciences, San Jose, CA, USA 
Collagen IV, mouse, Cultrex® Trevigen Inc., Gaithersburg, MD, USA 
Dulbecco's Modified Eagle Medium (DMEM), 
high glucose 
PAA Laboratories, belongs to General Electric, 
Fairfield, CT, USA 
Dulbecco's Modified Eagle Medium (DMEM), 
high glucose, no glutamine, no phenol red 
(Gibco) Life Technologies, Carlsbad, CA, USA 
Fibronectin Invitrogen GmbH, Karlsruhe, Germany 
Hank's Balanced Salt Solution (HBSS)(Gibco) Life Technologies, Carlsbad, CA, USA 
HEPES 1M (Gibco) Life Technologies, Carlsbad, CA, USA 
Kanamycin sulphate Carl Roth, Karlsruhe, Germany 
Laminin I (Laminin-111), mouse, Cultrex® Trevigen Inc., Gaithersburg, MD, USA 
Minimum Essential Medium (MEM) 
PAA Laboratories, belongs to General Electric, 
Fairfield, CT, USA 
Opti-MEM Life Technologies, Carlsbad, CA, USA 
Penicillin-Streptomycin (Gibco®) Life Technologies, Carlsbad, CA, USA 
Plasmocin InvivoGen Inc., San Diego, CA, USA 
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2.1.7. Antibodies 
Tab. 2-8: Monoclonal primary antibodies. 
Antigen Clone 
Specie
s Lot nr. ICC WB Source of supply 
EGFR D38B1 
rabbit 
3 
- 
1:10000 
Cell Signalling Technology, Inc., 
Danvers, MA, USA 
EGFR pY1068  D7A5 
rabbit 
0005 
- 
1:50000 
Cell Signalling Technology, Inc., 
Danvers, MA, USA 
FAK 4.47 
mouse 
1970370 - 1:7500 
Merck Millipore, Darmstad, 
Germany 
FAK pY397 
141-9 rabbit 
4891961 - 1:7500 
Life Technologies, Carlsbad, CA, 
USA 
GAPDH 9484 mouse GR9686-1 - 1:2000 Abcam, Cambridge, MA, USA 
Integrin ß5 D24A5 
rabbit 
0001 1:200 1:1000 
Cell Signalling Technology, Inc., 
Danvers, MA, USA 
Integrin α2 2/CD49b 
mouse 
81934 
- 1:500 
BD Biosciences, San Jose, CA, 
USA 
Integrin α3 42/CD49c 
mouse 
78973 
- 1:300 
BD Biosciences, San Jose, CA, 
USA 
Integrin α5 1/CD49e 
mouse 
81386 
- 
1:500 
BD Biosciences, San Jose, CA, 
USA 
Integrin α6  GoH3 
rat 
31 1:100 - 
Beckman Coulter GmbH, 
Krefeld, Germany 
Integrin β1 18/CD29 
mouse 
78008 
- 
1:500 
BD Biosciences, San Jose, CA, 
USA 
Integrin β4 7/CD104 
mouse 
78968 
- 
1:500 
BD Biosciences, San Jose, CA, 
USA 
Integrin β4 439-9B 
rat 
45416 
1:200 - 
BD Pharmingen, San Diego, CA, 
USA 
Keratin 14 LL001 
mouse 
#D1713 
- 1:1000 
Santa Cruz Biotechnology, Inc., 
Dallas, TX, USA 
Keratin 17 D73C7 
rabbit 
0001 
- 1:1000 
Cell Signalling Technology, Inc., 
Danvers, MA, USA 
Keratin 8 - rat - 1:10 1:10 1(Brulet et al., 1980) 
Keratin 8 pS431 5B3 mouse - 1:150 1:3000 2(Ku and Omary, 1997) 
Keratin 8 pS73 LJ4 mouse - 1:100 1:2000 2(Liao et al., 1997) 
Keratins 8/18 L2A1 mouse - - 1:3000 2(Chou et al., 1993) 
Pan-Keratin C11 
mouse 
1 1:400 
- 
Cell Signalling Technology, Inc., 
Danvers, MA, USA 
Paxillin 
349/paxilli
n mouse  81566 
1:100 1:7500 
BD Biosciences, San Jose, CA, 
USA 
Plectin/HD1 - 
mouse 
- 1:200 1:2000 3(Hieda et al., 1992) 
Talin 8D4 
mouse 
 083M4773 1:100 
- 
Sigma-Aldrich, St. Louis, MO, 
USA 
1The keratin 8 rat antibodies were produced in TROMA-I cells from “The Developmental 
Studies Hybridoma Bank”, Iowa, USA. 2Keratin 8 pS431, keratin 8 pS73, and keratins 8/10 
antibodies were provided by Prof. Bishr Omary. 3The plectin/HD1 antibodies were provided by 
Prof. Katsushi Owaribe. 
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Tab. 2-9: Polyclonal primary antibodies. 
Antigen Species Lot nr. ICC WB Source of supply 
FAK rabbit 0101 - 1:3000 MyBioSource, San Diego, CA, USA 
FAK pY397 rabbit 642568A - 1:3000 Life Technologies, Carlsbad, CA, USA 
Keratin 5 
guinea pig 
302041 
- 
1:5000 PROGEN Biotechnik GmbH, Heidelberg, Germany 
Pan-Keratin rabbit ON 2011 1:100 - PROGEN Biotechnik GmbH, Heidelberg, Germany 
Pan-Keratin guinea pig 202241 1:200 - PROGEN Biotechnik GmbH, Heidelberg, Germany 
Plectin 
guinea pig 
103141 / 
309241 
1:400 1:3500 PROGEN Biotechnik GmbH, Heidelberg, Germany 
Plectin (P1) 
guinea pig - 
1:100 
- 
1(Schroder et al., 1999) 
Plectin (P2) 
guinea pig - 
1:100 
- 
1(Schroder et al., 1999) 
Src pY418 
rabbit - - 
1:500 Life Technologies, Carlsbad, CA, USA 
Vimentin guinea pig 303081 1:100 1:1000 PROGEN Biotechnik GmbH, Heidelberg, Germany 
β-Actin 
rabbit 
057K480
3 
1:200 1:2000 Sigma-Aldrich, St. Louis, MO, USA 
1Plectin antibodies P1 and P2 were provided by Prof. Dr. Harald Herrmann. 
Tab. 2-10: Secondary antibodies. 
Antigen Conjugate Species Conc. Source of supply 
Guinea Pig IgG ( H+L) Cy3 goat 1:400 Dianova GmbH, Hamburg, Germany 
Guinea Pig IgG ( H+L) Alexa 555 goat 1:500 Life Technologies, Carlsbad, CA, USA 
Guinea Pig IgG ( H+L) Alexa 633 goat 1:200 Life Technologies, Carlsbad, CA, USA 
Guinea Pig IgG ( H+L) Alexa 488 goat 1:1000 Life Technologies, Carlsbad, CA, USA 
Guinea Pig IgG ( H+L) DyLight 488 donkey 1:500 Dianova GmbH, Hamburg, Germany 
Guinea Pig IgG ( H+L) HRP goat 1:5000 Dianova GmbH, Hamburg, Germany 
Guinea Pig IgG (H+L) Alexa 647 goat 1:200 Life Technologies, Carlsbad, CA, USA 
Mouse IgG ( H+L) Cy3 goat 1:500 
BIOTREND Chemicals, LLC, Destin, FL, 
USA 
Mouse IgG ( H+L) Alexa 647 goat 1:200 Life Technologies, Carlsbad, CA, USA 
Mouse IgG ( H+L) Alexa 555 goat 1:500 Life Technologies, Carlsbad, CA, USA 
Mouse IgG ( H+L) HRP goat 1:20000 Dianova GmbH, Hamburg, Germany 
Mouse IgG (H+L) Alexa 488 goat 1:1000 Life Technologies, Carlsbad, CA, USA 
Mouse IgG (H+L) Alexa 568 goat 1:500 Life Technologies, Carlsbad, CA, USA 
Mouse IgG (H+L) Alexa 633 goat 1:200 Life Technologies, Carlsbad, CA, USA 
Rabbit IgG ( H+L) Alexa 647 goat 1:200 Life Technologies, Carlsbad, CA, USA 
Rabbit IgG ( H+L) HRP goat 1:5000 Dianova GmbH, Hamburg, Germany 
Rabbit IgG (H+L) Alexa 488 goat 1:1000 Life Technologies, Carlsbad, CA, USA 
Rabbit IgG (H+L) Alexa 633 goat 1:200 Life Technologies, Carlsbad, CA, USA 
Rabbit IgG (H+L) Cy3 donkey 1:500 Dianova GmbH, Hamburg, Germany 
Rat IgG ( H+L) HRP goat 1:5000 Dianova GmbH, Hamburg, Germany 
Rat IgG (H+L) Alexa 555 goat 1:500 Life Technologies, Carlsbad, CA, USA 
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2.1.8. Labware 
Tab. 2-11: Labware. 
Name Source of supply 
10 ml serological pipette, sterile Corning Incorporated, Corning, NY, USA 
100 µl Bevelled, Filter Tip (Sterile) STARLAB INTERNATIONAL GmbH, Hamburg, Germany 
1000 µl, Filter Tip (Sterile) STARLAB INTERNATIONAL GmbH, Hamburg, Germany 
2 ml serological pipette, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
20 µl XL Graduated Filter Tip (Sterile) STARLAB INTERNATIONAL GmbH, Hamburg, Germany 
200 µl Graduated, Filter Tip (Sterile) STARLAB INTERNATIONAL GmbH, Hamburg, Germany 
25 ml serological pipette, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
5 ml serological pipette, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
50 ml Centrifuge Tubes with Screw Caps VWR International, Radnor, PA, USA 
96 well Tissue culture plates SPL Life Sciences Co., Ltd., Korea 
Amersham Hyperfilm ECL  GE Healthcare, Buckinghamshire, UK 
Bottle-Top-Filter, ZA92, 0.22 µm (500 ml) A. Hartenstein Laborbedarf GmbH, Würzburg, Germany 
CELLSTAR culture dishes, 100x20 mm Greiner Bio-One GmbH, Frickenhausen, Germany 
CELLSTAR culture dishes, 60x15 mm Greiner Bio-One GmbH, Frickenhausen, Germany 
Cover slips, d=24 mm, #1.5 Gerhard Menzel GmbH, Braunschweig, Germany 
CRYO.S, PP, with screw cap, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
cuvettes, 50-2000 µl Eppendorf AG, Hamburg, Germany 
Easy-Grip Cell Culture Dish, 35x10 mm Becton Dickinson Labware, Franklin Lakes, NJ, USA 
epT.I.P.S. Standard/Bulk 100-5000 µl Eppendorf AG, Hamburg, Germany 
EU Classic Thin-wall 8-tube Stripe 0.2 ml BIOplastics, Landgraaf, The Netherlands 
EU Optical Semi-Domed Cap BIOplastics, Landgraaf, The Netherlands 
Filter-Tips, 1000 µl (4x32) Qiagen, Venlo, Netherlands 
Glass Pasteur Pipettes BRAND GmbH, Wertheim, Germany 
Glass bottom dishes, d=14 mm MatTek Corporation, Ashland, MA, USA 
Imaging Plates 96 OG Zell-Kontakt GmbH, Nörten-Hardenberg, Germany 
Immobilon-P Transfer Membrane Merck Millipore, Darmstad, Germany 
Micro tube 1.5 ml SARSTEDT, Nümbrecht, Germany 
Micro tube 1.5 ml, green SARSTEDT, Nümbrecht, Germany 
Natural-rubber scraper Sigma-Aldrich, St. Louis, MO, USA 
Object slides, 76x26 mm R. Langenbrinck, Emmendingen, Germany 
PARAFILM Pechiney Plastic Packaging, Menasha, WI, USA 
Pipette tip 200 µl, yellow SARSTEDT, Nümbrecht, Germany 
Pipettor tips Standard MIKRO, 0.1-10 µl PP Carl Roth, Karlsruhe, Germany 
SafeSeal micro tube 2 ml, PP SARSTEDT, Nümbrecht, Germany 
tips Crystal-E-0.5-10 µl ratiolab GmbH, Dreieich, Germany 
Tissue culture flasks, 50 ml Becton Dickinson Labware, Franklin Lakes, NJ, USA 
Tube 15 ml, 120x17mm, PP, non-pyrogenic SARSTEDT, Nümbrecht, Germany 
Tube 50 ml, 114x28mm, PP, non-pyrogenic SARSTEDT, Nümbrecht, Germany 
Securline Lab Markers Aspen Surgical, Southbelt Dr. SE, MI, USA 
Syringe filter, 0.45 µm, (surfactant-free) Sigma-Aldrich, St. Louis, MO, USA 
Syringe Filter Unit, 0.22 µm, Millex-GP Merck Millipore, Darmstad, Germany 
Whatman®, Gel Blotting Papers VWR International, Radnor, PA, USA 
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2.1.9. Laboratory equipment 
Tab. 2-12: Cell culture equipment. 
Name Source of supply 
HERACell™ 150i CO2 Incubator Thermo Fisher Scientific, Waltham, MA, USA 
Heraeus™ BB15 CO2 Incubator Thermo Fisher Scientific, Waltham, MA, USA 
Integra VACUBOY® - Vacuum Hand Operator Integra LifeSciences, Plainsboro, NJ, USA 
MSC-Advantage Class II Biological Safety Cabinet Thermo Fisher Scientific, Waltham, MA, USA 
 
Tab. 2-13: Centrifuges. 
Name Source of supply 
Centrifuge 5417C Eppendorf, Hamburg, Germany 
Centrifuge 5417R Eppendorf, Hamburg, Germany 
Centrifuge 5810 Eppendorf, Hamburg, Germany 
Heraeus™ Sepatech Megafuge™ 3.0R Thermo Fisher Scientific, Waltham, MA, USA 
Rotanta 460R Hettich Zentrifugen, Tuttlingen, Germany 
 
Tab. 2-14: Electrophoresis equipment. 
Name Source of supply 
Mini-PROTEAN® 3 Cell System Bio-Rad, Hercules, CA, USA 
Mini-PROTEAN® Tetra Cell System  
(1 mm gel thickness) 
Bio-Rad, Hercules, CA, USA 
PerfectBlue™ Wide Gel System (40-2314) PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
 
Tab. 2-15: Power supplies. 
Name Source of supply 
Biometra Power Pack P25 Biometra GmbH, Göttingen, Germany 
Consort E455 Consort, Turnhout, Belgium 
Electrophoresis Power Supply EPS 3500 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
Electrophoresis Power Supply EPS 3500XL 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
Electrophoresis Power Supply EPS 3501XL 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
PP3000 Programmable High Voltage Power Supply Biometra, Göttingen, Germany 
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Tab. 2-16: Shakers and mixers. 
Shaker and mixer Manufacturer or source 
Biometra OV-4 hybridisation oven Biometra, Göttingen, Germany 
ELMI Intelli-Mixer RM-2l (rotator mixer) ELMI ltd., Riga, Latvia 
GFL 3005 orbital shaker GFL, Burgwedel, Germany 
Heidolph 3002 magnetic stirring hotplate Heidolph Instruments, Schwabach, Germany 
Heidolph Reax 2000 shaker Heidolph Instruments, Schwabach, Germany 
HLC Heating-ThermoMixer MHR 23 DITABIS Digital Biomedical Imaging Systems 
AG, Pforzheim, Germany 
Incubator shaker series Innova® 42 New Brunswick Scientific, belongs to Eppendorf, 
Hamburg, Germany 
MR Hei-Mix L (magnetic stirring hotplate) Heidolph, Schwabach, Germany 
Reverstir RS-8 (magnetic stirring plate) Toyo Kagaku Sangyo Ltd., belongs to Advantec 
Toyo Kaisha Ltd., Tokyo, Japan 
RH basic 2 IKAMAG (magnetic stirring hotplate) IKA-Werke GmbH & Co. KG, Staufen, Germany 
Roller mixer RS-TR05 Phoenix Instruments GmbH, Garbsen, Germany 
SM25 mechanical shaker Edmund Bühler GmbH, Hechingen, Germany 
SW-20C (shaking water bath) JULABO GmbH, Seelbach, Germany 
Techne Dri-Block® Heater DB-1 Bibby Scientific Limited, Staffordshire, UK 
TS-100, Thermo-Shaker Biosan, Riga, Latvia 
Variomag Electronicrührer mono (magnetic stirrer) Thermo Fisher Scientific, Waltham, MA, USA 
 
Tab. 2-17: Spectrometers. 
Name Manufacturer or source 
BioPhotometer plus Eppendorf, Hamburg, Germany 
DU800 Spectrophotometer Beckman Coulter, Brea, CA, USA 
Nanodrop™ 1000 (microvolume spectrometer) Thermo Fisher Scientific, Waltham, MA, USA 
TECAN infinite 200 (microplate reader) Tecan Group Ltd., Männedorf, Switzerland 
 
Tab. 2-18: Immunoblot and gel imaging equipment. 
Name Manufacturer or source 
Fusion-Solo.WL.4M Vilber Lourmat, France 
Kodak photographic step tablet no. 2 Eastman Kodak Company, Rochester, NY, USA 
PowerLook III (flatbed scanner) + UTA III 
Transparency Adapter UMAX, Taiwan 
Quantum ST4 1100/26MX Vilber Lourmat, France 
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Tab. 2-19: Other equipment used. 
Name Manufacturer or source 
Digital Thermometer GMH 3230 GHM-Greisinger, Greisinger, Germany 
Econo Pump EP1 Bio-Rad, Hercules, CA, USA 
Eismaschine B200 
ZIEGRA Eismaschinen GmbH, Isernhagen, 
Germany 
Gene Pulser® II (electroporation system) Bio-Rad, Hercules, CA, USA 
Heraeus® CO2-Auto-Zero (incubator used for 
bacteria) Thermo Fisher Scientific, Waltham, MA, USA 
Moulinex Micro-Chef FM 2515 (microwave oven) Moulinex, belongs to Groupe SEB, Ecully, France 
MultiTemp III (thermostatic circulator) 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
peqSTAR 96 Universal (thermal cycler) 
PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
peqSTAR 96 Universal gradient (thermal cycler) 
PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
pH211 Microprocessor pH Meter Hanna Instruments, Woonsocket, USA 
QIAcube® (robotic station for DNA purification) Qiagen, Venlo, Netherlands 
Spyder 3 Elite Datacolor, Lawrenceville, NJ, USA 
Systec VX-150 autoclave Systec, Wettenberg, Germany 
TFX-20.M (super bright transilluminator) Vilber Lourmat, France 
Vibra Cell VCX 400 (sonicator) + CV26 Probe Sonics & Materials, Inc., Newtown, CT, USA 
Wacom Bamboo Pen & Touch (graphic tablet) Wacom, Kazo, Japan 
Hypercassette™ (autoradiography cassette) GE Healthcare, Buckinghamshire, UK 
 
2.1.10. Microscopes 
Tab. 2-20: Components Zeiss LSM 710 Duo. 
Components Manufacturer or source 
Axio Observer.Z1 Carl Zeiss, Jena, Germany 
Objective Plan-Apochromat 63x / 1.40 Oil DIC 
M27 Carl Zeiss, Jena, Germany 
Laser module LGK 7872 ML8 (Ar: 458, 488, 514 
nm) Carl Zeiss, Jena, Germany 
Laser module LGK 7786 P (HeNe: 543 nm) Carl Zeiss, Jena, Germany 
Laser module LGK 7628-1F (HeNe: 633nm) Carl Zeiss, Jena, Germany 
Laser cassette 405 cw (diode laser 405 nm) Carl Zeiss, Jena, Germany 
Sapphire 488-200 Optically Pumped 
Semiconductor Laser Coherent, Santa Clara, CA, USA 
Compass 215 Diode-Pumped Laser (532 nm) Coherent, Santa Clara, CA, USA 
Definite Focus Carl Zeiss, Jena, Germany 
HXP 120 Compact Light Source Leistungselektronik JENA GmbH, Jena, Germany 
Incubator XL LSM710 S1 Pecon GmbH, Erbach, Germany 
Heating Unit XL S Pecon GmbH, Erbach, Germany 
CO2-Module S Pecon GmbH, Erbach, Germany 
IsoStation Vibration Isolated Workstation Newport Corporation, Irvine, CA, USA 
Zen system 2009 (Software) Carl Zeiss, Jena, Germany 
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Tab. 2-21: Components Zeiss TIRF 3 
Components Manufacturer or source 
Axio Observer.Z1 Carl Zeiss, Jena, Germany 
Definite Focus Carl Zeiss, Jena, Germany 
HXP 120 C Carl Zeiss, Jena, Germany 
Objective: alpha Plan-Apochromat 63x/1,46 Oil 
Korr Carl Zeiss, Jena, Germany 
Objective: alpha Plan-Apochromat 100x/1,46 Oil 
DIC Carl Zeiss, Jena, Germany 
Lasereinheit 405nm/50mW (Dioden Laser) Carl Zeiss, Jena, Germany 
TIRF Multiline Ar-Laser 458/488/514nm (100mW) Carl Zeiss, Jena, Germany 
Lasereinheit 561nm/40mW (Dioden Laser) Carl Zeiss, Jena, Germany 
Filter nr.: 38, 43, 46, 47, 49, 52, 53, 64, 73, 76 Carl Zeiss, Jena, Germany 
Inkubator XLmulti S1 RED LS Carl Zeiss, Jena, Germany 
TempModul S1 Carl Zeiss, Jena, Germany 
CO2 Modul S1 Carl Zeiss, Jena, Germany 
EMCCD Kamera evolve 512 Carl Zeiss, Jena, Germany 
AxioCam MRm Rev. 3 (camera) Carl Zeiss, Jena, Germany 
ZEN system 2011 (software) Carl Zeiss, Jena, Germany 
 
Tab. 2-22: Components Zeiss ApoTome 2. 
Components Manufacturer or source 
Axio Imager.M2 Carl Zeiss, Jena, Germany 
AxioCam MRm (camera) Carl Zeiss, Jena, Germany 
ApoTome.2 Carl Zeiss, Jena, Germany 
HXP 120 C Carl Zeiss, Jena, Germany 
Objective: Plan-Apochromat 63X/1,4 Oil DIC Carl Zeiss, Jena, Germany 
Filters.: 38, 46, 47, 49, 50, 43 Carl Zeiss, Jena, Germany 
 
Tab. 2-23: Components Olympus IX-70S. 
Components Manufacturer or source 
Olympus IX-70-S1F2 Fluorescence Microscope Olympus, Hamburg, Germany 
Olympus/IMAGO (camera) TILL Photonics GmbH, München, Germany 
CoolSNAP MYO CCD camera Photometrics, Tucson, AZ, USA 
Polychrome IV illumination system 
(monochromator) TILL Photonics GmbH, München, Germany 
Objective: planApo 60X/1,40 Oil Ph3 Olympus, Hamburg, Germany 
Objective: UPlanFI 4X/0.13 Olympus, Hamburg, Germany 
VMM-D1 Shutter Driver Vincent Associates, Rochester, NY, USA 
E-662 LVPZT-Amplifier/Servo piezo 
Physik Instrumente (PI) GmbH & Co. KG, 
Karlsruhe, Germany 
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Tab. 2-24: Components Zeiss Axiovert 135. 
Components Manufacturer or source 
Axiovert 135 Carl Zeiss, Jena, Germany 
Objective: LD A-Plan 20X/0.3 Ph1Var1 Carl Zeiss, Jena, Germany 
Objective: A-Plan 10X/0.25 Ph1Var1 Carl Zeiss, Jena, Germany 
Objective: N-Achroplan 2,5X/0,07 Carl Zeiss, Jena, Germany 
Zeiss Auto Arc HBO (light source) Carl Zeiss, Jena, Germany 
 
2.1.11. Bacteria strains 
Tab. 2-25: Bacteria strains. 
Bacteria Genotype Source 
Escherichia coli 
XL1-Blue 
F´::Tn10 proA+B+ lacIq Δ(lacZ)M15/ recA1 endA1 
gyrA96 (NalR) thi hsdR17 (rK– mK+) glnV44 relA1 lac 
Stratagene, La Jolla, 
USA 
Escherichia coli 
GM2163 
F−dam-13::Tn9 (Camr) dcm-6 hsdR2 (rK– mK+) leuB6 hisG4 
thi-1 araC14 lacY1 galK2 galT22 xylA5 mtl-1 rpsL136 (Strr) 
fhuA31 tsx-78 glnV44 mcrA mcrB1 
MBI Fermentas 
GmbH, St. Leon-Rot, 
Germany 
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2.1.12. Primers 
Tab. 2-26: Nucleotide primers. 
Primer Nucleotide sequence (5’3’) 
00-27 CCAGTCATAGCCGAATAGCCTCT 
06-98 CAGTTATCTAGATCCGGTGGATCC 
09-98 CGATGTTTAAACCTCGGACTCAGATCTCGAG 
09-100 GCACTAGTCAAATGTGGTATGGCTGATTATG 
09-101 GCCCGGGGTACCATGGCCTCCTCCGAGGAC 
09-102 CAAATGTGGTATGGCTGATTATG 
09-104 CGAGTCAGCCTTCCACTATG 
09-105 CAGCCCATCCACTAGGAAGG 
09-106 CCTGCATCGACAGCAATGG 
09-107 AGAACCTGAACGAGGTCTAC 
09-108 CAGCACTGGTCGTGGTCATC 
10-31 ATTCAGGATCCATCGCCACCATGGTGAGCAAGGG 
10-39 TCCTCCCTGGAGAAGAGCTA 
10-83 TGACGCAAATGGGCGGTAGG 
10-88 CTTAGCAGAAGCAGCGGCTAAGGAAGCCGCAGCAAAGGAAGCCGCAGCTAAGGCGGCTGCAG 
10-89 
GATCCTGCAGCCGCCTTAGCTGCGGCTTCCTTTGCTGCGGCTTCCTTAGCCGCTGCTTCTGCTA
AGGTAC 
11-001 AAGCTAGGATCCGCCACCATGGTGAGCAAG 
11-98 CTCCATGTCGTCCCAGTTG 
11-100 TCCGGACTTGTACAGCTCGTCCAT 
11-101 TGAAGCGCATGAACTCCTTG 
11-112 CTCTGCTTCTTCAGCTACAC 
11-99 CGGGATCCATCGCCACCATGGTGAGCAAG 
98-002 CAGCTCGACCAGGATGGGCA 
98-047 ATTGACGCAAATGGGCGGTA 
1534_top 
CGCGTCCCCGGTCTCAGTTCCTGAAGTTTATTCAAGAGATAAACTTCAGGAACTGAGACCTTTT
TGGAAAT 
1534_bottom 
CGATTTCCAAAAAGGTCTCAGTTCCTGAAGTTTATCTCTTGAATAAACTTCAGGAACTGAGACC
GGGGA 
4573_top 
CGCGTCCCCGCCAGTACATCAAGTTCATCATTCAAGAGATGATGAACTTGATGTACTGGCTTTT
TGGAAAT 
4573_bottom 
CGATTTCCAAAAAGCCAGTACATCAAGTTCATCATCTCTTGAATGATGAACTTGATGTACTGGC
GGGGA 
scramble_top 
CGCGTCCCCCCGTCACATCAATTGCCGTTTCAAGAGAACGGCAATTGATGTGACGGTTTT 
TGGAAAT 
scramble_bot
tom ATTTCCAAAAACCGTCACATCAATTGCCGTTCTCTTGAAACGGCAATTGATGTGACGGGGGGA 
The sequences marked in bold are siRNA coding regions. 
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2.1.13. Plasmids 
Tab. 2-27: Cloning vectors. 
Nr. Name Source of supply 
313 pEYFP-N1 Clontech Laboratories, Inc., Mountain View, CA, USA 
314 pECFP-N1 Clontech Laboratories, Inc., Mountain View, CA, USA 
376 pLVTHM 
deposited by Prof. Didier Trono at Addgene, Cambridge, MA, 
USA,  as plasmid #12247 (Wiznerowicz and Trono, 2003) 
381 pLVX-Puro  Clontech Laboratories, Inc., Mountain View, CA, USA 
 
Tab. 2-28: Plasmids used for cloning and experiments. 
Nr. Encoded construct Source 
592 
Gallus gallus paxillin-
DsRed2   provided by Prof. Rick Horwitz, (Webb et al., 2004)  
784 Human keratin 13-EGFP (Windoffer and Leube, 1999) 
2010 Cerulean 
deposited by Prof. Dave Piston at Addgene, Cambridge, MA, 
USA,  as plasmid #15214 (Rizzo et al., 2004) 
2066 Human keratin 8-mCherry provided by Dr. Anne Kölsch, (Kölsch, 2008) 
2077 Human integrin β4-EGFP provided by Prof. Jonathan C.R. Jones, (Tsuruta et al., 2003) 
2137 mApple-actin 
provided by Prof. James W. Nelson, for sequence see 
chapter 10.2 
Plasmids cloned in this work are described in chapter 2.2.13. 
 
2.1.14. Cell lines 
Tab. 2-29: Cell lines used for experiments and for generation of subclones. 
Cell line Cell type 
Expressed 
construct Previously published 
A431 human vulva carcinoma-derived - (Moll et al., 1982) 
AK13-1 A431-derived subclone 
human keratin 
13-EGFP 
(Windoffer and Leube, 
1999) 
MT5K14-26 
MCF-7 (mammary gland, breast carcinoma 
derived) subclone 
human keratin 
14-R125C-EYFP (Werner et al., 2004) 
804G rat bladder tumour-derived - (Borradori et al., 1997) 
HaCaT immortalized human keratinocytes - (Boukamp et al., 1988) 
B10 HaCaT-derived subclone 
human keratin 5-
EYFP (Moch et al., 2013) 
Lenti-X™ 
293T human embryonic kidney-derived - 
Clontech Laboratories, 
Inc., Mountain View, 
CA, USA 
The 804G cells were provided by Prof. Dr. Luca Borradori, HaCaT and MT5K14-26 cells were 
provided by Prof. Dr. Thomas Magin, and B10 cells were generated in our lab by Dr. Nicole 
Schwarz. 
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2.1.15. Software 
Tab. 2-30: Software (*marked software was updated automatically with patches). 
Name Version Manufacturer 
Amira 5.4 5.4 Visage Imaging, Inc., owned by Pro Medicus Limited, 
Richmond, Australia 
AxioVision 4.8.2.0 Carl Zeiss MicroImaging GmbH, Jena, Germany 
Chromas 1.4.5 (32 bit) Conor McCarthy, Griffith University, Southport, 
Australia 
Clone Manager 9 
Professional 
9.0 and 9.2 Scientific & Educational Software, Cary, NC, USA 
EOS Utility 2.11.2.0 Canon Inc., Tokyo, Japan 
Excel 2010 *14 Microsoft, Redmond, WA, USA 
FusionCapt Advance 16.06 Vilber Lourmat, France 
GENtle 1.9.4 Magnus Manske, University of Cologne, Germany 
GraphPad Prism 5 5.01 GraphPad Software, Inc., La Jolla, CA, USA 
Handbrake 0.10.0.6534 64bit The HandBrake Team 
Illustrator CS6 16.0. (64 bit) Adobe Systems Incorporated, San Jose, CA, USA 
Image Master 2D Elite 2002.01 Amersham Pharmacia Biotech, belongs to General 
Electric, Fairfield, CT, USA 
Image Pro Plus 6.0.0.260 Media Cybernetics, Inc. 
ImageJ (Fiji distribution) *Fiji 1.4 National Institutes of Health, USA 
Imaris x64 7.0.0 build 18828 
x64 
Bitplane AG, Zurich, Switzerland 
Java *6 and *7  Oracle, Redwood City, CA, USA 
KFmotion Analysis 2D  4.0.4 Gerlind Herberich, RWTH Aachen University, Aachen, 
Germany 
MATLAB Compailer 
Runtime (MCR) 
7.17 MathWorks, Natick, MA, USA 
Micro-Manager 1.4.15 20130721 University of California, San Francisco, CA, USA 
NanoDrop 1000 3.8.0 Thermo Fisher Scientific, Waltham, MA, USA 
Photoshop CS6 13.0. x64 Adobe Systems Incorporated, San Jose, CA, USA 
Python (x,y) 2.6.6.2 https://code.google.com/p/pythonxy/ 
Quantum-Capt 15.12 Vilber Lourmat, France 
Sigma Plot 12 12.0 build Systat Software, Inc., San Jose, CA, USA 
TILLvisION  Till Photonics, Gräfeling, Germany 
TMPGEnc 2.5 2.525.64.184 Hiroyuki Hori, Pegasys Inc. 
turnover 2D 2.4.1 Gerlind Herberich, RWTH Aachen University, Aachen, 
Germany 
Windows 7 Professional 
(64 bit) 
*NT 6.1 Microsoft, Redmond, WA, USA 
Windows XP 
Professional (64 bit) 
*NT 5.2  Microsoft, Redmond, WA, USA 
Zen 2009  Carl Zeiss MicroImaging GmbH, Jena, Germany 
Zen 2011 (black) 7.0 Carl Zeiss MicroImaging GmbH, Jena, Germany 
Zen 2011 (blue) 1.0.0.0 Carl Zeiss MicroImaging GmbH, Jena, Germany 
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2.2. Methods 
Enzymes, chemicals, and equipment were used as suggested by manufacturers when not 
described otherwise. 
 
2.2.1. Cleavage of DNA by restriction endonucleases 
Restriction endonucleases cleave double-stranded DNA within or in close vicinity to specific 
recognition sequences. Depending on the endonucleases used the cleaved ends are sticky or 
blunt, and can be ligated for further cloning. In cases when the enzymatic conditions were 
incompatible or not optimal for one endonuclease, then DNA was digested first with one enzyme 
and purified with “QIAquick pcr purification kit”, before other endonucleases were used. After 
digestion, endonucleases were inactivated by heat, or removed by agarose gel electrophoresis, or 
removed with “QIAquick pcr purification kit”. 
DNA can be protected from cleavage by some restriction endonucleases by methylation. This 
was the case for plasmids produced in XL-1-blue strain of E. coli, where dem methylase 
methylated sequences were protected against cleavage by XbaI. To overcome this restriction the 
dem methylase deficient strain GM-2163 was used to generate the template DNA. Another 
restriction that was considered for restriction of DNA was that different restriction 
endonucleases need different amounts of flanking DNA near target sites for successful cutting. 
 
2.2.2. DNA dephosphorylation 
The dephosphorylation of DNA 5’-termini was performed with calf intestine phosphatase (CIP) 
to prevent relegation of cut target vectors during ligation when both ends were complimentary. 
This reaction is Zn2+ dependent and the enzyme was inactivated by 75°C for 10 minutes, or by 
DNA extraction from an agarose gel. 
 
2.2.3. Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is a method for the amplification of DNA sequences from 
DNA templates. In this scenario DNA polymerases catalyse the addition of deoxynucleotides 
(dNTPs) to a template 3’-hydroxyl DNA strand in 5’3’ direction. Each deoxynucleotide added 
is complementary to the opposite in the template strand. The dNTPs were always aliquoted (4-5 
µl) and stored at -28°C prior to use. 
PCR consists of three different steps that are repeated 20-30 times. In the first step double-
stranded plasmid DNA is separated at a temperature of 96°C which is called melting. In the 
second step the temperature is lowered allowing binding of complementary nucleotide primers to 
the target sequence in a process called annealing. In the third step the temperature is increased to 
optimum for the DNA polymerase, and a new DNA strand complementary to the template is 
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generated in a process called elongation. The elongation starts where the primers have bound and 
is processed by the DNA polymerase in 5’3’ direction. With every repeat the amount of 
generated DNA increases but also the possibility of mutations. 
PCR oligonucleotide primers were designed with “Clone Manager” or “Gentle” Software. 
Following criteria were considered in the design process: high specificity toward target 
sequence, low specificity against other sequences in template, hybridisation temperature similar 
for both primers, low primer-dimer formation capability, and low capability for formation of 
secondary structures. 
Simple PCR was used to add unique restriction sites at ends of amplified DNA and to add or 
remove stop-codons in the same way. Therefore polymerases with inherent proofreading 
function (Phusion; Pfu Ultra II) were used to minimize errors. At the end of PCR polymerases 
were removed by “QIAquick pcr purification kit” or agarose gel electrophoresis. 
 
2.2.4. Site-directed mutagenesis PCR 
Site-directed mutagenesis is a method for specific mutation of nucleotides inside DNA 
sequences such as plasmids. The method is based on standard PCR with the difference that two 
overlapping primers are used at the site to be mutated. These primers contain the mutation of 
interest, preferably in the middle, which is flanked by at least ≈ 10 base pairs. In the PCR 
reaction the elongation time is chosen for the complete replication of DNA which works well for 
sequences longer than 10,000 base pairs. The possibility for errors by DNA polymerase increases 
with the length of amplified DNA sequences. To decrease error rates the PCR was done for a 
limited number of 20 cycles. The remaining methylated template DNA from bacteria was 
removed by DpnI restriction in opposite to the not methylated product DNA. Finally, the product 
was tested for the right size by agarose gel electrophoresis. Thereafter mutated plasmids were 
transformed into competent cells and the purified DNA was tested by restriction and/or 
sequencing. 
 
2.2.5. DNA linker hybridisation and phosphorylation 
Lyophilised single-stranded linker DNA was ordered from MWG Eurofins. Both strands were 
solved at a concentration of 5 pmol µl-1 in 40 µl double distilled H2O before heating for 2 
minutes at 95°C following hybridisation at room temperature for 2 hours. The hybridised linker 
was phosphorylated by T4 polynucleotide kinase that catalyses the transfer of γ-phosphate from 
ATP to 5’-hydroxyl termini of target DNA. The linker was used directly or stored at -28°C. 
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2.2.6. Electrophoretic separation of DNA fragments 
Electrophoresis is the motion of charged particles in a fluid/gel under the influence of a spatially 
uniform electric field. The electric field in electrophoresis can be described by Ohm’s law as for 
simple electric circuits with V = IR (V = electric field in volts; I = current in amperes; R = 
resistance in ohms). In normal cases the gel itself provides nearly all electric resistance with the 
tendency to increase over time during electrophoresis increasing the heat generated by constant 
electric field. When the charge of molecules to be separated is similar per length then molecules 
are separated by size/structure/mass. DNA molecules are in general negatively charged and 
therefore can move in electric field. Separated DNA molecules are detected by fluorescence of 
ethidium bromide, which enhances by binding to DNA, upon excitation with ultraviolet light. It 
should be noted that plasmids that are circular have also a different structure compared with 
linear DNA. For this reason plasmids were always linearised by restriction before electrophoretic 
separation. In general larger molecules are moving slower through gel pores, from the negative 
cathode to positive anode, when the distribution of negative charges and secondary structure are 
similar. 
Gels for separation were made of 0.5 - 2.0% high gelling agarose in Tris/Borate/EDTA (TBE) 
buffer. The solution was melted in microwave oven and 0.04% (v/v) ethidium bromide was 
added at a temperature below 60°C. Thereafter gels polymerised at room temperature within 30 
minutes. DNA probes were dissolved in DNA buffer. Brome phenol blue was used as migration 
marker for 500 base pairs and xylene cyanol for 4000 base pairs in 1% agarose gels. Note that 
the migration markers moves differently at different agarose concentrations. The electrophoresis 
was run in TBE buffer at beginning with 40 volts and thereafter with 90 volts when all probes 
were completely inside the gel. 
Tab. 2-31: Agarose concentrations for separation of DNA fragments of various size (Voytas, 2000). 
Agarose [%] Linear DNA fragment resolution in kilo bases (kb) 
0.5 30 - 1 
0.7 12 - 0.8 
1.0 10 - 0.5 
1.2 7 - 0.4 
1.5 3 - 0.2 
 
Tab. 2-32: Composition of buffers used for agarose gel electrophoresis for DNA separation. 
DNA buffer (10X) TE buffer (1X) TBE buffer (5X) 
67% (w/v) Sucrose  1 mM EDTA  0.45 M Tris base 
≈ 0.4% (w/v) Bromophenol blue or 
Xylene cyanol  10 mM Tris HCl  
0.45 M boric acid 
solve in TE buffer Adjust to pH 8.0 with HCl 10 mM EDTA 
  Adjust to pH 8.0 
The agarose gels were documented with Fusion-Solo.WL.4M. 
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2.2.7. DNA quantification 
The quantity of purified DNA was measured by spectrophotometry with NanoDrop 2000. For 
analysis the DNA sample was mixed and then the absorbance measured at wavelength of 260 nm 
in a total volume of 1 or 2 µl. The probes were solved in TE buffer and also this buffer was used 
for the blank value. 
Alternatively DNA quantity was measured by fluorescence intensity of separated DNA 
molecules by gel electrophoresis. The measured fluorescence was compared to a known mass 
from a DNA mass ladder in the same gel. 
 
2.2.8. Ligation of DNA fragments 
T4 DNA ligase catalyses the formation of a phosphodiester bond between 5’-phosphate and 3’-
hydroxyl termini of two DNA strands in an ATP and Mg2+ dependent way. This reaction was 
used to ligate double-stranded DNA with other DNA fragments with complimentary ends at 
ratios ranging from 1:1 to 1:8 (vector/insert). To optimize the ligation the lowest vector 
concentration was chosen preferably higher than 15 fmol for 20 µl reaction volume. The ligation 
was done for 1 hour at 16-20°C and it was used directly for transformation of competent cells or 
it was stored at -28°C. When necessary more than two DNA fragments were ligated in the same 
reaction. To test ligation efficiency control ligations were performed with vector or insert DNA 
alone. 
 
2.2.9. Preparation of competent bacteria 
Escherichia coli (E. coli) is a rod-shaped gram-negative bacterium that is commonly found in the 
lower intestine of warm-blooded organisms. E. coli grows in rich medium at a rate of 20-30 
minutes at 37°C in the log phase. The saturation phase is reached at 1-2*109 cells ml-1 in which 
the bacteria stop to divide rapidly. E. coli can also be grown on solid LB-agar plates (Elbing and 
Brent, 2002). For laboratory use different E. coli strains were developed optimised for DNA or 
protein synthesis. In this work XL-1 blue strain was used for plasmid generation and 
alternatively GM-2196 to avoid dem- methylation when dem- sensitive restriction enzymes were 
used. 
Tab. 2-33: Composition of TFB I. 
Name Final concentration Quantity for 100 ml 
RbCl2 100 mM 1.21 g 
MnCl2 50 mM 0.81 g 
Potassium-Acetate 30 mM 0.29 g 
CaCl2 10 mM 1 ml (1M) 
Glycerol 15% (w/v) 15 ml 
Adjust pH to 5.8 with 0.2 M acetic acid. 
Sterilise by filtration. 
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Tab. 2-34: Composition of TFB II. 
Name Final concentration Quantity for 100 ml 
CaCl2 75 mM 7.5 ml (1 M) 
RbCl2 10 mM 0.12 g 
MOPS 10 mM 0.29 g 
Glycerol 15% (w/v) 15 ml 
Adjust pH to 7.0. Sterilise by filtration. 
  
Preparation of competent cells according to (Hanahan et al., 1991): 
- inoculate 20 ml LB medium with a single colony of desired host strain (XL-1 blue has 
tetracycline resistance) 
- grow overnight at 37°C and 200 rounds per minute 
- inoculate 7 ml LB medium with 0.5 ml overnight culture (preculture) 
- grow bacteria until OD600 (optical density at 600 nm) reaches 0.3 
- use 5 ml preculture to inoculate 100 ml prewarmed (37°C) L-Broth 
- grow until OD600 reaches 0.48 
- chill bacteria on ice 
- centrifuge for 15 minutes at 4000 relative centrifugal force (RCF), at 4°C 
- discard supernatant 
- resuspend pellet in 30 ml ice-cold TFB I 
- incubate on ice for 1-2 hours 
- centrifuge as above and alternatively use 50 ml Falcon tubes 
- resuspend pellet in 4 ml ice-cold TFB II 
- dispense aliquots of 200 µl in precooled 1.5 ml tubes 
- freeze in N2 and store at -80°C for a maximum of one year 
 
2.2.10. Introduction of plasmid DNA into bacteria 
The exposure of E. coli to calcium ions enhances the binding of DNA and heat shock conditions 
increases the uptake of these DNA molecules. 
Chemical transformation based on (Hanahan, 1983): 
- thaw competent cells on ice for 10 minutes 
- add 1 µl pure plasmid DNA or 10-20 µl ligation preparation to the cells 
- mix shortly for 1 second 
- chill on ice for 30 minutes / preheat Agar plate at 37°C 
- heat shock cells in water bath for 105 seconds at 41.5°C  
- chill cells on ice for 10 minutes 
- add 1 ml LB medium or SOC medium to cells and mix gently 
- incubate cells for 30-60 minutes at 37°C 
- centrifuge cells at 1000 RCF for 5 minutes at RT and discard 1 ml supernatant 
- plate 50 µl of cells transformed with pure plasmids or otherwise plate 250 µl when the 
cells were transformed with ligated DNA 
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For selection of plasmid positive cells LB agar plates containing ampicillin (150 µg ml-1) or 
kanamycin (60 µg ml-1) resistance were used. The cells were evenly distributed with a glass 
spreader on the plates until the solution became dry. The plates were incubated over night at 
37°C in incubator or alternatively at room temperature for 2-3 days in a dark box. The spreader 
was sterilised with ignited 100% ethanol and before reuse cooled up to not harm bacteria. 
On the next day single colonies were picked with sterile wooden toothpicks and incubated in LB-
media like described below. Additionally the plates were stored for 1-2 weeks at 4°C. 
Tab. 2-35: Composition of LB Agar (Lennox broth agar). 
Name Quantity for 400 ml 
Tryptone 4 g 
Yeast extract 2 g 
NaCl 2 g 
Agar-Agar (Roth 5210.3) 6 g 
Distilled H20  Adjust to 400 ml 
Autoclave in 500 ml flasks at 121°C for 20 min. 
  
Tab. 2-36: Composition of LB medium (Lennox broth medium). 
Name Quantity for 1000 ml 
Tryptone 10 g 
Yeast extract 5 g 
NaCl 5 g 
Distilled H2O  Adjust to 1000 ml 
Autoclave in 1000 ml or 200 ml flasks at 121°C for 20 min. 
  
Tab. 2-37: Composition of SOC medium. 
Name Final concentration 
Yeast extract 0.5% (w/v) 
Tryptone 2% (w/v) 
NaCl 10 mM 
KCl 2.5 mM 
MgCl2 10 mM 
MgSO4 10 mM 
Glucose 20 mM 
Distilled H2O  Adjust to 1000 ml 
Sterilize by autoclaving at 121°C for 20 min. 
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2.2.11. DNA purification 
Purification of plasmid DNA from bacteria 
Plasmid DNA was purified from one bacteria colony. In ideal cases single bacteria colonies on 
agar plates with large distances to other colonies were picked with a sterile wooden toothpick 
and 5 ml of LB medium were inoculated for Miniprep. When the colonies were to near each 
other then single colonies were isolated by streaking. Therefore bacteria of interest were touched 
by a sterile wooden toothpick and were streaked on a new agar plate forming new single colonies 
after further incubation. 
In case of larger DNA preparations (Maxiprep) 200 ml LB-media were used instead of 5 ml in an 
Erlenmeyer flask. When possible the LB-media was inoculated with 1 ml overnight culture. The 
bacteria were grown in the same way as for Miniprep over night at 37°C and 200 rounds per 
minute with ampicillin (150 µg ml-1) or kanamycin (60 µg ml-1) depending on the plasmids 
resistance gene. 
The DNA purification was performed with “QIAprep spin miniprep kit” or “QIAfilter plasmid 
maxi kit” according to manufacturer’s protocols. The plasmid DNA was stored at -22 or -40°C in 
TE-buffer that was provided with the kits. 
Purification of linear DNA 
Unwanted enzymes or primers were removed from DNA prepared by PCR or endonuclease 
restriction with “QIAquick pcr purification kit” according to manufacturer’s protocol.  
Alternatively agarose gel electrophoresis was used to remove template DNA from PCR products. 
Therefore separated DNA of interest was identified on a UV-table and cut out from the gel 
before purification with “QuickLyse Miniprep Kit” according to manufacturer’s protocol. 
To concentrate DNA “DNA Clean & Concentrato-5” kit was used according to manufacturer’s 
protocol or DNA was dialysed against 10% (v/v) glycerol on cellulose membranes. 
 
2.2.12. DNA sequencing 
Sequencing of DNA plasmids was performed by Eurofins MWG Operon, Ebersberg, Germany. 
The automated sequencing results were compared with correct sequences with “Chromas” 
software. In case of errors the provided chromatograms were additionally checked to exclude 
misinterpretations. The final sequences were saved as cm5 files with “Clone manager” software. 
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2.2.13. Generation of plasmids 
 
2079 pLVHTM-CFP (generated by Dr. Anne Kölsch) 
The empty lentivector pLVHTM (plasmid 376) was restricted with PmeI and SpeI generating a 
10247 base pair (bp) fragment that was extracted from an agarose gel. The ECFP insert was 
generated by PCR from pECFP-N1 (plasmid 314) with primers 09-98 and 09-100. The product 
was cut with PmeI and SpeI, and ligated with the 10247 bp fragment generating the final 
construct with a size of 11093 bp. 
2099 Paxillin-dsRed2 (generated by Dr. Anne Kölsch) 
The lentiviral expression vector pLVX-Puro (plasmid 381) was cut with NdeI and XbaI resulting 
in a 7693 bp long fragment which was dephosphorylated. The 2765 bp long insert containing a 
part of CMV promoter sequence and complete paxillin-dsRed2 was generated by cutting plasmid 
592 with NdeI and XbaI. Both fragments were extracted from an agarose gel and ligated to the 
final product with a size of 10460 bp. The inserted paxillin sequence was completely sequenced 
with primers 11-112 and 10-83. Compared to gallus gallus paxillin NCBI Reference Sequence 
NM_204984.1 the paxillin has one silent mutation at position 1505 where C is changed to G. 
2101 Integrin β4-EYFP 
Plasmid 2102 was generated as backbone with EYFP for integration of integrin β4. Therefore 
plasmid 313 pEYFP-N1 was cut with XbaI and BamHI to remove EYFP resulting in a 3982 bp 
long fragment which was dephosphorylated. The new EYFP insert was created by PCR from 
plasmid 313 with primers 10-31 and 09-102. It was cut with XbaI and BamHI resulting in a 747 
bp long fragment that was integrated in to previously cut 3982 bp fragment of plasmid 313. 
Plasmid 2077 containing integrin β4-EGFP was cut with NdeI, NheI, and KpnI creating 357, 
5310 and 4314 bp long fragments. The 5310 bp fragment containing integrin β4 was 
dephosphorylated, extracted from agarose gel, and ligated into plasmid 2102 using NheI and 
KpnI restriction sites. The product was named plasmid 2101 integrin-β4-EYFP. The multi 
cloning site and EYFP were sequenced with primer 09-102, and integrin β4 was sequenced in 
plasmid 2105 (that is based on this plasmid) that is described below. 
2105 Integrin β4-helix20aa-EYFP 
Plasmid 2104 was generated as backbone for integration of integrin β4. Therefore plasmid 2102 
was cut with BamHI and KpnI generating a 4718 bp fragment that was dephosphorylated and 
extracted from an agarose gel. 
A linker was created from primer 10-88 and 10-89 encoding the amino acid sequence 
(GT)LAEAAA KEAAA KEAAA KAAA(GSIAT) (amino acids belonging to KpnI and BamHI 
restriction sites are surrounded by braces). The linker was phosphorylated with T4 PNK before 
ligation with 4718 bp fragment of plasmid 2102 resulting in plasmid 2104. 
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Plasmid 2104 was cut with NheI and KpnI resulting in a 4722 bp fragment that was extracted 
from agarose gel. Integrin β4 flanked by NheI and KpnI was prepared before to create plasmid 
2101 and was also used in this scenario to ligate with the 4722 bp fragment of plasmid 2104. The 
final product was named plasmid 2105 and was sequenced completely with primers 98-002, 09-
104, 09-105, 09-106, 09-107, 09-108, and 98-047. The integrin β4 sequence encodes the same 
amino acid sequence as deposited in NCBI GenBank with the code BC126411.1 GI:116496730. 
The gene has only one silent mutation at position 4845 with G changed to C. 
2107 shPlectin / 2108 shPlectin / 2112 scramble (generated by Dr. Nicole Schwarz) 
The backbone for all products was generated from plasmid 2079. Therefore the plasmid was cut 
with ClaI and MluI, dephosphorylated, and the 11076 bp fragment extracted from an agarose gel. 
The shRNA sequences to be inserted were ordered in form of primer nucleotides. For plasmid 
2107 the primer sequences 1534_top and 1534_bottom were used, as was done with primers 
4573_top and 4573_bottom for plasmid 2108, and primers scramble_top and scramble_bottom 
for plasmid 2112. Before ligation with the backbone vector the primer pairs were hybridised and 
phosphorylated with T4 PNK. 
2113 Keratin 13-mCerulean 
Plasmid 784 containing keratin 13-EGFP was cut with BsrGI and BamHI to remove EGFP 
resulting in a 5382 bp long fragment that was dephosphorylated and extracted from an agarose 
gel. The insert sequence containing mCerulean was generated from plasmid 2110 by PCR with 
primers 11-001 and 06-98. Thereafter the insert was cut with BamHI and BsrGI resulting in 721 
bp fragment that was ligated with the 5382 bp vector resulting in a 6103 bp product. Finally, the 
mCerulean insert was sequenced with primer 09-102. 
2154 Keratin 13-mApple 
Plasmid 784 containing keratin 13-EGFP was cut with BsrGI and BamHI to remove EGFP 
resulting in a 5382 bp long fragment that was dephosphorylated and extracted from an agarose 
gel. The insert sequence containing mApple was generated from plasmid 2137 by PCR with 
primers 11-99 and 11-100. Thereafter the insert was cut with BamHI and BsrGI resulting in 715 
bp fragment that was ligated with the 5382 bp vector resulting in a 6097 bp product. Finally, the 
mApple insert was sequenced with primer 09-102. 
 
2.2.14. Downregulation of proteins by short hairpin RNA (shRNA) 
Degradation of proteins by RNA interference (RNAi) is based on sequence-specific degradation 
of host mRNA through double-stranded RNA (dsRNA) identical to the target sequence (Fire et 
al., 1998). Short hairpin RNA (shRNA) consists of two complementary 19-22 bp RNA 
sequences linked by a short loop. The shRNA is processed in cytosol by Dicer to small 
interfering RNA (siRNA) duplexes which bind to the target mRNA. These complexes are 
incorporated into the RNA-induced silencing complex (RISC) which mediates target specific 
mRNA degradation (Kutter and Svoboda, 2008). Prior to usage the DNA sequence of shRNA 
has to be incorporated into genome of the cell. 
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2.2.15. Cell culture 
Cell culture is the method of growing cells outside of their natural environment under standard 
conditions. 
All cell lines were cultivated in Dulbecco's modified eagle's medium (DMEM) at 37°C and 5% 
CO2 humidified atmosphere without antibiotics and any other selection reagents (like G418). The 
processing steps were done at highly sterile conditions in laminar flow cabinet. S1 cells were 
cultivated in 60 mm petri dishes and S2 cells for security reasons in flasks. The cells were grown 
without extra matrix coating when not used directly for experiments. 
Mycoplasma test 
Cells were tested for mycoplasma bacteria approximately one time every month with Venor 
GeM kit by Sabina Hennes-Mades or by Vanessa Creuz. Additionally in fluorescence 
microscopy samples stained for DNA were tested for strong signal outside of nucleus which is 
typical for mycoplasma contamination. Contaminations were treated as described in chapter 
2.2.21. 
Cell medium: 
In general DMEM with phenol red and glutamine was used for cultivation of cells. For later 
experiments involving cells transduced with shRNA-plectin and scramble controls, DMEM 
without phenol red was used. This medium was also supplemented with GlutaMAX instead of 
glutamine. In general FCS from Invitrogen was used at a concentration of 10% (v/v) and for 
HaCaT cells FCS Gold at 10% (v/v) concentration. 
A431 cells were preferably passaged at 98-99% confluency. The cells were shortly washed with 
1PBS and then trypsinised for 1-2 minutes at room temperature with 1trypsin. When most cell 
contacts were divided then cells were detached by knocking two times against table. Finally the 
cells were resuspended in DMEM with a 2 ml pipet and split at ratios of 1:10 and 1:15 into new 
petri dishes. 
HaCaT cells were preferably passaged every 7 days (1-2 days post confluency). The cells were 
shortly washed with 2PBS and then incubated in it for 10-20 minutes at 37°C. When cell borders 
began to separate PBS was removed and the cells were incubated further in 2trypsin at 37°C. 
After 5 minutes trypsin was removed and the cells were incubated for further 5-10 min at 37°C. 
When large numbers of cells were separated from each other then cells were resuspended in 
DMEM with a 2 ml pipet. When the cells aggregated in to clumps then the optimum time point 
for resuspending was over. The cells were passaged at ratios of 1:7 and 1:10. 
804G cells were preferably passaged 1-2 days post confluency. The cells were shortly washed 
with 1PBS and then trypsinised with 1trypsin at 37°C. Trypsin was removed after 2 minutes and 
the cells were incubated for further 3 minutes at 37°C. When all cells were completely separated 
and round than then they were detached by knocking 2-4 times against table. The cells were 
resuspended and passaged at 1:15 and 1:20 ratios. When cells were not capable of becoming 
confluent within one weak then they were passaged at lower ratios for a few passages. 
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MCF-7 cells were preferably passaged at day one post confluency. The cells were washed with 
1PBS and then trypsinised at room temperature in 1trypsin for one minute. Thereafter trypsin was 
removed and the cells were incubated for 2-5 minutes at 37°C. Then cells were resuspended in 
DMEM with a 2 ml pipette. It should be noted that this cell line tends to form cell-aggregates 
during the passaging process with increased tendency when they are not well resuspended. The 
cells were passaged at ratios of 1:7 and 1:10. 
1PBS without Ca2+/Mg2+ (Biochrom) supplemented with 0.02% (w/v) EDTA 
2PBS without Ca2+/Mg2+ (Sigma-Aldrich) 
3Trypsin 0.25% (w/v) solved in 1PBS 
4Trypsin 0.05% (w/v) solved in 2PBS 
Conditions for experiments 
The main difference for a wide variety of experiments was that cells were cultivated on different 
matrices and different dishes (6-, 12-, 24-, 96-Wells, 35 mm petri dishes, and 35 mm glass 
bottom dishes). In some experiments cells were cultivated only for one hour after trypsinization 
in FCS containing DMEM and later without FCS. For more details see the corresponding 
experiments. 
 
2.2.16. Long term cell storage 
For long-term storage cells were cultivated under normal conditions in 100 mm Petri dishes. 
After trypsinisation cells were resuspended in 2.50 ml ice-chilled DMEM+FCS per Petri dish 
before 2.5 ml ice chilled freezing medium was added (20% DMSO, 20% FCS, 60% DMEM 
containing 10% FCS, all (v/v)). When more than one Petri dish with cells was prepared then all 
were merged together before addition of freezing medium. The cells were aliquoted at 1.5 ml per 
tube and chilled overnight in isopropanol at -80°C. For long term storage the cells were stored in 
liquid N2. After one or two weeks one aliquot was tested to verify if the procedure was 
successful. 
 
2.2.17. Cell counting 
Cells were counted with a hemocytometer (Neubauer improved chamber). The chamber has a 
counting grid of 3 mm2 that is divided in 9 square subdivisions. For measurement of cells the 
four corner squares were used that have a square of 1 mm2 and are divided in 4 smaller squares 
each. Before counting the cover glass was put on the chamber in such a way that Newton’s rings 
were formed on both sides, which guaranties 0.1 mm distance between the bottom of counting 
section and cover glass. Trypsinised cells (see chapter 2.2.15) were diluted at different 
concentrations depending on confluency and then the same volume of trypan blue was added to 
mark dead cells. For counting 10 µl of the solution was added under the cover glass. Cells were 
counted inside four 1 mm2 regions and a mean value was calculated for 1 mm2 which 
corresponds to 0.05 µl cell suspension without trypan blue. 
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2.2.18. Laminin-332-rich matrix coating 
Laminin-332-rich matrix coating was performed according to the method of (Langhofer et al., 
1993). Therefore 804G cells were grown for 3-4 days to confluency on surfaces to be coated and 
one day post-confluency they were detached by incubation in cold 20 mM NH4OH for 10-15 
minutes. The medium was discarded and the remaining cells/debris were detached by pipetting 
with distilled H2O (Aqua B. Braun, 1 ml per 35 mm Petri dish).  In the next step the surfaces 
were washed again two times with distilled H2O (2x4 ml per 35 mm Petri dish). Finally the 
surfaces were washed with the same amount of PBS without Ca2+/Mg2+. For storage PBS was 
removed end the samples were stored at -28°C for up to 2 months. 
 
2.2.19. Cationic lipid-mediated introduction of DNA into mammalian cells 
Mammalian cell can incorporate foreign DNA in to the genome and translate the genes it 
encodes to proteins. These genes can also be inherited which is used for stable cell line 
generation. This process is stressful for cells and it can induce cell death. Therefore it is optimal 
at good growth conditions and higher cell numbers. In cationic lipid mediated transfection 
negatively charged DNA backbone electrostatically binds to positively charged lipids. These 
complexes can enter the negatively charged membranes of cells where the DNA has a chance to 
be incorporated into the genome. 
In this work the gene of interest was transfected in form of plasmids into host cells and the 
translation was enhanced by a CMV promoter. For transfection 4-5 µl Lipofectamine 2000 was 
solved in 245 µl Opti-MEM and in another tube 4 µg plasmid DNA in the same amount of Opti-
MEM. The solutions were incubated for 5 minutes at room temperature and then merged 
together and resuspended. After 20 minutes incubation the total volume of transfection solution 
was added in the middle of 35 mm glass/plastic bottom dish containing the cells to be 
transfected. These were always cultivated in 2 ml total volume cell medium and 10% (v/v) FCS 
in single 35 mm Petri dishes or 6-Well plates. When live cell imaging had to be performed in the 
same dishes then cells were transfected at 40-50% confluency at day one or two after passaging. 
The cells were ready for imaging 24 hours later without becoming completely confluent. The 
transfection detergent was not removed from the cells because it is not stable for longer time 
periods according to the manufacturer and did not disturb noticeably cell growth of surviving 
cells. This protocol was optimised for A431 cells but it was also used for other cell lines without 
modifications.  
For generation of stable cell lines or for generation of mixed clones cells were transfected at 60-
80% confluency for higher efficiency. In general the transfection efficiency was between 0.1-
60% depending on the plasmids and DNA used. For example the efficiency was highest for 
EGFP in A431 cells without tagged proteins. Note that for preparation of virions a different 
protocol was used described in the next chapter. 
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2.2.20. Lentiviral transduction of DNA into mammalian cells 
Lentivirus transduction is more efficient than liposomal transfection and can be used for virtually 
all cell types such as dividing and nondividing cells, stem cells, and primary cell cultures. In this 
work replication-incompetent virions were generated using a Lenti-X™ HTX Packaging System.  
Protocol (bio security level S2): 
Day 1. In the morning Lenti-X 293T cells are thawed and cultivated in a 100 mm Petri dish in 10 
ml DMEM supplemented with 10% (v/v) FCS Gold. 
Day 2. In the evening cells should have a confluency of 50-60%, which is optimal to cultivate 
them for three further days. Prepare a solution of 5 µg DNA of interest (in a compatible vector), 
250 µl NaCl, and 15 µl Lenti-X™ HTX packaging mix. Prepare a second solution with 250 µl 
NaCl and 20 µl jetPEI® transfection reagent. Add both solution together, vortex, spin down, add 
to cells after 15 minutes, and incubate over night at normal cell culture conditions. 
Day 3. In the morning replace cell medium with 10 ml cell medium that is compatible with 
target cells. Place 500,000 target cells into one well (6-well dish). 
Day 4. In the evening collect the cell medium containing virions into a 100 mm Petri dish. 
Thereafter filter medium through a 0.45 µm cellulose acetate filter with a 20 ml syringe into a 50 
ml Falcon tube and store at 4°C. Add 10 ml cell medium to virus producing cells and cultivate 
them for one further day. 
Day 5. Collect cell medium containing virions as described before and discard cells. Add the 
collected medium to the previously collected virions and optionally test concentration with 
Lenti-X™ GoStix™. The target cells can now be infected with the virus. Therefore remove cell 
medium in the 6-well plate and add 2 ml virions. Add also 3 µl polybrene® to increase the 
infection rate. The virions can be stored at 4°C for multiple weeks. 
 
2.2.21. Generation of stable cell lines 
The generation of a stable cell line is the selection of a single cell and then generation of a line 
from it with identical genetic background. Therefore two different strategies were used to 
generate stable cell lines. In the first method the transfected plasmid contained a selection 
marker. This was antibiotic resistance, against G418 or kanamycin, and a fluorescent-tag 
encoded at the N- or C-termini of the gene of interest. In the second case for generation of 
shRNA clones only additionally transduced CFP from the same vector was used for selection. 
For selection the cells were cultivated to confluency in 6-Well plates or 35 mm Petri dishes and 
were then trypsinised extensively to generate single cells. The trypsinised cell solution was 
passaged at concentrations of 1:10, 1:20, 1:50, and 1:100 in to 100 mm plastic Petri dishes 
containing 8 ml cell medium and a selection antibiotic. Thereafter cells were cultivated for a few 
days until a small number of single cells remained with large distances to other cells above 1 cm. 
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Cell colonies were marked at this time point and not selected later. After 10-15 days when small 
colonies were established from the single cells then the medium was gently removed and trypsin 
was added on one side of the Petri dish for 10 seconds. Directly thereafter, selection antibiotics 
and penicillin-streptomycin were added to the cells. Single colonies were withdrawn under a 
microscope with a 200 µl Pipette and transferred into a 96-well plate. In case of weakly 
fluorescent constructs 96-wells plates with glass bottom were used and scanned with the 
Olympus IX-70s microscope. For selection of strongly fluorescent clones standard plastic 96-
well plates were used and the Zeiss Axiovert 135 microscope. Finally positive clones were 
transferred for cultivation into 6-well plates. The cell medium contained antibiotics until transfer 
into 60 mm Petri dishes. 
Lentivirus infected cells were selected in a different way because the virus vectors did not 
contain any specific drug resistance. Infected cells were cultivated for 1-2 passages under 
standard conditions before strong trypsinisation and resuspension into single cells. This cell 
suspension was diluted to a concentration of 9 cells ml-1 and 100 µl were added per well into a 
glass bottom 96-well plate. Within the following days wells were marked that did not contain 
single cells. The single A431 cells that survived the separation formed larger colonies after 14-21 
days. Positive clones were identified and cultivated further as described before with the 
difference that no antibiotics were used. 
 
2.2.22. Treatment of mycoplasma contamination 
Contaminated cells were treated with 25 µg ml-1 Plasmocin, with medium change every 3-4 days 
for 14 days under normal cell culture conditions. The cells were thereafter tested for 
mycoplasma. 
 
2.2.23. Two dimensional wound healing assay (scratch assay) 
Scratch assays were performed in plastic bottom 96-wells with 100,000 cells plated per well. 
Trypsin was inhibited by 10% (v/v) FCS in the standard cell medium or in case of FCS-free 
medium by prior addition FCS containing medium which was removed thereafter by 
centrifugation for 3 minutes at 200 RCF. 
Every cell clone was transferred into 12 wells and incubated for 4 hours at 37°C in 5% CO2 
humidified atmosphere before one scratch per well was performed. The scratches were done by 
hand with a 10 µl tip from top to bottom with the help of a ruler. After scratching the medium 
was changed with a multipipette to remove not adherent cells. The transmitted light signal of 
scratched cells was documented with Olympus IX-70s and a 4X objective at 1940x1460 pixel 
resolution with CoolSNAP MYO CCD camera at 37°C. Thereafter the scratch positions were 
saved with Micromanager software and used again 22 hours later for recording of the same 
positions. The cells were cultivated under normal cell culture condition during recording 
intervals in cell culture incubator. 
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The scratch areas were measured per hand with polygon selection tool in Fiji software, using a 
Wacom graphic tablet. Scratches that were not complete or were already closed after 22 hours 
were not counted. Finally, for every experiment a mean area of all scratches per clone was 
calculated. From this area the movement toward the wound in one dimension was calculated. 
 
2.2.24. Proliferation assay 
The viability and proliferation of cells was tested with the MTT assay. In this test the yellow 
tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is reduced 
to formazan by cellular NADP-H- and NAD-H-dependent oxidoreductases. This process 
increases with the metabolic activity of cells. Formazan itself is insoluble and has a dark purple-
blue colour that is well measurable by spectrometry. 
For analysis A431 cells were platted in 12 wells of a 96-well plastic plate at a concentration of 
40,000 cells per well in 100 µl cell medium. After 24 hours the cell medium was discarded and 
replaced with 50 µl MTT solution (1 mg ml-1 MTT solved in cell medium, 30 minutes before 
experiment) and incubated in it for 20 minutes at standard cell culture conditions. Thereafter 
MTT solution was discarded completely and the formed formazan solved by shaking under 
exclusion of light for 20 minutes at room temperature in 150 µl solvent solution (4 mM HCl and 
0.1% (v/v) Nonidet P40 solved in Isopropanol) per well. The quantity of formed formazan was 
measured at 565 nm absorbance in a TECAN Infinite 200 plate reader and a mean value for 
every clone was calculated from 12 wells. 
 
2.2.25. Drug and growth factor assays 
During live cell microscopy modulators were added without cancellation of the recording when 
not added before the experiment. The modulators were solved in the same volume of cell 
medium as used for live cell imaging under normal conditions. They were stored prior to 
addition in a 2 ml syringe in the climate chamber of the microscope at 37°C. The cell medium 
was removed with the help of a polytetrafluoroethylene coated pipe and pump within 15 seconds. 
Therefore a small hole was introduced into the lid of a Mattek glass bottom dish for a pipe 
connecting the medium with the pump. A second hole was also introduced for a 
polytetrafluoroethylene coated pipe connected to the syringe containing the modulators which 
were added by hand within 10-15 seconds. To prevent transmission of mechanical force from the 
pipes on the glass bottom dish the pipes were fixed with tesafilm® to the microscopic stage. 
EGF was stored aliquoted at -80°C prior to experiments and other modulators at -28°C. After 
thawing the modulators were stored at 4°C and were used within one day. Cetuximab and PF-
562,271 were two exceptions because they were stored at all time at 4°C. 
 
Material and Methods 
 
  63 
2.2.26. Cell lysis 
Cell lysis was performed for the preparation of probes for immunoblot analysis. Therefore cells 
were washed shortly on ice with cold PBS. To not influence the total lysate volume PBS was 
completely removed before addition of lysis buffer. Cells grown on 100 mm Petri dishes were 
lysed in 1 ml lysis buffer and cells from 60 mm dishes in 500 µl lysis buffer. Directly after 
addition of lysis buffer cells were removed with a natural-rubber scraper and resuspended. The 
lysates were centrifuged at 20,000 relative centrifugal force at 4°C for 20 minutes. The 
supernatant ≈ 80% of total volume was denatured in SDS buffer at 98°C for 10 minutes. Directly 
after heating the probes were chilled on ice for at least 2 minutes before long term storage at  
-28°C.  
Tab. 2-38: Lysis buffer 
Concentration Chemical 
2.5 mM  EDTA (stock solution: 0.5 M, pH 7.5) 
50 mM  Tris-HCl 
2.5 mM  EGTA (stock solution: 0.5 M, pH 7.5) 
50 mM  NaF 
5 mM  Sodium pyrophosphate 
10 mM  Glycerol phosphate 
1% (v/v) Triton-X 100 
Before usage add Roche Complete® and Roche PhosphoSTOP®. 
Tab. 2-39: 5X SDS denaturation buffer (based on Lämmli buffer) 
Amount Chemical 
15 ml 0.6 M Tris-HCl pH 6.8 + 0.4% (w/v) SDS 
12.5 ml Glycerol 
2.5 ml Mercaptoethanol 
2.5 g SDS 
0.4% (w/v) Bromophenol blue 
 
2.2.27. Quantitation of proteins 
The amount of protein in a solution was measured by Bradford colorimetric analysis. In this 
assay Coomassie Brilliant Blue G-250 is converted to a stable blue form (Amax=595 nm) upon 
binding to a protein (Sedmak and Grossberg, 1977). The resulting hue from binding to a protein 
of unknown concentration can be compared to the hue of a standard protein with known 
concentration (Bradford, 1976) as was done with BSA in this work. BSA was solved in H2O and 
used at following concentrations: 0.1-0.5, 0.7, 1.0, 1.2, 1.5, 2.0 mg ml-1. Between the 
experiments BSA dilutions were stored at -28°C. For analysis, unknown protein was dissolved 
1:10 in H2O and a volume of 2 µl was mixed with 98 µl Quick Start Bradford reagent. The BSA 
standard was dissolved in the same way and for the blank value pure H2O or lysis buffer was 
used instead of a protein solution. The probes were incubated for 10 minutes at room 
temperature without light and were thereafter measured at 595 nm wavelength in BioPhotometer 
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plus. From the intensity of BSA standard values a linear mathematic formula was calculated in 
Excel to determine the concentration of the protein of interest. 
 
2.2.28. Electrophoretic separation of proteins based on (Laemmli, 1970) 
The basics of gel electrophoresis are explained in chapter 2.2.6. For separation of proteins 
polyacrylamide gel electrophoresis was used where the pore size decreases with higher 
acrylamide concentrations. These gels are composed of a thinner stacking gel on the top and of a 
larger separation gel below. The stacking part has low porosity and low pH to concentrate 
proteins in a thin line before they entry into separation part. In general, 1 mm thick mini-gels 
(Mini-PROTEAN Tetra Cell System) were prepared according to the formula in Tab. 2-40 and 
Tab. 2-41. The charge of proteins per sequence was equalised with SDS that was also used for 
denaturation. In case of protein modifications, like phosphorylation, this was not possible across 
the complete protein sequence and resulted in small shifts from the expected mass after 
electrophoresis. The process of protein probe denaturation was described in detail in chapter 
2.2.26. 
Tab. 2-40: SDS-polyacrylamide separation gel. 
Chemical ↓ / gel concentration → 8%  10%  12% 
40% acrylamide 2000 µl 2500 µl 3000 µl 
3 M Tris-HCl, pH 8.8 + 0.1% (w/v) SDS 1900 µl 1900 µl 1900 µl 
60% D(+)-sucrose 1150 µl 1150 µl 1150 µl 
Distilled H2O 4950 µl 4450 µl 3950 µl 
To start polymerisation 50 µl APS 10% (w/v) and 5 µl TEMED were added to the gel solution 
directly before addition to the mini-gel system. Thereafter the solution was covered with 
isopropanol to prevent dehydration. After 45 minutes at room temperature isopropanol was 
removed completely and stacking gel added. 
Tab. 2-41: Stacking gel. 
Chemical ↓ / gel concentration → 4% 5% 6% 
40 %  acrylamide 500 µl 625 µl 750 µl 
0.5 M Tris-HCl, pH 6.8 + 0.1% (w/v) SDS 1275 µl 1275 µl 1275 µl 
Distilled H2O 3225 µl 3100 µl 2975 µl 
Stacking gel polymerisation was started with 25 µl APS 10% (w/v) and 5 µl TEMED. The 
solution was added quickly above the separation gel and a comb with ten pockets for protein 
probes was inserted. The polymerisation was finished within 30 minutes at room temperature. 
Polymerised gels were used directly or stored for up to one week in a plastic bag at 4°C coated 
with humid paper tissues. 
Material and Methods 
 
  65 
Gel electrophoresis was performed at 35-45 volts in stacking gel and at 50-100 volts after 
bromophenol blue reached the separation gel. For the electrophoresis SDS running buffer was 
used as electrolyte in Bio-Rad mini-gel system. The protein mobility was indicated by the 
prestained ProSieve QuadColor Protein Marker and bromophenol blue in the probe buffer. When 
bromophenol blue reached the last 5 mm of the gel then the protein separation was finished. 
Thereafter the stacking part of the gel was removed and only the separation gel used for further 
analysis. 
Tab. 2-42: Composition of 10X SDS running buffer. 
Name Final concentration Stock solution 
Tris 250 nM 30.3 g 
Glycine 1.921 M 144.19 g 
SDS 1% (w/v) 10 g 
Distilled H2O  adjust to 1000 ml 
 
2.2.29. Staining of proteins in SDS-polyacrylamide gels 
The localisation of proteins separated by electrophoresis in SDS-polyacrylamide gels was 
detected with colloidal staining solution (Tab. 2-43). This dye contains SERVA blue G-250 that 
binds to proteins. To improve background the gel was destained by shaking in water over night. 
Tab. 2-43: Colloidal staining solution. 
Name Final concentration Quantity for 1000 ml 
CuSO4 20 mM 5 g 
Acetic acid (CH3COOH) 10% (v/v) 100 ml 
Methanol 45% (v/v) 450 ml 
Coomassie Brilliant Blue G250 0.15% (w/v) 1.5 g 
Distilled H2O ≈ 45% (v/v) adjust to 1000 ml 
 
2.2.30. Protein immunoblot analysis (western blot) 
Immunoblot analysis was used to detect specific proteins by immunostaining. Therefore proteins 
were separated by gel electrophoresis as described in chapter 2.2.28. Thereafter the gel was 
washed for 5 minutes in ice cold blotting buffer and it was electroblotted with the Mini-
PROTEAN 3 Cell System on a PVDF membrane. The blotting process was performed at 37 
volts and 8°C over night (always for plectin) or at 100 volts for 90 minutes in ice cooled wet blot 
buffer (Tab. 2-44). Blotted membranes were washed shortly in TBS-T (Tab. 2-45) and were 
blocked for one hour at room temperature in 10% (v/v) Roti-Block to prevent unspecific binding 
of antigens to the membrane. Proteins were detected by incubation with primary antibodies for a 
minimum of 1 hour at room temperature and a maximum of 24 hours at 8°C. After incubation 
the membranes were washed for 15 minutes in TBS-T and then incubated with a HRP-coupled 
secondary antibody specific for the species the primary antibodies were made from. The 
incubation was done for one hour at room temperature or 2 hours at 8°C. The primary and 
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secondary antibody concentrations are described in chapter 2.1.7. Finally, the membranes were 
washed for 15 minutes in TBS-T and thereafter covered evenly with Luminol reagent (500 µl). 
Dehydration was prevented by covering the membranes with Sarogold Pro transparent film 
(Forasarogold GmbH, Rorschacherberg, Switzerland). For detection of chemiluminescence of 
marked proteins two methods described below were used. Optionally for detection of other 
proteins membranes were stripped as described in chapter 2.2.31. The membranes were stored in 
TBS-T at 4°C for 1-2 weeks or for longer time periods dry between Whatman® filter paper 
sheets at the same temperature. 
Tab. 2-44: Wet blot buffer. 
Name Quantity for 1000 ml 
Glycine 3.03 g 
Tris base 14.4 g 
distilled H2O 800 ml 
Methanol 200 ml 
 
Tab. 2-45: Tris-buffered saline and Tween-20 buffer (TBS-T). 
Name Concentration for 1000 ml 
NaCl 130 mM 
Tris base 50 mM 
Tween-20 0.1% (v/v) 
Adjust pH with HCl to pH 7.6  
Optionally a 10X stock solution can be prepared without Tween-20. 
Signal detection on Film. 
For detection Amersham Hyperfilm ECL was illuminated by the luminol reaction in 
autoradiography cassette for 5 seconds to 30 minutes depending on signal intensity. It was 
important to not overexposure the film when possible. The film was thereafter developed directly 
in developer for 5-120 seconds, washed in H2O, fixed for 2 minutes in fixer, and finally washed 
in H2O again. All steps were done under conditions that prevented unspecific illumination of the 
film. The film was documented on UMAX scanner with a transparency adapter and Image 
Master 2D Elite software. The scanner was also calibrated with Kodak photographic step tablet 
no. 2 film for accurate greyscale values. 
Signal detection by CCD-camera. 
PVDF membrane was filmed with Fusion-Solo.WL.4M. For exposure times up to 10 minutes the 
native resolution of 2048x2048 pixels was used. For weaker signals the CCD-detector was 
binned 2x2 or 3x3. Images were done within the dynamic range of the detector at 16 bit grey 
scale depth without overexposure. The ruler was documented additionally by illumination with 
LED-light and pasted into the fluorescence images with FusionCapt Advance software. 
Material and Methods 
 
  67 
2.2.31. Stripping of blot membranes 
Antibodies were stripped from proteins on PVDF membranes by incubation in 0.1 M glycine at 
pH 2.0. Depending on the binding intensity the membranes were incubated for 15-45 minutes at 
room temperature and in extreme cases the solution was prewarmed to 40°C. The stripping 
medium was changed one time during the incubation process when the incubation exceeded 20 
minutes. Finally the membranes were washed in TBS-T buffer (Tab. 2-45). It should be noted 
that antibodies with weak signal were preferably used first for detection of proteins. Membranes 
were stripped up to five times with good results.  
 
2.2.32. Ponceau S staining of PVDF membranes 
The efficiency of protein transfer by electroblotting on PVDF membranes was tested by staining 
with Ponceau S. The solution was removed after incubation for 10 minutes and membrane was 
washed shortly in TBS-T. Thereafter the membrane was washed in H2O until protein bands 
became visible. The staining was documented with the UMAX scanner.  
 
2.2.33. Immunocytochemistry (ICC) 
Immunocytochemistry (ICC) is a technique for detection of specific proteins by fluorescence in 
microscopic probes. The method uses primary antibodies that bind to the antigen of interest. 
These antibodies can be made visible by conjugating them with fluorophores prior to binding or 
by binding of secondary antibodies that are fluorescently labelled. 
Cells were cultivated on glass coverslips or glass bottom dishes as described in the 
corresponding experiments. For ICC cells were washed in 37°C warm PBS and then directly 
fixated with methanol/acetone or PFA/acetone as described below. After fixation cells were 
washed in PBS at room temperature for at least 5 minutes or were stored overnight in PBS at 
4°C. Before immunostaining nonspecific binding was optionally blocked with 5% (w/v) BSA in 
PBS for 1 hour followed by short washing in PBS. 
Primary and secondary antibodies were diluted in PBS containing 5% (w/v) BSA as described in 
chapter 2.1.7. The cells were incubated with primary antibodies for 60 minutes at room 
temperature, then were washed in PBS for 15 minutes, and incubated for 35-40 minutes with 
secondary antibodies. Unbound secondary antibodies were washed out for 20 minutes in PBS 
before PBS was removed by short washing in H2O. Finally, the probes were mounted with 
Mowiol on microscopic slides and were dried at 4°C overnight. Preferably fluorescence images 
were done within a few days after staining for best contrast and signal intensity. Alternatively, 
slides were stored at 4°C or -22°C. 
Material and Methods 
 
  68 
Methanol and acetone fixation: 
Cells were permeabilised and fixed in -22°C cold methanol for 3 minutes and then additionally 
fixed in acetone at the same temperature for 30 seconds. This fixation method is more 
compatible with primary antibodies used. However, the disadvantages are that cytosolic proteins 
can be lost after permeabilization and that the signal of protein fluorophores can decrease.  
PFA and acetone fixation: 
Cells were fixed at room temperature in 4% (v/v) PFA for 10 minutes and then permeabilised in 
acetone at -22°C for 30 seconds. Therefore fresh PFA from aliquots stored at -28°C was used. 
This protocol preserves better cytosolic proteins and the fluorescence of many fluorophore 
proteins. However, PFA fixation was not compatible with all primary antibodies used. 
 
2.2.34. Fluorescence microscopy 
The resolution limit of standard microscopes is described by Abbe’s law of diffraction: 
𝑑 =
𝜆
2𝑁𝐴
 
λ = average wavelength of illumination in transmitted light or the excitation wavelength band in 
fluorescence; NA = numerical aperture of the objective 
𝑁𝐴 = 𝑛 sin 𝜃 
n = refractive index of imaging medium (air, water, oil); 𝑠𝑖𝑛 𝜃 = sine of the aperture angle 
In fluorescence microscopy the emitted light has a specific wavelength that is longer than of the 
absorbed (excitated) light. Unlike phosphorescence, fluorescence emission ceases abruptly after 
excitation within ≈ 10-8 second. Different fluorophores have unique properties such as: minimum 
and maximum excitation/emission wavelength, extinction coefficient ε (quantity of certain 
wavelength absorbed), quantum yield QY (ratio of emitted photons per absorbed photons), 
lifetime (duration of excited state), and Stokes shift (difference between max. excitation and 
emission peaks). All these properties can be influenced by pH, conjugated probes, and other 
parameters.  
In this work two classes of fluorophores were extensively used. The first group were fluorescent 
proteins including: enhanced green fluorescence protein (EGFP), cyan fluorescent protein (CFP), 
enhanced yellow fluorescence protein (EYFP), dsRed2, and mApple. The main advantage is that 
these proteins can by expressed and detected in living cells. After fixation of cells they can also 
be detected well but their fluorescence capabilities can decrease, for example after exposure to 
methanol. The second class of fluorophores were non-proteins, chemicals such as Alexa® (488, 
555, 633, and 647), cy3, Hoechst 33342, and DAPI. They were used only for immunostaining. 
For example the resolution for EGFP fluorescence corresponds to 200-300 nm when an objective 
with NA ≈ 1.4 is used. 
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2.2.35. Structured illumination microscopy 
Zeiss ApoTome 2 (Tab. 2-22) is a structured illumination microscope that calculates optical 
sections from three images with different grid positions. In this way out-of-focus light is 
eliminated and only the focal plane is calculated with a similar result as in confocal microscopy. 
The microscope was also used as a normal wide-field microscope when structured illumination 
was switched off. When image series were done for comparison, one image was done with 80% 
exposure, and the same settings were used for the remaining images. In case of single images 
that were not compared with others always optimal settings were chosen for automatic exposure. 
This microscope was used only for fixed samples. 
 
2.2.36. Live cell imaging 
Live cell imaging was performed for documentation of fluorescently tagged proteins and 
transmitted light to document cell shape. Therefore inverse microscopes were used where the 
objective is positioned below the sample. Excitation light was always considered as harmful to 
cells, especially at lower wavelengths and longer exposure time. Therefore, best compromise 
between image quality and toxicity was chosen. Low light intensity was also preferred to 
minimalise bleaching of fluorophores which was problematic for some constructs as described in 
the corresponding experiments. Live cell recordings were performed in glass bottom dishes from 
Mattek with different coatings as described in corresponding experiments.  
When not otherwise stated, microscopy was performed at 37°C in Hanks-HEPES-solution, 
within 30-180 minutes after cells were withdrawn from cell culture incubator. In case of scratch 
assays standard cell culture medium was used in 96-well plastic plates for short time periods of 
15-30 minutes. In case of long term experiments (4-24 hours) additionally 5% CO2 humidified 
atmosphere and normal cell medium were used. 
Tab. 2-46: Hanks-HEPES-solution for live cell microscopy. 
Name Quantity for 500 ml 
Hank's Balanced Salt Solution (HBSS) 10X 50 ml 
Sodium bicarbonate 0.175 g 
Non-essential amino acids 100X 5 ml 
Essential amino acids 50X 10 ml 
GlutaMAX™ 100X 5 ml 
N-acetyl-l-cysteine (0.48 M solved freshly) 5 ml 
HEPES (1 M) 12.5 ml 
distilled H2O (Aqua B. Braun) Adjust volume to 500 ml. 
Adjust pH to 7.45 with NaOH and filtrate sterile 
through a 0.22 µm filter. 
 
Optionally add FCS directly before usage. The medium can be stored for up to one month at 4°C and for 
long term at -28°C. 
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2.2.37. Confocal laser scanning microscopy 
Zeiss LSM 710 Duo used in this work, consists of two different scanning units. The LSM 710 
basic unit is a slow confocal laser scanning microscope equipped with photomultiplier tubes 
(PMTs) for signal acquisition, and 405, 458, 488, 514, 543, 633 nm laser wavelengths for 
illumination. In contrast LSM 5 live unit is a fast confocal line-scanning microscope that uses 
single-line CCD detectors with image acquisition speed for complete samples similar to wide-
field microscopes. However, the noise to signal ratio is lower for these detectors in comparison 
to PMTs and the resolution in depth is decreased because slits are used instead of pinholes. The 
Live unit was only equipped with 489 and 532 nm lasers. Therefore the LSM 710 laser scanning 
microscope was preferred in this work. All images were recorded at 16 bit grey-scale resolution. 
As standard, unidirectional laser scanning was performed. When the image quality was not 
noticeably affected, bidirectional scanning was performed for higher acquisition speed. The 
ability of the microscope to scan multiple times to generate an average image was not used. 
Instead the images were acquired from one scan in real-time. When more than one fluorophore 
was used with overlapping emission spectra then the detection was adjusted for the specific 
signal. It was also tested if the illumination could activate unwanted fluorophores (for example it 
was tested at which intensity 543 nm illumination could activate EGFP when it was used for 
activation of red fluorophores). Therefore the illumination intensity was always chosen to not 
cause unspecific detection. When the emission separation was good then more than one 
fluorophore was detected at once (for example DAPI with PMT 1 and Alexa555 with PMT 2 in 
the same scan). 
For detection of fluorescence for motion analysis and FRAP analysis only PMT 2 was used for 
comparable results. When more than one fluorophore was detected, two different scans were 
performed to exclude signal bleaching, then both PMTs were used to not readjust emission 
spectrum for detection to save time. The multiband QUASAR detector was used to detect 
emission spectra of fluorophores, which were used in the settings for PMT detectors. When not 
otherwise mentioned a pinhole of ≈ 93 µm (≈ 2 airy units) was used for live cell imaging and a 
pinhole of ≈ 48 µm (≈ 1 AU) for images of immunostained samples. The pinhole was the same 
for all fluorophores when chosen once, without adjustment for different emission spectra to 
decrease recording time. 
Additional information on imaging parameters can be found in the corresponding experiments. 
The components of LSM710 Duo are listed in Tab. 2-20.  
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2.2.38. Total internal reflection fluorescence microscopy (TIRFM) 
Total internal reflection fluorescence microscopy (TIRF) uses evanescent wave to excite 
fluorophores. The excited region corresponds to the bottom membrane of adherent cells. The 
signal-to-noise ratio is extremely reduced in this method because only the region of interest is 
excited. Also the phototoxicity is very low compared with wide-field microscopy. In this work 
the Zeiss TIRF 3 was used for experiments with the components described in (Tab. 2-21). The 
optimal laser settings for every filter used were calculated with the microscopes half-automatic 
adjustment system as advised by the manufacturer. 
 
2.2.39. Fluorescence recovery after photobleaching (FRAP) 
Photobleaching is the irreversible photochemical destruction of fluorescence capabilities of a 
fluorophore. The experiments were performed with Zeiss LSM 710 Duo (Tab. 2-20) with 
different settings than used for normal fluorescence microscopy. 
The bleaching was done with a 488 nm laser at 100% intensity, pixel dwell time of 6.3 µs, and 
0.7 µm z-interval for complete cell height. The light control potentiometer for laser was set to a 
value at which cells did not contract within the experiment time. Technically, repeated scanning 
in two dimensions should lead to the same results. However, here it was done in three 
dimensions, to save time, because these settings were needed for recording of fluorescence 
recovery which is described in detail in corresponding experiments. 
The analysis is described in chapter 3.4.2 and was done on a hardware calibrated (with Spyder 3 
Elite) Hewlett-Packard LP2475W LCD monitor. 
 
2.2.40. Image: data formats, editing, and analysis 
All images were recorded with highest greyscale range possible (8-16 bit) and saved in a lossless 
data format. Images from LSM 710, ApoTome 2, and TIRF 3 were saved in Carl Zeiss 
proprietary data formats (lsm5, zvi) and images from other sources were saved as TIFF files. 
For image analysis and image export Fiji software was used which supports all microscopy data 
formats used in this work. This software was also used for creation of projections from three 
dimensional data. For final editing of images for publication Photoshop CS6 was used to adjust 
greyscale/colour range and convert the images into other colour formats. This software was also 
used to create composite images and adjust greyscale gamma when mentioned. Image 
compositions, captions, and illustrations were done with Illustrator CS6 or Photoshop CS6. For 
accurate greyscale reproduction, grey scale images were saved in grey gamma 2.2 colour space 
and colour images in sRGB IEC61966-2.1 (better choice for the digital version of this 
document). For image processing hardware calibrated wide gamut monitors were used. 
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Movies were created with Image pro plus software and saved in multi TIFF data format. 
Captions, time stamps, and scale bars were added thereafter when necessary with Image pro plus 
or Fiji software. Finally, the TIFF files were converted to uncompressed AVI (Audio Video 
Interleaved) data format with Image pro plus and thereafter to MPEG-1 data format with 
TMPGEnc software and H.264 (MPEG-4 AVC) data format with Handbrake software. 
 
2.2.41. Keratin motion and turnover analysis 
Keratin motion and bulk flow were calculated from time-lapse images of fluorescently-tagged 
keratins in living cells. All recordings were done on Zeiss LSM 710 confocal microscope. The 
pinhole was set to 2 airy units, dichroic beam splitter to 488/543 nm and the sample was scanned 
at time intervals of 30 seconds (12.6 μs pixel dwell time). The signal was acquired at 16-bit 
range and at a resolution of 1024x1024 pixels. Keratin 13-EGFP was recorded upon excitation 
with a 488 nm laser at 1% laser power (light control potentiometer set to standby) at 480–599 nm 
signal range. Keratin 5-EYFP (HK5-YFP) was recorded upon excitation with 3.5% laser power 
and the emitted light was recorded at 505–599 nm. For all experiments the same zoom settings 
were used. Additional details are described in the corresponding experiments. 
The keratin motion analysis software (KFmotion Analysis 2D) and turnover analysis software 
(turnover 2D) were developed by Dr. Gerlind Herberich. The utilised mathematical procedures 
are described in chapters 3.4.3 and 3.4.4, and in more detail in (Herberich, 2014; Moch et al., 
2013).  
Mean keratin speed and heat maps 
The parameters used for detection of keratin movement with KFmotion Analysis 2D software are 
documented in chapter 10.3. The software generates maps with mean keratin movement per pixel 
from complete recordings (file: magOfMean_BVF_t0_t”x”.raw, where “x” is a number 
dependent on frames analysed). The results can be imported in Fiji software as a heat map 
(image type: 32 bit real, little-endian byte order). The movement is coded in grey values, which 
have the same length unit as was used in the analysed recordings. The calculated speed 
corresponds to movement within one minute. Because the images were acquired at time intervals 
of 30 seconds, the speed was multiplied with factor 2. Finally, a threshold for lowest values was 
set to remove noise caused by Brownian motion, vibrations of the system, and etc. The threshold 
was defined as 100 nm min-1 and was removed from speed (grey values) of every pixel. The 
following script performs all of these calculations in Fiji software and measures the total mean 
speed: 
run("Multiply...", "value=2"); 
setThreshold(100, 500000);  
wait(100); 
run("Create Selection"); 
run("Measure"); 
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The final results were also presented as a heat map where a colour LUT was added to describe 
changes in keratin movement. Alternatively keratin movement results from normalised 
recordings of different cells were overlaid and averaged. 
Vector maps of mean keratin movement 
The KFmotion Analysis 2D software also calculates vectors of mean keratin movement for 
complete recordings. These vectors can be visualised with Paraview 3.10.1 64 bit software by 
loading the corresponding mhd-files. Optionally, vectors calculated from multiple recordings can 
be averaged into one presentation with KFmotionAnalysisPostMeanMotionOverCells software 
that was written by Dr. Gerlind Herberich and is included in digital form. In the next step the 
vectors have to be transformed with the calculator function into a two dimensional presentation. 
Therefore the following formula was used: 
(MetaImage_X*iHat+MetaImage_Y*jHat+0*kHat)*2 
In the next step the 2D glyph presentation was chosen and the vector appearance adjusted. When 
multiple experiments were compared then minimum and maximum speed were set to most 
extreme results present in the data sets (vector size is coded as greyscale).  
Keratin bulk flow and heat maps 
The parameters used for detection of keratin bulk flow with turnover 2D software are 
documented in chapter 10.3.  
The software generates a map with keratin bulk flow per pixel from analysed recordings (file: 
mean_turnover.raw). The results can be imported in Fiji software as a heat map (image type: 32 
bit real, little-endian byte order). The positive grey values correspond to keratin assembly and 
negative to keratin disassembly in arbitrary units (AU). To calculate keratin bulk flow the 
positive grey values were measured, which correspond to total keratin assembly in the cell. This 
was done by setting a threshold at zero and removing all values that were equal to zero or 
smaller. The Fiji macro below does all of these steps and measures the total bulk flow as 
integrated densitometry. 
setThreshold(0.0000000, 1000000000000); 
run("NaN Background"); 
wait(100); 
run("Measure"); 
The final results were also presented as a heat map where a colour LUT was added to describe 
changes in keratin bulk flow. Alternatively keratin movement results from normalised recordings 
of different cells were overlaid and averaged. 
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2.2.42. Statistical analysis 
Statistical analysis was performed with GraphPad Prism® software. The data sets were tested for 
Gaussian distribution (normal distribution) with D’Agostino & Pearson omnibus k2 test and by 
Shapiro-Wilk normality test. Data that passed both test was assumed to correspond to Gaussian 
distribution.  
Statistical significance testing was performed in four different ways depending on the data 
analysed. Data from the same cells before and after addition of a modulator was assumed as 
paired (matched). In contrast, when two different cell clones were compared then the resulting 
data was assumed as not paired. The p values for paired data were calculated with paired t test 
when data corresponded to Gaussian distribution or with Wilcoxon matched pairs test when this 
was not the case. For paired data the confidence interval was set to 95%. Otherwise, when data 
was not paired then p values were calculated with unpaired t test when data corresponded to 
Gaussian distribution or with Mann-Whitney test when this was not the case. The p values were 
always two-tailed and were considered significant below 0.05. Note that nonparametric tests 
used for data without Gaussian distribution are less powerful than parametric tests used for 
Gauss distributed samples because they do not report confidence intervals. 
Note that mean values and standard deviation were only used to describe data that corresponded 
to Gaussian distribution. In other cases median values were used. 
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3. Results 
The main question in this work was to examine which proteins beside actin and tubulins are 
involved in regulation of keratin network dynamics in single cells. To answer this question 
keratin filament dynamics were observed in living cells and novel analysis tools were developed 
to measure them in quantitative terms. 
 
3.1. Cell lines and conditions for experiments 
The aim of this section is to shortly introduce the chosen cell lines, and conditions at which they 
were cultivated and investigated. 
A431 
A431 vulva carcinoma-derived cells were chosen because of their ability to form 
hemidesmosome-like structures (Rabinovitz et al., 1999), and because they are an established 
model to study EGF-induced pathways [for review see (Rexer et al., 2009)]. Furthermore, this 
cell line had been used successfully before to study keratin dynamics with fluorescently-tagged 
proteins (Windoffer and Leube, 1999). 
HaCaT 
HaCaT cells are immortalised keratinocytes (Boukamp et al., 1988) and were chosen as a non-
cancer cell line control. This cell line was of interest because it forms hemidesmosome-like 
structures under normal cell culture conditions (Hormia et al., 1995). 
804G 
The rat bladder tumour-derived 804G cell line (Izumi et al., 1981) was chosen because it forms 
HD-like structures, and because it produces laminin-332-rich matrix that can be used for 
cultivation of other cell lines (Langhofer et al., 1993; Riddelle et al., 1991). 
MCF-7 
MCF-7 cells are breast cancer cells (Soule et al., 1973). In this work clone HK-14-26 was used 
that is stably transfected with the mutated keratin 14 R125C, which is also tagged with enhanced 
yellow fluorescent protein (EYFP). The R125C mutation prevents the formation of keratin 
networks as is the case in epidermolysis bullosa simplex (EBS). Instead, in these clones, keratins 
assemble into aggregates that are moving in a similar way as normal keratin networks (Werner et 
al., 2004). These aggregates were of interest because they can be followed by simple 
observations. 
The sources of cell lines used for experiments and for generation of cell clones are summarised 
in Tab. 2-29. 
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Conditions for experiments 
The aim was to establish standardised cell culture and live cell microscopy conditions. 
The cell culture conditions were primarily optimised for A431 cells, because they were 
investigated in most experiments. The same conditions were used for the other cell lines, with 
only minor differences in the passaging procedure as described in chapter 2.2.15. In short, cells 
were cultivated on plastic Petri dishes in DMEM with or without phenol red as pH indicator. 
Sodium bicarbonate was used as a buffering system in 5% CO2 humidified atmosphere. 
Antibiotics were not added to reduce possible toxic effects. All cell lines were cultivated first for 
two weeks after thawing before experiments were performed. The experiments were done within 
15 passages. 
For experiments involving live cell microscopy, cells were grown on 0.15-0.17 µm thick glass 
surfaces with experiment-specific coatings. For these experiments two different optimisations 
were used as described in chapter 2.2.36. In short, for most experiments DMEM was changed to 
Hanks-HEPES-solution that reduced autofluorescence because it did not contain phenol red. This 
medium contained HEPES to increase pH stability because CO2 support was not available for 
microscopes during the major part of this work. The experiments were performed in Hanks-
HEPES-solution within 2-3 hours after addition to minimize adaption effects. After CO2 support 
became available, long term experiments (4-24 hours) were performed with 5% CO2 humidified 
atmosphere in DMEM without phenol red. Further optimisations were experiment-specific and 
are described in the corresponding chapters. 
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3.2. Keratin network organisation and dynamics in living cells 
In cultivated cells large parts of the keratin network are always in motion. The movement of 
these structures is detectable with fluorescently-tagged keratins (Windoffer and Leube, 1999).  
The aim in this section was to characterise keratin networks in A431 and HaCaT cells before 
more complex experiments. 
 
3.2.1. Keratin organisation in A431 and HaCaT cells 
The aim was to describe keratin network morphology in investigated cell culture models. 
With confocal microscopy it is possible to make three dimensional reconstructions from 
overlapping scans in z-direction. This kind of scanning is slow with conventional laser scanning 
microscopes and can be problematic when dynamic processes in living cells are investigated. 
Therefore in case of keratins it is not optimal, but it can be done with good image quality as cells 
do not show strong cell shape changes. The differences between overlaid z-sections are then only 
small and neglectable at higher scanning speeds. The line scanner of LSM Live 5 is capable of 
very fast recording, but the standard resonance scanner of the LSM 710 was preferred because of 
better image quality, and lower bleaching as described in chapter 2.2.37. For analysis single and 
unpolarised cells were chosen that were not affected by mechanical contact to other cells. 
The A431 cell clone AK13-1 was cultivated without FCS on laminin-332-rich matrix because 
these conditions have been shown to produce single A431 cells that are strongly spreaded. 
Therefore these conditions are optimal to investigate keratin networks at resolutions 
corresponding to Abbe’s law of diffraction which apply to conventional microscopes. The other 
advantage was that these cells were often not polarised. 
The keratin 13-EGFP-marked cytoskeleton of clone AK13-1 is shown in Fig. 2-1 A for a cell 
cultivated for 24 hours after plating and in Fig. 2-1 B for another cell cultivated for 48 hours. 
The orthogonal views in x-z and y-z directions were done through cell middles. The cell 
cultivated for 24 hours is higher (≈ 9 µm) in z-direction compared to the cell that was cultivated 
for 48 hours (≈ 7 µm). In both cases the nucleus is surrounded by a keratin cage that is well 
noticeable in the orthogonal views. Another observation is that the keratin network is more 
concentrated around the nucleus at 24 hours than at 48 hours. Interestingly, large parts of the 
keratin network are concentrated in a planar and thin section (≈ 1 µm) at the bottom of both cells. 
Correspondingly the bottom plane shown in Fig. 2-1 B’ contains the most keratin network detail 
compared to the upper sections shown in Fig. 2-1 B’’-B’’’’ . 
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Fig. 2-1: Keratin 13 network morphology in living A431 cells. 
Cell clone AK13-1 was cultivated on laminin-332-rich matrix without FCS. In A keratin 13-EGFP was scanned in 
one cell 24 hours after plating and in B in another cell 48 hours after plating. Note that the keratin network forms a 
cage around the nucleus in both cases, and it is also more concentrated around the nucleus after 24 hours compared 
to 48 hours.  In B’-B’’’’ single x-y sections from B are shown at indicated depth by stairs. The keratin network 
mostly concentrates at the cell bottom under the nucleus. Scale bars are 10 µm. 
The results from clone AK13-1 were compared to HaCaT clone B10 that is stably expressing 
keratin 5-EYFP. The HaCaT cells were cultivated for 48 hours on laminin-332-rich matrix, and 
unlike the A431 cells in the presence of FCS. This was done because FCS withdrawal from 
HaCaT cells resulted, in contrast to A431 cells, in lowered spreading of single cells and 
increased polarisation. The keratin 5-EYFP-marked cytoskeleton of clone B10 is shown in Fig. 
2-2 in the same way as it was done for clone AK13-1 in Fig. 2-1. The keratin network 
architectures are similar in both cell lines and can be segmented in two sections, the bottom 
plane of the cell and a cage around the nucleus. The main difference is that the keratin network 
in the bottom plane of HaCaT cells is less planar, and that it has a warp around the nucleus as 
marked with arrows in ortho views in Fig. 2-2.  The circular warp area is also well noticeable in 
the confocal plane at 2.2 µm z-depth by blurry signal as marked by arrow. In the cell middle the 
keratin network touches the bottom plane again. When single confocal planes of clone B10 are 
compared at the same interval as it was done for clone AK13-1 in Fig. 2-1 B’-B’’’, then it is 
noticeable that the keratin network is less planar, and it is more translocated between 2.2 and 3.4 
µm in z-direction. 
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Fig. 2-2: Keratin 5 network morphology in a living HaCaT cell. 
Cell clone B10 was cultivated on laminin-332-rich matrix in the presence of FCS for 48 hours. The live images 
show keratin 5-EYFP. Note that the keratin network forms a cage around the nucleus. On the right side single planes 
are shown where depth in z-direction is indicated by stairs. The keratin network in the bottom plane is not 
completely planar and it is bending at positions marked with arrows. Scale bars are 10 µm. 
In general, the keratin networks in A431 and HaCaT cells can be segmented into a bottom plane 
and into a cage surrounding the nucleus. The difference is that the keratin bottom plane is thicker 
and less planar in HaCaT cells. 
 
3.2.2. Keratin filament movement in A431 and HaCaT cells 
The aim was to test if keratin motion analysis can be done using only a single confocal plane and 
which motility patterns can be extracted from these recordings. 
In the cell lines that were expressing fluorescently-tagged keratins, keratins moved and 
assembled continuously. In this chapter these dynamic processes were investigated in two 
different cell clones by recording the fluorescence with confocal microscopy in the bottom plane. 
For observations single and unpolarised cells were chosen. 
The single cell clone AK13-Pax1 expresses keratin 13-EGFP together with the focal adhesion 
protein paxillin-dsRed2. It was generated by transfection of the A431 cell clone AK13-1 with 
paxillin-dsRed2 (plasmid 592) as described in chapter 2.2.21. This clone was chosen for 
experiments because of the detailed keratin network morphology as shown in Fig. 2-3 A. Within 
the figure different regions of keratin organisation and motility are described. Accordingly 
keratin filament precursors are formed in area 1 in close vicinity to the cell border. The 
precursors move toward the cell interior, where they elongate to short filaments in area 2, before 
they integrate into the keratin network in area 3. The keratin network can be separated into the 
peripheral network in area 3, and the keratin cage around the nucleus in area 4 that was described 
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in the previous chapter. The keratin filaments in area 3 are moving towards area 4 where they are 
bundled into thicker filaments that are either moving slower or appear static. These dynamic 
processes are documented in movie_01. 
In contrast HaCaT clone B10 formed keratin networks that are less planar than these in A431 
cells. These keratin networks were in general more difficult to record at high image quality in 
single confocal planes. However, keratin filament assembly and movement are similar to A431 
cells as shown in movie_02. The main differences shown in Fig. 2-3 B are that keratin precursors 
are smaller and less bright, and that zones 3 and 4 cannot be distinguished. The keratin 
precursors were merging directly into the keratin network that was more static compared to the 
A431 cell clone. 
 
Fig. 2-3: Keratin filament motion in A431 and HaCaT cells. 
The confocal images show fluorescently-tagged keratins in the bottom planes of single living cells. The cells were 
cultivated on laminin-332-rich matrix. In A keratin 13-EGFP fluorescence is shown in A431 cell clone AK13-1-
Pax1 that was cultivated for 20 hours prior to recording. In B keratin 5-EYFP fluorescence is shown in HaCaT clone 
B10 that was cultivated for 91 hours prior to recording. The overall laser intensity used for recording of clone B10 
was lower than for AK13-1-Pax1, and resulted in weaker signal. In zone 1 keratin filament precursors are formed 
that move toward zone 2, where they merge with other precursors forming longer filaments that are integrated into 
the keratin network in zone 3. The filaments in zone 3 move toward zone 4 where they are bundled into thicker 
filaments. Note that in clone B10, unlike in clone AK13-1-Pax, the zones 3 and 4 cannot be distinguished. The 
movements of the keratin networks are documented in movie_01 and movie_02. Note that the gamma grey values 
were adjusted to make less bright filaments visible. Scale bars are 10 µm. 
In summary, the two dimensional time lapse recordings, at the bottom plane were well suited to 
monitor keratin motion. The recordings of both cell lines showed that the keratin motion and 
assembly processes were topologically structured, and confirmed that the movement was 
directed toward the nucleus in cell center. 
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3.2.3. Keratin filament formation and integration into the keratin network 
The aim was to describe the process of keratin filament precursor (KFP) formation, elongation, 
and integration into the keratin network.  
The A431 cell clone AK13-Pax9 expresses keratin 13-EGFP and the dsRed2-tagged focal 
adhesion protein paxillin. It was generated in the same way as clone AK13-Pax1 in previous 
chapter. 
In AK13-Pax9 KFPs are formed in close vicinity to focal adhesions as marked with arrows in 
Fig. 2-4 A and as shown in the corresponding movie_03. The number of focal adhesions and 
KFPs were both simultaneously increased by addition of 50 ng ml-1 EGF. In general, KFPs 
elongate into longer filaments as marked with green, pink and red arrows in Fig. 2-4 B. At time 
point ≈ 29 minutes the filament marked in red merges with another small filament, creating a 
longer linear filament. This elongation is repeated with the longer filament marked in blue 3 
minutes later. These events occur by keratin end-to-end annealing. Alternatively, keratin 
filaments can fuse sideways thereby creating branching points. This is shown for the enlarged 
red filament at time point ≈ 42 minutes, when it binds two other filaments, one marked in pink 
and the other in yellow. The complete process is shown in movie_04 covering a larger area. 
Interestingly, the keratin filament connections appear to occur by directed processes and not by 
random collisions. It can also be seen that some connections are lost immediately after 
formation. These freed filament-ends search again for other positions to attach. After KFPs have 
elongated into longer filaments they integrate into the keratin network. This process is depicted 
in Fig. 2-4 C. The marked filament (time point 6.7 minutes) integrates into the keratin network at 
time point 11.7 minutes. After integration the filament is bundled to a thicker and brighter 
filament at time point 20 minutes. The complete process is shown in movie_05. 
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Fig. 2-4: KFP-formation, elongation, and integration into the keratin network. 
Cells were cultivated on laminin-332-rich matrix for two days after plating. The images in A and B show A431 cell 
clone AK13-Pax9 recorded in one confocal plane with Zeiss LSM live 5. The cell was treated with 50 ng ml-1 EGF 
at time point 10 minutes. The arrows mark elongating keratin filaments that fusion with other filaments.  
Background noise was removed in both channels with Fiji software by gauss filtering (radius 0.5 for EGFP, and 0.7 
for dsRed2) and rolling ball algorithm (radius: 50). The complete sequence for A is shown in movie_03 and for B in 
movie_04 for an enlarged region. In C A431 cell clone AK13-1was recorded for one hour after addition of 2 ng ml-1 
EGF with LSM 710 in one confocal plane. The arrows mark the same keratin filament during its integration in to the 
keratin network. The complete sequence is shown in movie_05. 
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3.2.4. Keratin dynamics before and after mitosis 
The aim was to investigate how keratin networks are reorganised during mitosis. To date this 
has not been done in high resolution at a reasonable speed. 
Cell division is a very sensitive process that is inhibited by light (Gorgidze et al., 1998). For this 
reason three dimensional time lapse confocal recordings were done with low laser excitation at 
488 nm and at larger intervals of 5-10 minutes. The cells were cultivated during microscopy in 
normal cell medium (DMEM), or Hanks medium, with 5% CO2. The ambient light was 
neglectable because experiments were performed at night. In the experiments single A431 cells 
without connections to other cells from clone AK13-1 were investigated. The main idea was that 
single cells are likely to divide within 2-3 days after plating. Two cell divisions were recorded in 
normal cell medium and one in Hanks-HEPES-solution. 
Before mitosis the keratin network disassembled and reorganised into dynamic keratin 
aggregates as shown in Fig. 2-5 and corresponding movie_06. This process occurred 
approximately one hour before cell division and was completed within 5 minutes. During this 
time the cell shape changed from a flat cell to a round cell. Division required less than 10 
minutes as can be seen between time points 210 and 220 minutes. After cell division keratin 
aggregates were disassembled within 5-10 minutes, and keratin filament network reformed 
within this time period. The resulting keratin network was composed of thin filaments that were 
highly dynamic. With increased time the thickness and number of keratin filaments increased 
and the network became more static as can be seen within 25 and 230 minutes after division.  
The other experiments are shown in movie_07 and movie_08. All observations showed similar 
processes for keratin network rearrangement during cell division with the noticeable difference 
in movie_08 that the keratin network disassembly occurred ≈ 20 minutes before cell division and 
less keratin aggregates were formed (the cell was plated for 24 hours in DMEM without FCS and 
recording was performed in Hanks-HEPES-solution, the other recordings were performed in 
DMEM with cells plated for 80 and 60 hours).  
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Fig. 2-5: Keratin network dynamics during cell division. 
A431 cell clone AK13-1 was cultivated for 80 hours without FCS on laminin-332-rich matrix. In the time-lapse 
images keratin filament network is disassembled into aggregates within one hour before cell division. After division 
the keratin network is reassembled within 5 minutes. The images were extracted from movie_06 and show complete 
cells from confocal sectioning. The background was subtracted in Fiji software with rolling ball algorithm (radius = 
100) and Gaussian filtering. Scale bar is 10 µm. 
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3.2.5. Keratin and focal adhesion dynamics during cell migration 
The aim was to investigate keratin dynamics at the onset of cell migration. 
Cell migration was induced in A431 cell clone AK13-Pax9 by addition of 50 ng ml-1 EGF. The 
process is documented in movie_09 and summarised in Fig. 2-6. Before migration was induced, 
the cell shape did not undergo major changes within 30 minutes, as is shown for 30 and zero 
minutes before addition of EGF. However, the distribution of FAs marked with paxillin-dsRed2 
changed during this time. After addition of EGF the formation of lamellipodia was increased and 
movement was induced with a delay of 15-20 minutes. In the direction of movement new FAs 
were established and directly thereafter new keratin precursors formed at their positions. The 
keratin network and cell morphology were strongly affected. At time point 45 minutes after 
addition of EGF the cell was more rounded and less spread when compared to time points before 
addition of EGF. During movement the keratin 13 network concentrated on the trailing side and 
extended toward the direction of movement in the leading edge. The cell left retraction fibres 
behind during the migration process as indicated by arrows. Lamellipodia were also observed 45 
minutes after addition of EGF at the leading edge as indicated by white arrows. 
 
Fig. 2-6: Keratin network dynamics during cell migration. 
A431 cell clone AK13-Pax9 was cultivated for 28 hours in presence of FCS on laminin-332-rich matrix. The images 
were extracted from movie_09 and show a cell treated with 50 ng ml-1 EGF at time point 30 minutes. After addition 
of EGF the cell begins to migrate in the indicated direction. During this process the keratin network morphology is 
changed, but KFPs are formed in the complete cell periphery. The background in the paxillin-dsRed2 channel was 
subtracted by Gaussian filtering and the contrast enhanced to compensate for photobleaching. Scale bar is 10 µm. 
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3.2.6. Keratin filament precursor formation in retraction fibres 
The aim was to investigate if keratin filament precursors (KFPs) are formed in retraction fibres 
as it was observed in axon like extensions of SW-13 cells (Woll et al., 2005). 
Retraction fibres are formed in moving cells. They stretch for more than half a cell diameter in 
A431 cells until they get separated from the cell body. Interestingly, KFPs are nucleated and 
transported in these fibres as shown in Fig. 2-7 and corresponding movie_10. The KFP 
movement can continue as long as the fibres are connected to the cell body. The KFP movement 
is microtubule-like (stop and go). In the presented example the KFP mean speed was 2.38 µm 
min-1 (SD = 0.14; n = 17). Note that only KFPs moving toward the cell body were measured in 
Fiji software. KFPs that moved in the opposite direction or that were not moving for longer than 
20 seconds were not measured. The nucleation of KFPs occurred in close vicinity to small 
paxillin positive structures as indicated by black arrows. These structures became weaker with 
increased time, indicating low turnover (bleaching), or disassembly. The number of nucleated 
KFPs decreased also with increased time as can be seen at time point 400 seconds. 
 
Fig. 2-7: KFPs are nucleated and transported in retraction fibres. 
A431 cell clone AK13-Pax6 was cultivated on laminin-332-rich matrix for 43 hours. The time-lapse images shown 
were extracted from movie_10.  The images show KFPs marked by white arrowheads that are moving inside 
retraction fibres. Possible focal adhesions that are paxillin-dsRed2-positive are marked by black arrows. The 
complete retraction fibres can be seen in the transmitted light images as marked by yellow arrows. Note that the 
background in the fluorescence channels was removed by Gaussian filtering and that the illumination in the 
transmitted light channel was corrected. Scale bar is 5 µm. 
To investigate if the movement of KFPs in retraction fibres correlates with that of microtubule 
polymerisation, A431 cells were transfected with EGFP-tagged EB3 (end-binding protein 3). 
The EB3 protein localizes with the microtubule plus end (Nakagawa et al., 2000), and can be 
used to calculate their movement/growth from time lapse recordings (Stepanova et al., 2003). 
Retraction fibres were formed in A431 cells in response to EGF treatment, as shown in Fig. 2-8 
for different experiments. The mean speed of microtubule growth was calculated from movie_11 
in the same way as for KFPs in previous example, with the difference that the movement was 
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tracked for only 20 instead of 100 seconds. In general, EB3 was more difficult to track than 
KFPs because the signal at microtubule ends was not stable. Three time points are summarised 
and color-coded in Fig. 2-8 A and A’’. The microtubule movement was with 2.85 µm min-1 (SD 
= 1.66; n = 37) in the same range as KFP movement. The microtubules were also moving in both 
directions in the retraction fibres. A difference was that microtubule movement did not stop for 
time periods longer than 20 seconds as it was the case for KFPs.  
Immunostaining of fixed cells revealed that the retraction fibres in EGF-treated cells were 
strongly integrin α6 positive as shown in Fig. 2-8 B. Plectin/HD1 was only found in the 
retraction fibres parts near the cell body as shown in Fig. 2-8 C’. 
 
Fig. 2-8: Microtubule movement and integrin α6 signal is observed in retraction fibres.  
A431 cells were cultivated on laminin-332-rich matrix for 60 hours. Retraction fibers were formed in the cells after 
treatment with 100 ng ml-1 EGF for 2-3 hours.  In A the cell was transfected with EB3-EGFP. The image shows the 
construct colour-coded at three different time points and at a higher magnification in A’. The arrows show the 
movement of single microtubule ends. Note that the white colour corresponds to overlaid signal from all three time 
points. In A’’ the transmitted light image for time point 520 seconds is shown. The complete sequence is 
documented in movie_11. In B the cells were methanol/acetone fixed and integrin α6 was detected by antibody 
staining. DNA was made visible with DAPI. The cells shown have left long retraction fibers behind that are positive 
for integrin α6 signal. In C one EB3-EGFP transfected and fixed cell is shown that is flanked on left and right by not 
transfected cells. Noticeably EB3 is localised in retraction fibres as marked by arrow. In C’ plectin was stained with 
plectin/HD1 antibodies. The plectin signal is very weak in the retraction fibres and it is not as far reaching as the 
EB3 signal. Scale bars are 5 µm. 
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3.3. Influence of hemidesmosome-like structures on keratin dynamics 
The aim was to establish hemidesmosome-like (HD-like) structures in different cell lines to 
investigate their influence on keratin filament dynamics. 
 
3.3.1. Formation of hemidesmosome-like structures in 804G cells 
The aim was to establish imaging techniques for detection of HD-like structures. 804G rat 
cancer cells were chosen because of their ability to form these structures on uncoated glass and 
plastic surfaces (Langhofer et al., 1993). In this process three different plectin antibodies were 
tested. 
804G cells were cultivated in DMEM in the same way as A431 cells (3.1). When the cells 
became confluent they formed layers of single cell height. This cell line did not form strong cell-
cell connections, but adhered far stronger than A431 cells to glass or plastic surfaces within 2-3 
days (trypsinization of 804G cells for detachment was 5 times longer than for A431 cells). Three 
different plectin antibodies were tested as shown in Fig. 2-9 by immunocytochemistry. 
 
Fig. 2-9: Comparison of three different plectin antibodies in immunocytochemistry. 
The confocal images in A-B’’ show bottom sections of confluent 804G cells that were methanol/acetone fixed, and 
immunostained with indicated plectin antibodies. Colocalised signal is shown in A’’ and B’’ in yellow colour. The 
HD1/plectin antibodies recognise the same patterns as plectin P1 antibodies, which also recognise additional 
structures.  The plectin P2 antibodies recognise most structures in comparison to the other two antibodies. DNA was 
stained with DAPI. Scale bar is 10 µm. 
The mouse HD1/plectin antibodies in images A and B is known to be specific for plectin in 
hemidesmosomes (Hieda et al., 1992). These antibodies detected patterns that resembled HD-
like structures. The guinea pig plectin P1 antibodies are known to recognise human plectin 
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(Schroder et al., 1999). However, image A’’ shows that this antibodies were capable of detecting 
the same structures as HD1/plectin antibodies in rat cells and also other structures as color-coded 
in red.  The guinea pig plectin P2 antibodies recognise plectin in human, mouse, and rat 
(Schroder et al., 1999). Fig. 2-9 B’’ shows that they bound to the same structures as HD1/plectin 
antibodies and also to filamentous structures in other regions as color-coded in red. 
In general confluent 804G cells always showed plectin patterns resembling HD-like structures. 
 
3.3.2. Formation of HD-like structures in HaCaT keratinocytes 
The aim was to investigate HD-like structures with integrin antibodies produced in rat. For this 
purpose human keratinocytes were chosen.  
HaCaT cells were treated 5-10 times longer with trypsin than A431 cells because they adhered 
strongly to plastic surfaces and to each other. All HaCaT cells formed HD-like structures on 
uncoated glass surfaces within three days after plating as shown in Fig. 2-10 A’’ and B’’ by 
integrin β4 and keratin colocalisations. Integrin β4 patterns which are needed for formation of 
HD-like structures were often organised in rings or half rings and continued in neighbouring 
cells. This was most likely when only a few cells were connected in a symmetrical way to each 
other as shown in Fig. 2-10 A’ with arrows. These continuations of integrin β4 were more 
difficult to detect in large cell clusters as shown in Fig. 2-10 B’ with arrows.  
 
Fig. 2-10: HD-like structures in HaCaT cells. 
HaCaT cells were cultivated for 3 days on glass surfaces and were methanol/acetone fixed before immunostaining. 
In A and B keratins were detected with guinea pig pan-keratin antibodies. In A’ and B’ integrin β4 was detected 
with rat antibodies, and DNA was stained with Höchst 33343. HD-like structures are present in colocalisations of 
keratin and integrin β4 as shown in A’’ and B’’. Note that the integrin β4 patterns in A’ and B’ are continued in 
neighbouring cells as indicated by arrows. Scale bars are 10 µm. 
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Fig. 2-11: Time-dependent formation of HD-like structures in HaCaT cells. 
The figures show maximum intensity projections from confocal sectioning of HaCaT cells cultivated for indicated 
time points on uncoated glass surfaces. The cells were methanol/acetone fixed and immunostained with HD1/plectin 
and integrin β4 antibodies. DNA was stained with DAPI. With increased time circular patterns resembling HD-like 
structures were formed as shown by overlaid signal in yellow colour. Scale bar is 10 µm. 
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HD-like structure formation in HaCaT cells began directly after adhesion as documented in Fig. 
2-11. These structures resembled rings after 24 hours, and their size together with cell adhesion 
area increased significantly within 2 days. 
Another observation was that cell adhesion was enhanced in the first hour after plating when 
glass surfaces were coated with laminin-332-rich matrix, in comparison to uncoated surfaces 
(data not shown). 
In general, HaCaT cells formed extensive HD-like structure patterns on glass surfaces within 72 
hours after plating. This process was independent of connections to other cells. 
 
3.3.3. Establishment of HD-like structures in A431 cells 
The aim was to establish conditions for the formation of HD-like structures in A431 cells. 
To establish reproducible conditions for the formation of HD-like structures, A431 cells (75,000 
cells cm-2) were cultivated on glass cover slips that were either uncoated, or coated with collagen 
I (5 µg ml-1), collagen IV (2.5 µg ml-1), laminin-111 (20 µg ml-1), or fibronectin (1 µg ml-1). The 
cells were grown in standard DMEM medium with 10% FCS for 58 hours. After two days A431 
cells became 90-98% confluent and formed cell layers of single cell height. The aim was to 
express HD-like structures in all cells. Patterns resembling HD-like structures were detected with 
antibodies against plectin and integrin β4. In Fig. 2-12 A large cell clusters are shown in which 
HD-like structures are not present. However, single cells inside confluent layers did sometimes 
form patterns resembling HD-like structures as indicated by arrows in Fig. 2-12 B. The images 
also show that these patterns have similar appearance on differently coated surfaces. Another 
observation was that integrin β4 signal localised at borders to other cells, outlining them without 
the formation of any patterns. These accumulations were thinner than 500 nm and are marked by 
arrows in Fig. 2-12 A. They were found when cells did not have typical patterns resembling HD-
like structures, or when HD-like patterns were weakly expressed. 
In summary, glass surfaces without coating yielded only in a few cases prominent 
plectin/integrin β4 patterns, where 99% of cells remained without these structures. Fibronectin 
coating only slightly increased the number of patterns resembling HD-like structures in 
comparison to uncoated glass surfaces. Laminin-111 and collagen I coatings were not very 
efficient at induction of these patterns, but were more efficient than fibronectin. An additional 
problem with both matrices was that the patterns had often a weak signal. This also remained 
when laminin-111 was tested at other concentrations ranging from 1-20 µg ml-1. Cells plated on 
surfaces coated with 5-20 µg ml-1 collagen IV efficiently formed patterns resembling HD-like 
structures, but still ≈ 50% of cells were negative. 
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Fig. 2-12: Formation of patterns resembling HD-like structures in A431 cells on different matrices.  
A431 cells were cultivated for 58 hours on indicated matrices before they were methanol/acetone fixed for 
immunocytochemistry with indicated antibodies. The confocal images show cells in the bottom plane. In A integrin 
β4 signal was predominantly found at cell borders as marked with arrows. Inside central cell areas no typical 
patterns resembling HD-like structures are found, or they are very weak. In B selected cells are shown that contained 
patterns that resemble HD-like structures. These patterns are color-coded by yellow where HD1/plectin and integrin-
β4 colocalised. All images in A were done with the same acquisition settings. Otherwise, in B the contrast was 
adjusted for good signal quality. Scale bars are 10 µm. 
The efficiency of HD-like structure formation was not satisfactory on these matrices. For this 
reason laminin-332-rich matrix was tested in further experiments. Laminin-332-rich matrix was 
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prepared from 804G cells as described by (Langhofer et al., 1993). In short, 804G cells were 
cultivated to 100% confluency on glass cover slips.  After one day post confluency the cells were 
washed away with 20 mM NH4OH leaving produced matrix. A431 cells were then cultivated on 
these matrices for two days to confluency in medium conditioned by 804G cells. For more 
information see chapter 2.2.18.   
Laminin-332-rich matrix was efficient in induction of HD-like structures as shown in Fig. 2-13. 
HD-like structures were found in ≈ 99% of cells. 
 
Fig. 2-13: Formation of HD-like structures in A431 cells on laminin-332-rich matrix. 
A431 cells were cultivated for 52 hours on laminin-332-rich matrix in conditioned medium from 804G cells. For 
immunocytochemistry the cells were methanol/acetone fixed. HD-like structures are shown by overlaid plectin and 
keratin signal in yellow colour as marked by arrows. DNA was detected with DAPI. Scale bar is 10 µm. 
In further experiments HD-like structures were studied in A431 subclone AK13-1 that is stably 
expressing keratin 13-EGFP. HD-like structures were induced in the same way by laminin-332-
rich matrix as described previously. In Fig. 2-14 A-C it is shown with arrows that the 
endogenous EGFP-tagged keratin colocalizes on specific spots with plectin, integrin α6, and 
integrin β4. 
AK13-1 cells formed HD-like structures also in normal cell medium that was not conditioned 
with 804G cells as shown in Fig. 2-14 D. The efficiency of HD-like structure formation was then 
slightly decreased to ≈ 90% of cells. HD-like structures were found not only in confluent cell 
layers, but also in single cells that were not connected to other cells. However, single A431 cells 
were scarce after cultivation for over 48 hours in 10% FCS, because of high division rates under 
these conditions. The most prominent HD-like structures were predominantly localised in cells at 
borders of confluent layers. 
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Fig. 2-14: Formation of HD-like structures in A431 cell clone AK13-1 on laminin-332-rich matrix. 
The confocal images show cells in the bottom plane that were methanol/acetone fixed for immunocytochemistry. 
The cells in A-C were cultivated for 52 hours in conditioned medium from 804G cells and in D for 48 hours in 
normal cell medium. HD-like structures are indicated by arrows and by yellow/orange colour, in the overlaid images 
on the right side. Note that keratin bundles are localised at sites of HD-like structures. Scale bars are 10 µm. 
For further experiments it was necessary to slow down the division rate of A431 cells to increase 
the number of single cells. In the first approach minimum essential medium (MEM) instead of 
DMEM was tested. This medium led to fewer HD-like structures and was therefore not used 
later. In the second approach cell number for plating was decreased to 20,000 cells cm-2. With 
this method single cells were sometimes found 48-60 hours after plating.  In a third approach 
FCS withdrawal one hour after plating led to a few single cells without connections to other 
cells. This method is described in more detail in the following chapter. 
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3.3.4. Time dependent formation of HD-like structures in A431 cells 
The aim was to investigate how the formation of HD-like structures in A431 cells occurs after 
plating. 
 
Fig. 2-15: Time-dependent formation and disassembly of patterns resembling HD-like structures. 
The confocal images show A431 cells in the bottom plane that were cultivated on laminin-332-rich matrix. For 
immunocytochemistry the cells were fixed with methanol/acetone at indicated time points. In A cells form ring-
shaped patterns one hour after plating that resemble HD-like structures. In these patterns marked with arrows 
integrin α6 and plectin colocalize as shown in yellow colour. In B at time point of 6 hours these structures are 
almost absent, instead integrin α6 signal is localised at cell borders without plectin as shown by arrows. In C after 
24 hours HD-like patterns are noticeable in cells at border of confluent cell layers as indicated by arrows. DNA was 
detected with DAPI. Scale bars are 10 µm. 
When A431 cells were plated on laminin-332-rich matrix they became well attached within ≈ 5 
minutes. Patterns resembling HD-like structures were detected 30-60 minutes thereafter as 
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shown in Fig. 2-15 A. The patterns were frequently circularly shaped as shown by arrows. 
Within 3-12 hours after plating these structures dissolved, or became less prominent. Integrin α6 
translocated to the cell periphery as shown in Fig. 2-15 B by arrows. It was noticeable that 
integrin α6 signal, but not plectin, was mostly located in regions where neighbouring cells were 
connected. The HD-like structures were re-established again at time point 24 hour in a small 
minority of cells, mostly in cells at borders of confluent layers, as shown in Fig. 2-15 C by 
arrows. 
In comparison, A431 wild type cells tested under the same conditions as A431 cell clone AK13-
1, assembled and disassembled HD-like structures in the same way. It should be noted that 72-90 
hours after plating A431 cells became confluent, and at specific positions formed layers that 
were higher than one cell. In this phase HD-like structures were smaller and less bright than 
earlier (data not shown). The cells also had less space to adhere with increasing time because cell 
number increased.  
In summary, A431 cells form patterns that resemble HD-like structures within one hour after 
plating. These structures are disassembled soon afterwards and begin to reassemble 24 hours 
later in some cells. The patterns are then changed from circular rings to stripes. 
 
3.3.5. Involvement of growth factors in formation of HD-like structures in A431 
cells 
Under normal conditions growth factors in form of FCS were always added to the cell medium. 
The aim in this experiment was to investigate how FCS withdrawal affects the formation of HD-
like structures. 
In the following experiments A431 cells were solved after trypsinisation in medium containing 
FCS to inhibit trypsin. FCS was removed from cells shortly thereafter by centrifugation for three 
minutes at 200 RCF. The cells were then cultivated in FCS free medium on laminin-332-rich 
matrix, and after 2 and 49 hours samples were fixed and stained with integrin β4 antibodies as 
shown in Fig. 2-16. The integrin β4 patterns formed after 2 hours without FCS in image A are 
similar to HD-like structures in cells cultivated with FCS, as shown in Fig. 2-15 A. In some 
cases without FCS these structures were also absent as shown in Fig. 2-16 A’. After 49 hours 
integrin β4 was predominantly localised in rings around the nucleus, as shown with arrows in 
Fig. 2-16 B for single cells, and in B’’-B’’’ in cell clusters. Some cells also did not form these 
ring-shaped structures as shown in image B’. In a statistical approach single cells, without 
contacts to other cells, were tested for integrin β4 rings at time points of 24, 48, and 72 hours 
after plating. Therefore confocal images were recorded with identical settings in the bottom 
plane for all time points. All integrin β4 patterns that resembled a ring, or half ring, near the 
nucleus were counted as rings. The results in Fig. 2-16 F show that the number of cells with 
integrin β4 rings decreased in a time dependent manner, from 40% at 24 hours after plating, to 
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25% after 48 hours, and to 10% after 72 hours. The decrease in total fluorescence of stained 
integrin β4 decreased accordingly as shown in Fig. 2-16 C. 
 
Fig. 2-16: Decreased formation of HD-like structures in A431 cells after FCS withdrawal. 
The confocal images show the bottom plane of AK13-1 cells that were cultivated on laminin-332-rich matrix 
without FCS. The cells were methanol/acetone fixed at indicated time points before immunocytochemistry. In A, B, 
B’’, and B’’’ HD-like structures that are organised in rings are marked with arrows. In A’ and B’ no HD-like 
structures are found and keratin organisation is loose. C shows that fluorescence signal of integrin β4 decreases with 
increasing time, from 24 to 72 hours after plating in serum-starved cells. Error bars are standard error of the mean. D 
shows that the number of cells with integrin β4 rings around nucleus decreases with increasing time after plating, 
from 24 to 72 hours for serum-starved cells. Scale bars are 10 µm. 
The integrin β4 rings around the nucleus also influenced keratin network organisation. Keratin 
filaments were bundled to thicker filaments in close vicinity to them, as shown in Fig. 2-16 B for 
single cells, and in Fig. 2-16 B’’’ for confluent cells. The keratin networks was always organised 
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in ring structures when integrin β4 rings were present. Otherwise when the integrin β4 rings were 
missing keratin networks could be organised loose as shown in Fig. 2-16 A’ and B’. In general, 
other integrin β4 structures than rings, or half rings, were found in limited number of cells. 
Without FCS they were much weaker than in cells treated with at least 1-2% FCS. The optimum 
FCS concentration for formation of HD-like structure was determined to be 5-10%. 
In summary, A431 cells formed much less HD-like structures when FCS was withdrawn after 
plating. This procedure was used in later experiments, with the modification that FCS was 
withdrawn one hour after plating, after nearly all cells adhered. This procedure facilitated the 
handling and was easier to standardise. 
 
3.3.6. Labelling of HD-like structures by fluorescently tagged integrin β4 
The aim was to study the influence of HD-like structures on keratin dynamics in vivo by 
fluorescently-tagged integrin β4 and fluorescently-tagged keratins. 
The plasmid encoding integrin β4-EGFP was a gift from by Prof. Jonathan C.R. Jones. The 
sequenced construct corresponded to NCBI GenBank entry BC143738.1 GI:219518901. The 
used sequence contained a silent mutation that did not alter encoded amino acid sequence. The 
plasmid was transfected with Lipofectamine reagent in 804G and A431 cells. In limited cases the 
transfection resulted in the formation of patterns that resembled HD-like structures as shown in 
Fig. 2-17 A and C. In many cases the transfection resulted in fluorescence that looked similar to 
endoplasmic reticulum as shown in Fig. 2-17 B. This second kind of structure was very dynamic 
compared to HD-like structures. It showed continuous motion from cell periphery toward cell 
interior as can be seen in movie_12. In other cases cells have shown only cytosolic signal 
without any specific structures. The different forms of integrin β4-EGFP also coexisted in many 
cases. In limited cases the integrin β4-EGFP was only found in patterns as expected for HD-like 
structures (stripes in A431 cells). In 804G cells that incorporated integrin β4-EGFP into HD-like 
structures, circular “empty” spaces of 250-400 nm in diameter were found in these regions 
(arrows in Fig. 2-17 C). Phalloidin staining revealed that these “empty” spaces were filled with 
actin (arrows in Fig. 2-17 D-D’). These spaces without integrin β4 were also present in non-
transfected cells (Fig. 2-17 D’). The integrin β4-EGFP construct furthermore colocalised with 
plectin in HD-like structures (yellow colour in Fig. 2-17 E). 
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Fig. 2-17: Fluorescence patterns formed by integrin β4-EGFP. 
A431 and 804G cells were transfected with integrin β4-EGFP plasmids one day before imaging. The A431 cells 
were cultivated on laminin-332-rich matrix and the 804G cells on glass surfaces. The confocal images show the 
bottom planes. In A-C single images from live recordings are shown and in D-E images form immunocytochemistry 
of methanol/acetone fixed cells. Integrin β4-EGFP formed in both cell lines patterns resembling HD-like structures 
as shown in A, C and D. However, other structures as shown in B were present in some transfected cells 
(movie_12). In D circular empty spaces are present integrin β4-EGFP patterns. These spaces are filled with actin as 
shown in D’. Actin was detected with phalloidin-TxR, plectin with HD1/plectin antibodies, and DNA with DAPI. 
Scale bars are 10 µm. 
 
3.3.7. Generation of clones expressing integrin β4-EYFP 
The aim was to generate cell clones stably expressing fluorescently-tagged integrin β4. 
HD-like structures marked by integrin β4-EGFP were mostly of low brightness. This problem 
was especially noticeable after methanol/acetone fixation that decreased brightness of EGFP 
further. To increase the brightness of integrin β4 marked structures, two different constructs with 
EYFP instead of EGFP were created. The cloning procedures are described in detail in chapter 
2.2.13.  In short, in plasmid 2077 encoding integrin β4-EGFP the EGFP-tag was replaced with 
EYFP resulting in plasmid 2101. In the second construct EGFP was replaced, and an additional 
linker integrated between integrin β4 and EYFP, resulting in the plasmid 2105. The linker 
encoded an amino acid sequence that is typical for an α-helix. The aim was to make the 
fluorophore more flexible and to test if this would increase the number of incorporated integrin 
β4-EYFP molecules in HD-like structures. However, no significant differences in transfection 
and quality of patterns resembling HD-like structures were observed with plasmid 2105 when 
compared to plasmid 2077 or 2101. The phenomenon with other structures marked additionally 
to patterns resembling HD-like structures remained as described in 3.3.6. 
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The transfection efficiency was low for all integrin β4 constructs. Therefore stably transfected 
A431 cell clones were generated with both EYFP versions of integrin β4. Seven clones were 
selected that expressed plasmid 2105. Clone 2 showed EYFP signal only in cytosol. The other 
six clones formed EYFP positive patterns that resembled HD-like structures. Clone 28 had the 
strongest expression of plasmid 2105 resulting in the brightest structures. 
In all further experiments integrin β4 from plasmid 2105 is referred as integrin β4-EYFP. The 
generated clones are carrying the name A431-IB4-X, where X is the clone number. 
 
3.3.8. Live dynamics of keratin and integrin β4 
The aim was to investigate the influence of HD-like structures on keratin dynamics and 
morphology. 
Keratin 8-mCherry was transfected in A431-IB4 cell clones that stably express integrin β4-
EYFP. Fig. 2-18 shows live images of integrin β4-EYFP in the bottom cell layer.  To these 
structures keratin 8-mCherry was attached forming large connection-sites that are marked with 
arrows. In Fig. 2-18 A the connection between integrin β4 and keratin remained stable during the 
complete recording for 9.5 minutes. The structures were not recorded longer because of strong 
bleaching. In Fig. 2-18 B the cell retracted on the right side at time point of ≈ 13 minutes. The 
HD-like structures disassembled within 3-4 minutes, and structures that did not disassemble were 
retracted toward the cell interior together with keratin 8. The corresponding movie_13 and 
movie_14 show that HD-like structures were not completely static, but flexible, or were moving. 
They showed remodelling processes within the time range of seconds to minutes.  
After longer imaging periods (30 frames in 15 minutes) it was not always clear, if integrin β4-
EYFP was completely bleached, or translocated. Longer gaps between the images (>45 seconds) 
have proven not helpful because of strong z-shift behaviour of the LSM 710, that had not been 
equipped with automatic focus stabilization at time of experiments (z-stage correction was done 
manually during the recording process). The exact z-stage position was critical for imaging of 
HD-like structures, because small shifts led to loss of signal at sites of interest. At lower 
excitation intensities HD-like structures were unsharp and background noise increased as shown 
for raw data in Fig. 2-19 A. However, the bleaching of integrin β4-EYFP in time lapse 
recordings was significantly decreased with these settings. The image quality was further 
enhanced by denoising. The ImageJ plugin PureDenoise was preferred to other filters integrated 
in Fiji software. It was used with its automatic/global settings as shown in Fig. 2-19 A and 
corresponding movie_15. The denoising produced small artefacts that were not problematic. The 
overall detail quality increased strongly. In general two times less excitation led to similar detail 
quality as in images recorded with standard laser intensities. The main difference to recordings at 
higher excitation intensities was that they were sharper compared to denoised images. In Fig. 
2-19 two versions of fluorescently-tagged keratin 13 constructs bind to HD-like structures. 
Keratin 13 formed similar HD-like structure patterns as already shown for keratin 8 in Fig. 2-18. 
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Fig. 2-18:  Live dynamics of HD-like structures in A431 cells. 
In A cell clone A431-IB4-14, and in B cell clone A431-IB4-9, were cultivated on laminin-332-rich matrix for 72 
hours. The cells were transfected with keratin 8-mCherry plasmids one day before recording. The time-lapse 
confocal images were extracted from movie_13 and movie_14, and show cells at the bottom planes. HD-like 
structures that anchor keratin filaments are marked by arrows. In A the marked structures are static for the recorded 
time. In B these structures are dynamic and disassemble, with the consequence that keratin and the cell on the right 
side retract. Scale bars are 10 µm. 
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Fig. 2-19: Live confocal images of HD-like structures enhanced by denoising. 
In A cell clone A431-IB4-16, and in B cell clone A431-IB4-14, are shown that were cultivated on laminin-332-rich 
matrix for 72 or 66 hours. The clones had been transfected with keratin 13-mApple or keratin 13-mCerrulean 
plasmids one day before recording. All confocal images were done at low laser excitation as shown in A for raw 
data. The other images in A and B were additionally denoised with the ImageJ plugin PureDenoise. In A after 60 
frames the signal of integrin β4-EYFP is decreased but can still be recognised after denoising. The peripheral HD-
like structures that are marked by arrows translocate toward the cell interior. The complete sequence is shown in 
movie_15. In B HD-like structures are shown in white colour in the overlaid images. They have also a more central 
localisation in the cell. Scale bars are 10 µm. 
TIRF microscopy that became available later was the gentlest way to image HD-like structures. 
Time lapse series of over 100 images were possible with moderate bleaching at imaging speeds 
up to 15 frames per second. However, the illumination was uneven at high laser angles that were 
needed to create evanescent waves. In Fig. 2-20 A integrin β4 structures were well detectable 
after 60 frames within 10 minutes. The recording shows small HD-like structures that are marked 
with arrows. Within 10 minutes the small patterns formed one larger structure by moving 
together. The keratin filaments, bound to these small integrin β4 islands, concentrated during this 
process in a single area. The cells still formed new keratin filaments when HD-like structures 
were present. This resulted in keratin movement especially in zones where HD-like structures 
were not present as shown with asterisks in Fig. 2-20 B. Both movies_16 and movie_17 from 
Fig. 2-20 show keratin filament formation and keratin network movement. 
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Fig. 2-20: Live TIRF images of HD-like structure in A431 cells. 
Cell clone A431-IB4-9 was cultivated on laminin-332-rich matrix for 52 hours. The cells were transfected with 
keratin 13-mApple plasmids one day before recording. The image quality was enhanced by interpolation in Zen 
2011 software. In A dynamic HD-like structures are marked with arrows that merge together within 10 minutes to a 
larger structure. The complete sequence is shown in movie_16. In B zones outside of HD-like structures are marked 
with asterisks where keratin filaments are continuously moving. HD-like structures are white in the composite 
image. Keratin signal gamma was changed to 0.75 in Photoshop CS6 to make weak keratin signal stronger and 
integrin β4-EYFP signal was denoised with PureDenoise. The complete sequence is shown in movie_17. Scale bars 
are 10 µm. 
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3.4. Changes in keratin dynamics of A431 cells after adhesion 
The hypothesis to be investigated was that keratin dynamics are decreased when cells form HD-
like structures. The aim was to measure keratin dynamics before and after formation of HD-like 
structures. To achieve this goal, new methods had to be developed for the standardised 
measurement of keratin motion and turnover. 
 
3.4.1. Standardised cell lines 
The first aim was to standardise cells for analysis by live cell microscopy. The established 
parameters are described here for better understanding of the following experiments. 
Widely spread (flat) cells without connections to other cells were used for quantitative 
experiments. These cells were present in A431 and HaCaT cell culture 48 hours after plating. In 
case of A431 cells laminin-332-rich matrix enhanced cell spreading. At longer time intervals 
after plating the number of single cells decreased, especially in presence of 10% FCS. For this 
reason experiments at time intervals longer than 82 hours after plating could not be performed 
with A431 cells. Cells selected for analysis were similar in adhesion area (± 25%) and preferably 
circular and not polarised. Cells with more than one nucleus, apoptotic cells, or dividing cells 
were excluded from analysis. Cells were always cultivated for at least one hour in FCS to 
completely inactivate trypsin and to adhere. When cells were described to be incubated without 
FCS, then FCS was withdrawn one hour after passaging. For more detail on cell preparation see 
chapter 2.2.15. 
 
3.4.2. Keratin turnover measured by fluorescence recovery after photobleaching 
(FRAP) 
Keratin turnover was measured by FRAP in cells at different time points after plating.  
Clone AK13-1 was cultivated for 1-81 hours without FCS at a concentration of 50,000 cells/cm2. 
For FRAP analysis keratin13-EGFP fluorescence was bleached in half of the cell (Fig. 2-21 A) 
with parameters described in 2.2.39. The fluorescence was decreased by 20-40% depending on 
filament size and cell height. For analysis only cells were used in which 40-60% of the total cell 
area was photobleached. Fluorescence recovery recording was started 60 seconds after bleaching 
at intervals of 5 minutes. Both cell halves (67 x 67 µm) were imaged at 0.2% laser intensity, 
pixel dwell time 1.58 µs, and the same z-interval of 0.7 µm for complete cell height as used for 
bleaching. The fluorescence was detected at a spectrum of 490-548 nm with a resolution of 512 x 
512 pixels. A lower resolution of 256x256 pixels has shown as insufficient for recognition of 
bleached and unbleached cell halves.  
The fluorescence recovery was measured for a total time of 25 minutes for analysis and at 27 
minutes for documentation at higher quality. Note that the thicker keratin filaments in cell 
middle recovered fluorescence slower than thinner filaments in cell periphery (Fig. 2-21 A-A’).  
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Fig. 2-21: Keratin turnover measured by FRAP at different time points after plating. 
Clone AK13-1 was cultivated without FCS on laminin-332-rich matrix for indicated time periods. In A-A’ 
projections of keratin 13-EGFP are shown from confocal images. Values for fluorescence recovery describe the 
amount of fluorescence transferred from unbleached to bleached cell halves. Time point of zero minutes was 
scanned one minute after start of photobleaching. In B fluorescence recovery in photobleached cell halves is shown 
for all FRAP experiments. Statistical differences were determined by two-tailed, 1Unpaired t test, or 2Mann-Whitney 
test depending on whether data corresponded to Gaussian distribution or not. The whiskers are 5-95% percentiles. In 
C the FRAP recording settings were tested for bleaching on a single cell. The cell was recorded for 46 minutes at 
time intervals of 60 seconds and shows no problematic bleaching of EGFP during this time period. Scale bar is 10 
µm. 
Analysis of recorded images was done with Fiji software. In detail, the z-stacks of single cells 
were converted to 32 bit sum projections. The background was measured by integrated 
densitometry at four arbitrary locations of 9.82 µm2 for every time point outside of the cell, it 
was averaged per pixel, and subtracted from complete image. The bleached and unbleached cell 
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halves were outlined for every time point and corresponding sums of grey values were measured. 
The borders of unbleached and bleached cell regions were readjusted when cell shape changed.  
The fluorescence in bleached part was defined as 𝐼𝑡=𝑛
𝑏  and for the unbleached part as 𝐼𝑡=𝑛
𝑢  (t = 
time point n, b means bleached, u means unbleached). Fluorescence recovery in the bleached 
part was calculated from the differences between 𝐼𝑡=𝑛
𝑏 − 𝐼𝑡=0
𝑏  and 𝐼𝑡=𝑛
𝑢 − 𝐼𝑡=0
𝑏 . The florescence 
distribution calculated in this way for time point 0 was always 0% in bleached part and was 
defined as 100% in unbleached part. The gain of fluorescence in bleached part was proportional 
to loss of fluorescence in unbleached cell part with increasing time. Note that this procedure 
allowed neglecting the differences in bleaching efficiency in different cells. 
In Fig. 2-21 B the fluorescence recovery rates for all experiments are summarised. Cells 
investigated 1-11 and 24-33 hours after plating did not differ significantly in keratin 13 recovery 
when measured for 5-25 minutes. At 25 minutes a mean value of 21.3% (SD = 7.2) keratin was 
translocated in cells that were plated for 1-11 hours, and 20.6% (SD = 4.9) in cells that were 
plated for 24-33 hours. Cells that were investigated 48-57 and 72-81 hours after plating also did 
not differ significantly in keratin recovery. After 25 minutes a mean value of 12.9% (SD = 3.9) 
keratin was translocated in cells that were plated for 48-57 hours, and 12.2% (SD = 4.7) in cells 
that were plated for 72-81 hours. Cells plated 33 hours prior to experiments showed a 
significantly higher keratin turnover than cells that were plated for longer than 48 hours. At time 
point of 5 minutes post-bleach the calculated p value was significant with 0.0004, as was the 
case for later time points between 10-25 minutes with p < 0.0001. 
With increased time after plating the cells were easier to analyse because of less cell shape 
changes. This was a problem for time points of 1-11 hours after plating where a significant 
number of cells could not be analysed due to major cell shape changes. Note also that these cells 
showed high variations in turnover (Fig. 2-21 B). The control in Fig. 2-21 C shows that the 
recording conditions for FRAP did not cause significant photobleaching within 46 minutes when 
a z-stack of a complete cell was scanned every 60 seconds. 
In general, the keratin 13 turnover in serum starved clone AK13-1 plated on laminin-332-rich 
matrix decreased significantly from day 1 to day 2 after plating. This was also confirmed for 
experiments in presence of FCS (data not shown). 
 
3.4.3. Keratin movement measured by computational analysis 
The aim was to develop an alternative method for quantitative measurement of keratin dynamics 
that would provide information about keratin movement. The software for analysis was 
developed by Dr. Gerlind Herberich as described in 2.2.41. 
Clone AK13-1 was cultivated in the same way as described for FRAP experiments (3.4.2). For 
analysis fluorescence was recorded in single cells by confocal microscopy in one confocal plane 
for 15 minutes every 30 seconds (2.2.41). The recording parameters were chosen such that image 
quality was as good as possible without bleaching (Fig. 2-22 E). The keratin motion was 
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computed in two different ways from recorded images as illustrated in Fig. 2-22 A and as 
described in chapter 2.2.41. In the first case the shape of keratin cytoskeleton was not adjusted 
(Fig. 2-22 B), in the second case the keratin cytoskeleton was normalised to a circular cell shape 
(Fig. 2-22 B’). The keratin network normalisation also allowed compensation for cell shape 
changes during recording. The border of keratin network for normalisation was recognised by 
keratin 13-EGFP signal as shown by outlines in Fig. 2-22 B. Note that by normalisation the cell 
area was changed in a disproportionate (not linear) way from nm2 to AU2.  
 
Fig. 2-22: Workflow for calculation of keratin motion from time lapse recordings. 
Clone AK13-1 was cultivated without FCS for 33 hours on laminin-332-rich matrix. In A the process of keratin 
motion detection from time lapse images of fluorescently tagged keratins is illustrated. In B the motion of keratin 
13-EGFP was analysed in a single cell recorded for 15 minutes every 30 seconds. The vectors and heat maps 
demonstrate the mean keratin movement.  In B’ the keratin network information from Fig. B was normalised to a 
circular form prior to motion analysis. In C the automatically recognised shape of the keratin cytoskeleton was 
outlined in black colour. The cell shape recognised in the transmitted light microscopic image was outlined by hand 
in white colour. In D keratin motion heat maps from Fig. B and B’ are shown after subtraction of background. In E 
recording parameters were tested for photobleaching, which is not noticeable. Whiskers are maximum and 
minimum. The generation of the figures is described in more detail in chapter 2.2.41. 
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The vector fields of not-normalised and normalised cells show that keratin movement was 
directed towards the cell interior. Speed of keratin 13 is represented by thickness of vectors and 
by colour in heat maps. In the not-normalised cell keratin was moving fastest in the cell 
periphery with maxima of 350-710 nm min-1 towards the cell interior. In the normalised cell 
keratin was moving in the same way with maxima of 300-586 AU min-1. The movement in the 
cell middle was in the range of background noise, which was defined as < 100 nm min-1 for not-
normalised data and < 100 AU-1 for normalised data. The keratin 13 mean speed was calculated 
after subtraction of background noise as shown in Fig. 2-22 D. The keratin 13 network in not-
normalised cell was moving with a mean speed of 215 nm min-1, and in normalised cell with 198 
AU min-1. Note that the motion analysis did not include keratin precursors in the cell periphery 
because they were filtered out by the denoising algorithm.  
The automatically normalised shape of keratin network was compared to the cell shape from 
transmitted light images (Fig. 2-22 C). As expected it is inside the cell and corresponds to the 
keratin network. The normalisation accuracy is resolution dependent and decreased when cells 
retracted. Therefore normalisation was only done in further experiments when adhered cell area 
did not decrease more than 10% compared to the start of experiment. 
 
Quantitative analysis of keratin movement at different time points after plating. 
Keratin motion was calculated from recordings of cells cultivated for 24-33 (n=50) and 48-57 
(n=84) hours. In general, keratin was moving toward the cell interior in all datasets as shown by 
vector fields calculated form normalised recordings (Fig. 2-23 A). The heat maps (Fig. 2-23 B) 
show that keratin was moving fastest in the cell periphery in a ring shaped area, and that in an 
area under the nucleus movement was nearly absent. It is also well recognisable that keratin was 
moving slower in the older cells.  
The mean keratin speed for not-normalised recordings decreased significantly from 24-33 to 48-
57 hours after plating by 34.5% [from 165.3 nm min-1 (SD = 45.2) to 108.3 nm min-1 (SD = 
30.0)] (Fig. 2-23 C). The decrease in speed was highly significant with a p value < 0.0001. The 
mean keratin speed calculated from normalised recordings did not correspond to a Gaussian 
distribution. Therefore median speed was compared (Fig. 2-23 D), which decreased by 42.5% 
(from 132.0 to 75.91 AU min-1) with a significant p value of < 0.0001. In comparison the 
median for not-normalised recordings decreased by 33.6% (from 162.8 to 108.1 nm min-1) with 
also a significant p value < 0.0001. 
In general, keratin movement decreased significantly from day 2 to day 3 after plating in A431 
cells. 
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Fig. 2-23: Keratin movement at different time points after plating. 
Clone AK13-1 was cultivated without FCS for indicated time periods on laminin-332-rich matrix. The movement 
was calculated from confocal images done at time intervals of 30 seconds for 15 minutes. In A and B mean keratin 
movement calculated from normalised recordings was overlaid and averaged. In A keratin is moving toward the cell 
interior, and correspondingly in B the highest movement is detected in the cell periphery. Scale bar is 5000 AU. In 
C mean keratin speed is shown for not-normalised recordings and in D for normalised recordings. Statistical 
differences were determined by two tailed 1unpaired t test or 2Mann-Whitney test depending on whether data 
corresponded to Gaussian distribution. Whiskers are 5-95% percentiles. 
 
3.4.4. Keratin bulk flow measured by computational analysis 
The aim was to use keratin movement information from computational analysis to calculate 
turnover of moving keratins with topological information of assembly and disassembly. The 
software for analysis was developed by Dr. Gerlind Herberich. 
For calculation of keratin 13-EGFP bulk flow, keratin movement calculated for different time 
points after plating were used from the previous chapter. The signal intensity was assumed 
proportionally to keratin mass. Keratin sources were detected when new keratin signal appeared 
and keratin sinks when keratin signal disappeared. For more detail see chapter 2.2.41. 
Keratin formation and disassembly decreased significantly from 24-33 to 48-57 hours after 
plating (Fig. 2-24 A). The assembly (sources) was detected in a ring-shaped area in the cell 
periphery as indicated in yellow-red, and disassembly (sinks) was detected in a smaller ring 
inside the cell as indicated in green-blue. In the cell middle no keratin assembly or disassembly 
was detected as indicated in black. It was also noticeable that a black ring between the sources 
and sinks regions existed where keratins remained stable during transport. This indicates that 
zones of keratin assembly and disassembly are spatially separated. 
 
Results 
 
  110 
The results for keratin bulk flow did not correspond to a Gaussian distribution. Therefore median 
bulk flow was compared. As expected, the median keratin bulk flow for not-normalised 
recordings decreased significantly from 24-33 to 48-57 hours after plating by 56% (from 3.13 to 
1.38 AU min-1) (Fig. 2-24 B). The decrease was highly significant with a p value < 0.0001. For 
normalised recordings this was also the case, the median keratin bulk flow decreased 
significantly by 64% (from 2.75 to 0.99 AU min-1) (Fig. 2-24 C). The decrease was also highly 
significant with a p value < 0.0001. 
 
Fig. 2-24: Keratin bulk flow at different time points after plating. 
The data for keratin 13-EGFP movement used here to calculate keratin bulk flow is presented in Fig. 2-23. In A 
mean keratin bulk flow calculated from normalised recordings was overlaid and averaged. Keratin filaments are 
mostly formed in cell periphery in the area marked in red. Thereafter the filaments are transported toward the cell 
interior where they are disassembled in the area marked in blue. Scale bar is 5000 AU. In B keratin bulk flow is 
shown for not-normalised recordings and in C for normalised recordings. Statistical differences were determined by 
two tailed Mann-Whitney test. Whiskers are 5-95% percentiles. 
In general, keratin bulk flow decreased significantly from day 2 to day 3 after plating in A431 
cells. 
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3.5. Influence of epidermal growth factor (EGF) on keratin dynamics 
In previous work it was described that keratin precursors are formed in lamellipodia during cell 
migration induced by EGF (Felkl et al., 2012). Another effect of EGF is that it induces 
disassembly of HD-like structures (Margadant et al., 2008). Otherwise new focal adhesions are 
formed in response to EGF and old focal adhesions are disassembled (1.5.1). The resulting 
hypothesis to test was that keratin dynamics could be increased by EGF. 
 
3.5.1. General observations after treatment of A431 cells with EGF 
The aim was to determine optimal concentrations of EGF for experiments in A431 cells. 
Clone AK13-1 was cultivated in the same way as described for FRAP experiments in chapter 
3.4.2. In the initial experiments EGF was tested at different concentrations (0.5-150 ng ml-1). 
Before the addition of EGF old medium was completely removed from cells. The concentration 
of 20 ng ml-1 EGF was decided as optimal for further experiments because it induced cell 
ruffling and enhanced formation of keratin filament precursors (KFPs) within one minute after 
addition. Epidermal growth factor receptor (EGFR) was also activated on Y1068 within one 
minute after addition of EGF as shown by immunoblot analysis in Fig. 2-25 A. The 
phosphorylation level of Y1068 decreased rapidly within 15 minutes post activation to initial 
values. Interestingly, focal adhesion kinase (FAK) was partially inactivated by 
dephosphorylation of Y397 after activation of EGFR. The inactivation of FAK was transient and 
the activation levels increased again when the phosphorylation of EGFR on Y1068 returned to 
normal levels. EGFR, FAK, and β-actin were used as loading controls in the immunoblot and did 
not change within 30 minutes after addition of EGF. Cell ruffling was increased in response to 
EGF as shown in Fig. 2-25 B by outlined cell borders before and after addition of EGF (± 15 
minutes). Another change in cell morphology was that the cell nucleus retracted in response to 
EGF. The corresponding keratin 13-EGFP images are shown in Fig. 2-25 B’. After addition of 
EGF the ratio of thinner keratin filaments in periphery increased, and thicker keratin filaments 
concentrated around the nucleus. Cells often showed partial or complete retraction when they 
were exposed for longer time periods (>20 minutes) to EGF as shown in Fig. 2-25 C. However, 
retraction was not problematic in most cases for time periods below 20 minutes after addition of 
EGF (less than 15% retraction in x-y direction). 
Interestingly, single cells did usually not migrate after addition of 0.5-150 ng ml-1 EGF for more 
than a half cell length. Consistently, however, cells retracted with increased time after EGF 
treatment. For confluent cell layers it was not clear if they migrated in response to EGF because 
they retracted strongly or were drawn in one direction by other cells. Experiments with EGF 
gradients induced by addition of agarose mixed with 1-150 ng EGF failed to induce reproducible 
and directed cell migration when added to 1 ml cell medium. 
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Fig. 2-25: Keratin network morphology was changed and cell ruffling increased after treatment with EGF. 
Clone AK13-1 was cultivated without FCS on laminin-332-rich matrix before treatment with 20 ng ml-1 EGF. In A 
cells were cultivated for 48 hours before treatment with EGF and immunoblot analysis was performed. FAK 
antibodies were from mouse. In B microscopic transmitted light images are shown before and after addition of EGF. 
The cell borders are outlined in intervals of three minutes as indicated by different colours. The cell shape changes 
increased after addition of EGF. In B’ keratin 13-EGFP signal is shown for the cell in Fig. B. Grey gamma value 
was adjusted to 0.4 in Photoshop to make weak signal in periphery visible. Note that more keratin precursors were 
formed after EGF addition and that the keratin network became thinner in periphery and more concentrated in cell 
middle around the nucleus. In C a different cell under the same conditions as shown in B retracted within 20 
minutes after EGF addition. Scale bars are 10 µm. 
In general, EGF addition changed keratin morphology, and increased the movement and 
formation of keratin filaments. However, it remained unclear if keratin turnover was affected. 
 
3.5.2. Quantitative analysis of EGF effect on keratin dynamics in A431 cells 
The aim was to further investigate the effect of EGF on keratin dynamics, described in the 
previous chapter, by quantitative analysis. 
Clone AK13-1 was cultivated for 48-57 hours without FCS and analysed in the same way as 
described in 3.4.3 for keratin motion and in 3.4.4 for keratin bulk flow.  The only differences 
were that single cells were recorded for 15 minutes before and after addition of 20 ng ml-1 EGF. 
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Between the recordings an intermission of two minutes was necessary to remove medium (≈ 15 
seconds) and add EGF (≈ 10 seconds). The remaining time was necessary for the sample to 
stabilize in z-direction and to readjust x-y stage when necessary. 
 
Fig. 2-26: Increased keratin dynamics by EGF in A431 cells. 
Clone AK13-1 was cultivated without FCS for 48-57 hours on laminin-332-rich matrix. Keratin 13-EGFP signal 
was recorded for 15 minutes before and after addition of 20 ng ml-1 EGF. The recording was done at 30 seconds 
time intervals and with two minutes delay after addition of EGF. In A recorded keratin networks were normalised 
before movement was calculated, overlaid, and averaged. The vector fields show that keratin is moving toward the 
cell interior. The heat maps show that the movement is fastest in the cell periphery and that it increases after EGF 
addition. In B mean keratin speed calculated from not-normalised networks is shown and in C from normalised 
recordings. In D keratin bulk flow was calculated from normalised recordings, overlaid, and averaged. It is 
noticeable that keratin assembly increases in the cell periphery after EGF addition as is the case for keratin 
disassembly in the cell middle. In E keratin bulk flow from not-normalised and normalised results was transformed 
to percent values. Statistical analysis was performed by two tailed 1Wilcoxon matched pairs test or paired t test 
depending whether data corresponded to Gaussian distribution. Whiskers are minimum and maximum. Scale bars 
are 5000 AU. 
The keratin 13 motion toward the cell interior increased in cell periphery significantly after 
addition of EGF (Fig. 2-26 A). In the cell middle the keratin network remained mainly 
stationary.  
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The median keratin speed calculated from not-normalised recordings increased by 40.4% after 
addition of EGF (from 122.1 to 171.4 nm min-1) (Fig. 2-26 B). This increase was highly 
significant with p = 0.0005. The median keratin speed calculated from normalised recordings 
showed the same behaviour with an increase by 30.9% (from 85.19 to 111.5 AU min-1) (Fig. 
2-26 C). The increase was also highly significant with a p value of p = 0.0012. The difference to 
results from not-normalised recordings was that the results corresponded to Gaussian 
distribution. 
The keratin bulk flow before and after addition of EGF are shown in Fig. 2-26 D. Keratin 
assembly (sources) indicated by a yellow ring in the cell periphery increased after EGF addition. 
Keratin disassembly (sinks) shown in a green ring inside the cell increased proportionally. In the 
cell middle keratin assembly or disassembly were not detected before and after addition of EGF 
as shown in black. It was also noticeable that a black ring between the sources and sinks 
remained where keratin was only transported and no keratin assembly or disassembly was 
detected.  
The mean keratin bulk flow calculated from not-normalised and normalised recordings 
corresponded to Gaussian distribution. For not-normalised data it increased by 36.0% [from 5.78 
AU min-1 (SD = 2.57) to 7.86 AU min-1 (SD = 3.58)] with a significant p value of 0.0043. The 
same was true for normalised data where mean bulk flow increased by 36.1% [from 3.80 AU 
min-1 (SD = 1.90) to 5.17 3.80 AU min-1 (SD = 2.78)] with a significant p value of 0.0036. For 
direct comparison the mean keratin bulk flow was set to percent values in Fig. 2-26 E. Note that 
otherwise the AU from both methods cannot be compared directly because they have different 
dimensions. 
In general, EGF addition increased keratin motion and bulk flow in A431 cells. 
 
3.5.3. Analysis of keratin turnover by FRAP in A431 cells after addition of EGF 
The FRAP experiments were performed as controls for keratin bulk flow analysis from the 
previous chapter. 
FRAP experiments were performed in the same way as described in chapter 3.4.2 with the 
exceptions that fluorescence recovery was measured at time intervals of 2 minutes and for a total 
time of 10 minutes. These modifications were necessary because after treatment with 20 ng ml-1 
EGF the cell shape changes increased. This made the recognition of the bleached and unbleached 
keratin network with increasing time less accurate. It is also possible that photobleaching 
enhanced retraction of cells after EGF treatment. The cells were bleached 2 minutes after 
addition of EGF when the observation stage stabilised. 
All measured data corresponded to Gaussian distributions with the exception of the 4 minutes 
control value. The keratin 13 turnover was already significantly increased 5 minutes after 
addition of EGF when it was measured 2 minutes after bleaching (Fig. 2-27 B). Within 13 
minutes after EGF addition (10 minutes post bleach) the turnover increased by 53% with a mean 
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value of 12.6% (SD = 3.6) compared to 8.3% (SD = 2.9) from the control. The difference was 
highly significant with a p value < 0.0001 as was also the case for 6 and 8 minutes post-bleach. 
 
Fig. 2-27: FRAP analysis of keratin turnover after addition of EGF. 
Clone AK13-1 was cultivated without FCS for 47-57 hours on laminin-332-rich matrix. In A the cell was treated 
with 20 ng ml-1 EGF.  For FRAP analysis keratin 13-EGFP was bleached in the top cell half two minutes after EGF 
addition. Ten minutes after bleaching 12.3% of fluorescence was transferred from the unbleached into the bleached 
part of the cell. Scale bar is 10 µm. In B the previous experiment was repeated for other cells and fluorescence 
recovery was measured at 2 minute intervals. The controls represent cells that were not EGF treated. Statistical 
analysis was performed by two tailed 1paired t test or 2Wilcoxon matched pairs t test depending whether data 
corresponded to Gaussian distribution. Whiskers are 5-95% percentiles.  
In general, the FRAP experiments confirmed in A431 cells an increase of keratin turnover in 
response to EGF treatment. 
 
3.5.4. Inhibition of EGF effect on keratin dynamics by Cetuximab® 
The aim was to confirm that the increase of keratin dynamics after EGF treatment of A431 cells 
was induced by EGFR signalling. This was tested with Cetuximab® (Erbitux®) antibodies that 
inhibit EGFR-mediated signalling. 
Clone AK13-1 was cultivated and analysed in the same way as described in chapter 3.5.2. 
Keratin 13-EGFP was recorded in single cells for 15 minutes before and after addition of 1 µg 
ml-1 Cetuximab. Subsequently 20 ng ml-1 EGF and 1 µg ml-1 Cetuximab were added and 
recorded for another 15 minutes. Between the recordings intermissions of three minutes were 
done to remove medium and to add new medium with the corresponding agents. 
The median keratin speed for not-normalised networks increased slightly after addition of 
Cetuximab (from 136.1 to 144.5 nm min-1) but with a not significant p value of 0.2031 (Fig. 2-28 
A). This was also similar when the inhibited cells were treated with EGF/Cetuximab which 
resulted in a not significant p value of 0.0512 (the median increased from 144.5 to 157.3 nm min-
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1). In this experiment medians were compared because the control did possibly not correspond to 
a Gaussian distribution. 
Interestingly, the immunoblot analysis shows that the EGFR is phosphorylated on Y1068 after 
addition of 1 µg ml-1 Cetuximab within three minutes as shown in Fig. 2-28 B. After 18 minutes 
of Cetuximab treatment the level of Y1068 phosphorylation decreased to pre-treatment levels as 
was the case for cells that were treated only with EGF (20 ng ml-1). However, the treatment of 
cells with EGF that were not Cetuximab pretreated resulted in stronger phosphorylation of 
Y1068. As expected the phosphorylation of Y1068 did not increase after addition of EGF when 
the cells were pretreated with Cetuximab as shown for time points 3 and 18 minutes post 
addition. FAK and β-actin were used as loading controls in the immunoblot and were not 
affected by Cetuximab and EGF in total amount. 
 
Fig. 2-28: Cetuximab® prevents EGF mediated increase in keratin motion. 
Clone AK13-1 was cultivated without FCS on laminin-332-rich matrix. The cells were either untreated (control), 
treated with 1µg ml-1 Cetuximab, treated with 20 ng ml-1 EGF together with 1µg ml-1 Cetuximab, or with 20 ng ml-1 
EGF only. In A cells were cultivated for 48-57 hours and mean keratin speed was calculated from time lapse 
recordings of keratin 13-EGFP (recorded at intervals of 30 seconds). The cells were treated with Cetuximab and 
EGF three minutes before analysis. Statistical analysis was performed by two tailed 1Wilcoxon matched pairs test or 
2paired t test depending on whether data corresponded to Gaussian distribution. Whiskers are minimum and 
maximum. In B immunoblot analysis of Cetuximab effect was performed on cells cultivated for 48 hours. The FAK 
antibodies were from mouse. The proteins were separated by 10% SDS-PAGE. 
In general, inhibition of EGFR by Cetuximab prevented significantly an increase in keratin 
motion in response to EGF addition. 
 
3.5.5. Keratin 8 phosphorylation in response to EGF 
The aim was to test, if keratin 8 is phosphorylated on S73 and S431 in an EGF-dependent 
manner. Both residues were described to be phosphorylated downstream of EGFR signalling 
(Ku et al., 2002; Ku and Omary, 1997). 
Clone AK13-1 was prepared in the same way for treatment with 20 ng ml-1 EGF as described in 
chapter 3.5.2. EGF treated cells were tested for phosphorylation of keratin 8 on S74 and S431 by 
immunoblot analysis (Fig. 2-29). The phosphorylation levels of S73 increased in a time 
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dependent manner from 5 to 30 minutes after addition of EGF. The phosphorylation of S431 was 
increased in the same way from 10 to 30 minutes after addition of EGF. The total protein 
controls with keratin 8/18 and β-actin were unchanged in response to EGF. 
 
Fig. 2-29: EGF induced phosphorylation of keratin 8 on S73 and S431. 
Clone AK13-1 was cultivated for 48 hours without FCS on laminin-332-rich matrix. The cells were treated with 20 
ng ml-1 EGF and investigated at different time points by immunoblot analysis. Note that the phosphorylation of 
keratin 8 did increase in a time dependent manner after addition of EGF. The proteins were separated by 10% SDS-
PAGE. 
 
3.5.6. Quantitative analysis of EGF effect on keratin dynamics in HaCaT cells 
The aim was to test, if EGF increases keratin dynamics in a different cell line than A431.  
HaCaT clone B10 stably expressing keratin 5-EYFP was cultivated for 48-53 hours with FCS on 
uncoated glass surfaces. The cells were cultivated in presence of FCS because FCS withdrawal 
led to strongly asymmetrical cells that were difficult to compare. The mean keratin speed and 
bulk flow after addition of 20 ng ml-1 EGF were analysed in the same way as described in 
chapter 3.5.2. The only difference was that keratin 5-EYFP was recorded for analysis with 
settings described in chapter 2.2.41. 
Keratin 5 motion towards the cell interior in the cell periphery increased significantly after 
treatment with EGF (Fig. 2-30 A). In the cell middle under the nucleus the keratin network 
remained stationary. The median keratin speed calculated from not-normalised networks 
increased strongly in response to EGF by 66.1% (from 148.2 to 246.1 nm min-1) with a 
significant p value of < 0.0001 (Fig. 2-30 B). This was also the case for speed calculated from 
normalised recordings which increased by 41.5% (from 143.4 to 202.9 AU min-1) with a 
significant p value of 0.0039 (Fig. 2-30 C). Unlike the not-normalised data the normalised results 
did not correspond to Gaussian distribution. 
Keratin 5 filament formation and disassembly increased significantly after treatment with EGF 
(Fig. 2-30 D). Keratin assembly (sources) in the cell periphery increased after EGF treatment as 
was the case for keratin disassembly (sinks) inside the cell. In the cell middle no keratin 
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assembly or disassembly was detected before and after EGF treatment as indicated in black. It 
also was noticeable that a black ring between the sources and sinks remained where keratin was 
only transported and no assembly or disassembly was detected. The size of this stable zone 
decreased after EGF treatment. 
 
Fig. 2-30: Increased keratin dynamics after EGF addition in HaCaT cells. 
Clone B10 was cultivated for 48-53 hours on glass surfaces. Keratin 5-EYFP was recorded for 15 minutes before 
and after addition of 20 ng ml-1 EGF. The recording was done at 30 seconds time intervals and with two minutes 
delay after addition of EGF. In A recorded keratin networks were normalised before movement was calculated, 
overlaid, and averaged. The vector fields show keratin movement toward cell interior, and the heat maps an increase 
in keratin movement after EGF addition. In B mean keratin speed calculated from not-normalised networks is shown 
and in C from normalised recordings. In D keratin bulk flow from normalised recordings is overlaid and averaged. 
Note that keratin assembly increases in cell periphery after EGF addition as is the case for keratin disassembly in 
central parts of the cells. In E keratin bulk flow calculated from normalised recordings is shown and in F from 
normalised recordings. Statistical analysis was performed by two tailed, 1paired t test, or 2Wilcoxon matched pairs 
test depending whether data corresponded to Gaussian distribution. Whiskers are minimum and maximum. Scale 
bars are 5000 AU. 
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The median keratin bulk calculated from not-normalised recordings increased after EGF 
addition by 142% (from 0.52 to 1.26 AU min-1) with a significant p value of 0.0003 (Fig. 2-30 
E). This was also the case for median bulk flow calculated from normalised recordings which 
increased by 96% (from 0.45 to 0.88 AU min-1) with a significant p value of 0.0039 (Fig. 2-30 
F). As calculated for keratin movement the normalised bulk flow results did not correspond to 
Gaussian distribution.  
In general, EGF increased keratin dynamics in HaCaT cells in the same way as was previously 
described for A431 cells. 
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3.6. Focal adhesion kinase (FAK) and keratin network dynamics 
The observations of keratin filament formation in close vicinity to focal adhesions (FAs) led to 
the hypothesis that FAs could be involved in keratin filament formation. FAK was one target 
tested to examine this hypothesis because it regulates FA-dynamics (1.6.1). Preliminary data 
from epidermolysis bullosa simplex (EBS) disease model cells showed decreased keratin motion 
and turnover in response to FAK inhibition as shown in Fig. 2-31. In EBS arginine-125 of 
keratin 14 is mutated to cysteine. This mutation prevents the formation of keratin filaments 
enhancing the formation of keratin granules that move toward the cell interior where they 
disassemble. The aim was to test in detail if FAK regulates the dynamics of keratin networks. 
 
Fig. 2-31: FAK inhibitor PF-562,271 inhibits the formation and movement of keratin granule. 
MCF-7 cells stably expressing HK-14-R125C-EYFP were transfected with paxillin-dsRed2 to mark FAs. The 
mutated keratin 14 prevents the formation of keratin filaments as is the case in EBS disease. After treatment with 
PF-562,271 (100 nM) the formation of keratin granules near FAs was inhibited within 15 minutes. The black arrow 
marks a granule before addition of the inhibitor, and the red arrow marks another thereafter. After addition of the 
inhibitor granule growth and movement was decreased. These effects could not be reversed after removal of the 
inhibitor as shown for time points 43-83 minutes. The complete time lapse sequence is documented in movie_18. 
Scale bar is 10 µm. 
 
3.6.1. Pharmacological inactivation of FAK  
The aim was to test whether specific pharmacological FAK inhibitors affect keratin dynamics. 
To account for possible off-targeting three structurally different inhibitors were used. In this 
section low but efficient inhibitor concentrations were determined to inactivate FAK by 
inhibiting the phosphorylation of Y397. 
Inhibitor concentrations needed for major decrease of Y397-phosphorylation of FAK were 
determined by immunoblot analysis of clone AK13-1 (Fig. 2-32 A-C). The optimal 
concentrations were then tested for 30 minutes as shown in Fig. 2-32 A’-C’. FAK-14 inhibitor 
prevented phosphorylation of Y397 at a concentration of 15 µM with a 5-10 minutes delay. This 
inhibitor was soluble in water unlike the other two inhibitors that were dissolved in pure 
dimethyl sulfoxide (DMSO) and were used at a final DMSO concentration of 0.5% (v/v). PF-
573,228 prevented phosphorylation of Y397 at a concentration of 1 µM and PF-431,396 at 250 
nM within one minute. All inhibitors showed constant inhibition up to 30 minutes and did not 
change total FAK levels within 20 minutes. Interestingly, FAK-14 was the only inhibitor that 
increased the phosphorylation of EGFR on Y1068 within one minute after addition. This 
phosphorylation decreased within 10 minutes to levels below the initial phosphorylation. 
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Additionally, the activation level of sarcoma kinase (Src) was tested by examining its 
phosphorylation at Y418. Src was of interest because it is activated directly by FAK (but not 
only) and could be another candidate that modulates keratin dynamics. Interestingly, FAK-14 
(15 µM) increased phosphorylation of Src on Y418 one minute after addition and inactivated Src 
within 10 minutes. Otherwise, PF-573,228 (1 µM) enhanced the phosphorylation of Y418 within 
10-30 minutes after addition. PF-431,396 (0.25 µM) decreased phosphorylation of Y418 at time 
point 15 minutes after addition, but the phosphorylation increased within 15 minutes to at least 
the same level as before the addition of the inhibitor. 
 
Fig. 2-32: Time and concentration dependent inactivation of FAK. 
Clone AK13-1 was cultivated for 48 hours without FCS on laminin-332-rich matrix. The effect of specific FAK 
inhibitors was tested by immunoblot analysis. In A FAK-14, in B PF-573,228, and in C PF-431,396 were tested on 
clone AK13-1 at different concentrations 10 minutes after addition. In A’-C’ single concentrations for every 
inhibitor were tested in a time dependent manner for 30 minutes. Proteins were separated by 8% SDS-PAGE. Note 
that the immunoblot in A, and the first in A’ were developed on film. All other immunoblots were recorded with a 
CCD-camera. 
All inhibitors tested were able to inhibit the phosphorylation of FAK on Y397. FAK-14 (15 µM) 
was the slowest inhibitor. It was also the only inhibitor that induced phosphorylation of EGFR 
on Y1068 with following dephosphorylation. Another noticeable effect of FAK-14 that was not 
found in cells treated with the other inhibitors was strong dephosphorylation of Src on Y418. 
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3.6.2. Keratin dynamics examined after inhibition of FAK 
The aim was to test if pharmacological inactivation of FAK affects keratin dynamics. For this 
objective inhibitor concentrations determined in previous chapter were used. 
Clone AK13-1 was prepared and analysed in the same way as described in 3.5.2. Keratin 13-
EGFP movement was recorded for 15 minutes before and with a 5 minutes delay after addition 
of FAK inhibitors.  
The mean keratin 13-EGFP speed calculated from not-normalised recordings is shown in Fig. 
2-33 A and from normalised recordings in Fig. 2-33 B.  The median speed of not-normalised 
keratin networks decreased by 11.9% (from 148.5 to 130.9 nm min-1) after addition of FAK-14 
(15 µM) resulting in a significant p value of 0.0002. This was also the case with a decrease of 
6.8% when networks were normalised for analysis (from 127.2 to 118.6 AU min-1) resulting in a 
significant p value of 0.0187.  The decrease in keratin movement was also noticeable by visual 
inspection of the recordings at 10-20 minutes after addition of FAK-14. Otherwise, PF-573,228 
(1 µM) decreased median keratin speed calculated from not-normalised networks by 1.6% (from 
150.8 nm to 148.4 nm min-1), but the decrease was not significant with a p value of 0.073. For 
normalised networks this was similar with a decrease of 1.4% (from 131.7 to 129.8 AU min-1) 
resulting in a not significant p value of 0.3545. Visual inspection of the recordings has shown no 
noticeable changes in keratin movement or cell ruffling after inhibitor addition. At higher 
inhibitor concentrations > 50 µM and 15-20 minutes incubation the keratin movement direction 
was noticeably affected and at an even higher concentration of 200 µM the keratin movement 
stopped (data not shown). However, these higher concentrations were not considered specific. 
Because PF-573,228 showed that the inactivated FAK had no significant effect on keratin 
movement, PF-431,396 was tested as additional control. The number of experiments was small 
with 6-7 at different concentrations but sufficient to characterise major effects. At 0.25 µM the 
median speed calculated from not-normalised networks decreased by 11.5% (from 176.4 to 
156.1 nm min-1), but resulted in a not significant p value of 0.1094. Speed calculated from 
normalised networks decreased only slightly by 0.8% (from 157.2 to 155.9 AU min-1) resulting 
in a not significant p value of 0.8438. At a higher concentration of 0.5 µM the decrease was 
stronger for not-normalised networks with (from 165.6 to 151.2 nm min-1) resulting in a 
significant p value of 0.0313. For normalised networks the mean keratin speed decreased by 
2.0% (from 138.8 to 136.0 AU min-1) resulting in a not significant p value of 0.0938. By visual 
inspection of the recordings a decrease in keratin speed was not noticeable. It should be noted 
that in experiments with PF-431,396 the cell ruffling was noticeably higher than in previous 
experiments with the other two inhibitors. In the previous experiments also the mean keratin 
speed in controls was lower. At concentrations >50 µM the PF-431,396 decreased keratin 
movement and at concentrations >100 µM it led to strong cell retraction (data not shown).  
The topological analysis of keratin 13 movement from normalised networks shows significant 
decrease in keratin movement in cell periphery after treatment with FAK-14 (15 µM) (Fig. 2-33 
E). For the higher concentration of 0.5 µM PF-431,396 a weak decrease in keratin movement 
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was noticeable, but not for the lower concentration of 0.25 µM. Note that because of the low 
number of experiments the topological maps for PF-431,396 are not as averaged as for the other 
inhibitors. PF-573,228 (1 µM) did not show any significant differences on keratin movement in 
the heat map after addition. 
The results for keratin 13 bulk flow calculated from not-normalised networks are shown in Fig. 
2-33 A’ and from normalised networks in Fig. 2-33 B’. Only FAK-14 decreased significantly 
median keratin bulk flow after addition, as was already the case for mean keratin movement. 
The calculated bulk flow for not-normalised networks decreased by 41.5% (from 3.95 to 2.31 
AU min-1) resulting in a significant p value of 0.0002. For normalised networks the bulk flow 
decreased by 39.1% (from 1.84 to 1.12 AU min-1) resulting in a significant p value of 0.002. For 
PF-573,228 treated cells the median keratin bulk flow calculated from not-normalised networks 
decreased by 9.9% (from 2.52 to 2.27 AU min-1) with a not significant p value of 0.1046. 
Interestingly, for normalised networks the calculated median keratin bulk flow increased by 
31.5% (decreased from 1.11 to 1.46 AU min-1) resulting again in a not significant p value of 
0.7209. 
In cells treated with PF-431,396 (0.25 µM) the median keratin bulk flow decreased by 24.7% 
(from 3.48 to 2.64 AU min-1) but resulted in a not significant p value of 0.1094. In contrary, for 
normalised data the calculated bulk flow increased by 18.1% (from 1.66 to 1.96 AU min-1) 
resulting again in a not significant p value of 0.8438. At a doubled concentration PF-431,396 
(0.5 µM) did not have an effect on median keratin bulk flow calculated from not-normalised 
networks (remained at 3.34 AU min-1), and unlike previously calculated for movement the 
resulting p value of 0.0938 was not significant. For normalised networks the median increased 
by 27.7% (from 2.02 to 2.58 AU min-1) as was already the case for lower inhibitor concentration. 
The resulting p value of 1.000 was clearly not significant. Note that the differences in values 
calculated for mean bulk flow in experiments with PF-431,396 were large making the data not 
useful to determine small changes at the low number of experiments.  
The calculated results for keratin bulk flow from normalised recordings were overlaid in Fig. 
2-33 F.  
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Fig. 2-33: Keratin dynamics examined before and after inhibition of FAK. 
Clone AK13-1 was cultivated for 48-57 hours without FCS on laminin-332-rich matrix. Keratin 13-EGFP was 
recorded at a time interval of 30 seconds for 15 minutes before and after addition of inhibitors with a 5 minutes 
delay after addition. In A mean keratin speed was calculated from not-normalised recordings as was done in C for 
keratin bulk flow. In B mean keratin speed was calculated from normalised recordings as was done in D for keratin 
bulk flow. In E the results for normalised keratin movement were overlaid and averaged as was done in F for keratin 
bulk flow. In G keratin 13-EGFP recovery was measured by FRAP analysis. The cells were bleached in half and the 
fluorescence transfer measured from unbleached to bleached cell halves at indicated time points. The FAK-14 
treated cells were bleached 5 minutes after addition of the inhibitor. The inhibitors were used at following 
concentrations: 15 µM FAK-14, 1 µM PF-573,228 (PF-228), and *0.25, or **0.5 µM PF-431,396 (PF-396). 
Statistical analysis was performed with two tailed 1Wilcoxon matched pairs test or 2paired t test depending whether 
data corresponded to Gaussian distribution. Whiskers are 5-95 percentiles. Scale bar is 5000 AU. 
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The keratin 13-EGFP turnover was tested in additional experiments after addition of FAK-14 (15 
µM) by FRAP analysis as described in chapter 3.5.3, with the modification that analysis was 
started with a 5 minutes delay after addition of inhibitor. In these experiments only FAK-14 was 
investigated for comparison with keratin bulk flow results (Fig. 2-33 G). Median keratin 13-
EGFP fluorescence recovery in bleached cell halves decreased 9 minutes after addition of FAK-
14 and 4 minutes after bleaching (from 4.57% compared to 3.53% in untreated controls) 
resulting in a significant p value of 0.0324. Within 15 minutes after addition of FAK-14 and 10 
minutes after bleaching the fluorescence recovery decreased further (3.57% compared to 7.72% 
in control cells) resulting in a significant p value < 0.0001.  
In summary, the experiments show that FAK-14 (15 µM) decreased keratin movement, bulk 
flow, and turnover. However, in further experiments with PF-573,228 (1 µM) and PF-431,396 
(0.25 µM) it could not be confirmed that pharmacological inhibition of FAK at specific inhibitor 
concentrations leads to a significant decrease in keratin dynamics. 
 
3.6.3. Keratin dynamics examined after inhibition of Src 
The hypothesis was that Src could be involved in regulation of keratin dynamics because the 
FAK-14 inhibitor that decreased keratin turnover in previous chapter inhibited Src as shown in 
chapter 3.6.1. The aim was to test if pharmacological inhibition of Src influences keratin 
dynamics. 
Clone AK13-1 was cultivated and analysed in the same way as described in chapter 3.6.2 with 
the modifications that keratin 13-EGFP was recorded for 10 minutes before and after inhibition 
of Src with a 5 minutes delay. Src was inhibited by SKI-606 (Bosutinib) by inhibiting the 
phosphorylation of Y416 which is necessary for activation. The inhibitor was dissolved in pure 
DMSO and used at a final concentration of 0.5% DMSO (v/v). The concentration of SKI-606 for 
experiments was determined by treatment of cells for 5 minutes at different concentrations 
before immunoblot analysis (Fig. 2-34 A). SKI-606 induced a major decrease of Y416 
phosphorylation at a concentration of 2.5 µM which was used for further experiments. 
The results for mean keratin 13-EGFP speed calculated from not-normalised networks are shown 
in Fig. 2-34 B and for normalised networks in Fig. 2-34 C. The mean keratin speed decreased 
for not-normalised networks after Src inhibition by 11.9% [from 166.0 nm min-1 (SD = 21.5) to 
148.2 nm min-1 (SD = 16.9)] resulting in a significant p value of 0.0143. For normalised 
networks mean speed decreased after Src inhibition by 3.6% [from 138.0 AU min-1 (SD = 15.3) 
to 133.1 AU min-1 (SD = 9.1)], but resulted in a not significant p value of 0.2118. A decrease in 
overall keratin movement was too small to be noticeable by visual inspection of not-normalised 
recordings. However, in cell periphery areas existed where filaments were moving slower. It 
should be noted that the cell shape changes were negligible in this experiments and that the 
normalisation of keratin networks decreased the signal resolution for detection of keratin 
movement making normalisation contra productive for the detection of small changes. 
Nevertheless, topological projections of normalised keratin speed maps show a noticeable 
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decrease in overall keratin movement (Fig. 2-34 F). The direction of keratin movement was not 
noticeably changed within 5-15 minutes after addition of SKI-606 as shown by vector fields in 
Fig. 2-34 E. 
 
Fig. 2-34: Keratin dynamics after inhibition of Src. 
Clone AK13-1 was cultivated for 48-57 hours without FCS on laminin-332-rich matrix. For analysis of mean keratin 
speed and bulk flow keratin 13-EGFP was recorded at time intervals of 30 seconds for 10 minutes before and with a 
5 minutes delay after addition of 2.5 µM SKI-606. The immunoblot in A shows cells after treatment with different 
concentrations of SKI-606 (Bosutinib) for 5 minutes. In B keratin mean speed calculated from not-normalised 
recordings is shown and in C for normalised recordings. In D keratin bulk flow is shown for not-normalised 
recordings. In E vector fields of keratin movement calculated from normalised data were averaged and overlaid, as 
was done in F for corresponding heat maps of keratin movement, and in G for keratin bulk flow. Statistical analysis 
was performed with two tailed 1paired t test or 2Wilcoxon matched pairs test depending if data corresponded to 
Gaussian distribution. Whiskers are minimum to maximum. Scale bars are 5000 AU. 
Median keratin bulk flow calculated from not-normalised networks decreased after addition of 
SKI-606 by 22.6% (from 1.46 to 1.13 AU min-1) resulting in a significant p value of 0.0137 (Fig. 
2-34 D). The median bulk flow calculated from normalised networks decreased by 6.0% (from 
5.70 to 5.36 AU min-1), but resulted in a not significant p value of 0.3594. The results for bulk 
flow calculated from not-normalised data were considered more accurate because normalisation 
was not necessary as described for calculation of keratin speed previously. However, decrease in 
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keratin bulk flow was noticeable in topological projection calculated from normalised recordings 
(Fig. 2-34 G).  
In an additional experiment a single AK13-1 cell was recorded for 45 minutes after addition of 
SKI-606 (2.5 µM) instead of 15 minutes as was done for quantitative analysis previously. The 
keratin movement toward cell interior was noticeably decreased 30 minutes after addition of the 
inhibitor and filament growth toward cell periphery was increased as shown in movie_19. This 
experiment indicates that SKI-606 affects keratin dynamics stronger at later time points than 5-
15 minutes that were used for quantitative analysis previously. 
In summary, the keratin movement and bulk flow decreased slightly but significantly within 5-15 
minutes after addition of 2.5 µM SKI-606. In a simple recording it was also shown that this 
effect increases in a time dependent manner. The mean values for speed and bulk flow calculated 
from normalised keratin networks were considered as less accurate and suboptimal for detection 
of small changes. However, topological maps calculated from normalised recordings of keratin 
movement confirmed noticeable decrease in keratin dynamics as was calculated from not-
normalised recordings. 
 
3.6.4. Effect of FAK-inhibition by PF-573,228 on keratin dynamics in EBS disease 
model 
The aim was to investigate if the decrease in keratin transport and turnover in EBS disease 
model cells shown in Fig. 2-31 in response to PF-562,271 (0.1 µM) was a specific effect of FAK 
inhibition. 
In chapter 3.6.1 it was shown that PF-573,228 (1 µM) inhibits the phosphorylation of FAK on 
Y397 in A431 cells within one minute after addition. In the following experiment the effect of 
PF-573,228 on keratin dynamics in clone HK14-26 (MCF-7 cell line) was tested. In the 
experiment PF-573,228 was used at a concentration of 50 µM which is 50 times greater than in 
the previous experiments with A431 cells. This concentration was considered as more than 
sufficient to inhibit FAK. However, this was not tested by immunoblot analysis for MCF-7 cells. 
The inhibitor was solved in pure DMSO and used at a final DMSO concentration of 0.6% (v/v). 
PF-573,228 (50 µM) did not affect keratin movement and assembly noticeably within 30 minutes 
after addition as shown in Fig. 2-35. In the magnified time-lapse images one keratin granule is 
marked with a black arrow 15 minutes before the addition of inhibitor. This granule is formed 
(nucleated) at time point 0 minutes before it moves toward the cell interior where it is 
disassembled at time point 31 minutes. A second granule that is nucleated two minutes after the 
addition of the inhibitor is marked with a pink arrow at time point of 17 minutes. This granule 
moved and nucleated in the same way as the black marked granule previously and was 
disassembled at time point ≈ 52 minutes. The complete time-lapse sequence is shown in 
movie_20. The addition of PF-573,228 (50 µM) led with increased time to weak cell retraction. 
After 30 minutes (time point 45 minutes in the movie) it was noticeable that keratin granules 
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merged together forming larger granules, as is also better noticeable at time point 55 minutes in 
the movie. This behaviour corresponds to a lower keratin turnover. 
 
Fig. 2-35: Treatment of MCF-7 cells forming keratin granule with FAK inhibitor PF-573,228. 
Clone HK-14-26 stably expressing HK-14-R125C was cultivated on glass surfaces for 2-3 days. The cells were 
treated at time point 15 minutes with PF-573,228 (50 µM). The time lapse images were done by wide field 
fluorescence microscopy (Olympus IX-70s). Before the addition of inhibitor one keratin granule was marked with a 
black arrow and after addition of the inhibitor one another with a pink arrow. The keratin granules were formed in 
the cell periphery before they moved toward the cell interior where they were disassembled. The image series was 
extracted from movie_20. Scale bars are 5 µm. 
In general, the PF-573,228 (50 µM) did not influence noticeably keratin dynamics within 20 
minutes after addition in MCF-7 cell clone HK-14-26. With increased time after addition (>30 
minutes) larger keratin granule were formed. This effect increased when cells were treated with 
100 µM of the inhibitor. However, inhibitor concentrations in range of 50 µM were not 
considered as only specific for FAK. 
 
Results 
 
  129 
3.7. Plectin downregulation 
Plectin deficiency causes aberrant keratin cytoskeleton organisation (Osmanagic-Myers et al., 
2006) and reduces/prevents the binding of intermediate filaments to hemidesmosomes (Andra et 
al., 1997; Koster et al., 2004). The formation of vimentin filament precursors occurs in a plectin 
1f dependent manner at focal adhesions (Burgstaller et al., 2010), and the repeat 5 domain of 
plectin inhibits formation of keratin 5/14 filaments (Steinbock et al., 2000). Plectin was also 
found at branching points of vimentin networks in regions that are conserved in other IFs 
(Foisner et al., 1988). In Fig. 2-36 it is shown that keratin filaments and precursors can 
colocalise with plectin. The hypothesis was that plectin could influence keratin dynamics which 
was investigated in this section. 
 
Fig. 2-36: Colocalisation of keratin filaments with plectin. 
A431 cells were grown for 48 hours without FCS on laminin-332-rich matrix. For immunocytochemistry cells were 
fixed with methanol/acetone. The images present confocal scans of the bottom plane. Note that the plectin signal 
marked with the middle arrow did not colocalize with integrin β4 as is the case in HD-like structures. Plectin was 
detected with guinea pig antibodies and pan-keratin with mouse antibodies. Scale bar is 10 µm. 
 
3.7.1. Effect of plectin downregulation on cells in cell culture 
The aim was to downregulate plectin by shRNA and to test if the downregulation affected keratin 
filaments and related proteins. 
Two different shRNAs recognizing sequences 1534-1554 (plasmid 2107) and 4573-4593 
(plasmid 2108) of human plectin 1 (NCBI reference sequence NM_201380) were provided by 
Dr. Nicole Schwarz. The target sequences are shared by all known plectin isoforms. The 
plasmids additionally encoded CFP as transduction marker. As control a scramble shRNA in the 
same backbone vector (plasmid 2112) was provided. 
The effect of plectin downregulation was tested by transient transduction of A431 and HaCaT 
cells as shown in Fig. 2-37. Plectin was strongly downregulated in transduced cells marked with 
asterisks in images on the left side. In comparison the neighbouring cells that were not 
transduced show high plectin levels. The downregulation of plectin led to near complete absence 
of HD-like structures as shown in the middle images. For comparison in the cells where plectin 
was not downregulated these structures are marked with integrin β4 antibodies as indicated by 
arrows. In A431 cells in images on the right side in plectin downregulated cells keratin filaments 
appeared to be thicker resulting in a more compact network organisation. This was especially 
noticeable in flat cells that were widely spread. Note that thin filaments appear blurry in the 
images because they were below the resolution limit of the microscope. In contrast, in HaCaT 
cells keratin filaments are not changed upon plectin downregulation as shown in the image 
below. Another observation was that in HaCaT cells integrin β5 positive focal adhesions were 
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found between HD-like structures as shown in the images on the bottom. This was not the case 
in both plectin downregulated cells where the position of focal adhesion was not affected by HD-
like structures that were missing. This resulted in localisation that is not concentrated on the cell 
borders. 
 
Fig. 2-37: Transient downregulation of plectin by shRNA. 
A431 cells were grown for 48 hours on laminin-332-rich matrix and HaCaT cells for 72 hours on uncoated glass 
surfaces. The cells were infected one week prior to experiments with shRNA 2108 targeting all plectin isoforms. For 
analysis by immunocytochemistry the cells were methanol/acetone fixed. Cells that were transfected with shRNA 
are marked with asterisks and show strong plectin downregulation in comparison to neighbouring cells that were not 
transfected. Integrin β4 positive HD-like structures are marked with arrows in cells where plectin was not 
downregulated. These structures are absent in transfected cells. The plectin downregulation led to thicker keratin 
filaments in A431 cells but not in HaCaT cells. Focal adhesions are found in HaCaT cells between HD-like 
structures. In plectin downregulated cells where these structures are absent the localisation of focal adhesions is 
altered. Plectin was detected with guinea pig antibodies and pan-keratin with mouse antibodies. Scale bars are 10 
µm. 
Transient transduction led to cells with different levels of plectin which were not optimal for 
standardised experiments. The fluorescence intensity of CFP marker for shRNA transduction did 
not reflect the efficiency of plectin downregulation Therefore stably transduced subclones from 
clone AK13-1 were generated with plectin shRNA, or scramble shRNA. In this work plectin 
downregulated clones 2108-4 and 2108-7 with shRNA 2108 (shPlectin) were characterised in 
detail. They were preferred to clones generated with shRNA 2107 because of stronger plectin 
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downregulation in the tested clones. For controls the randomly selected scramble control clones 
2112-3 and 2112-9 were used.  
Plectin was downregulated by 80-90% in the shPlectin clones in comparison to controls as 
shown by immunoblot analysis in Fig. 2-38 A. The downregulation was stable for at least 30 
passages and occurred independently in cells that were cultivated with or without FCS for 48 
hours. The clones were additionally investigated for proteins that potentially could be affected by 
plectin downregulation and could influence keratin intermediate filaments (Fig. 2-38 A). Integrin 
β1 and integrin α3 protein levels were reduced, and FAK was activated to a lower degree on 
Y397, in response to plectin downregulation. Integrin β4 protein levels were only reduced by 
plectin downregulation when cells were cultivated without FCS. The protein levels of integrin 
α2, α5, β5, FAK, paxillin and EGFR were not altered by plectin shRNA. GAPDH and β-actin 
were used as independent total protein controls. 
Immunocytochemistry of shPlectin clones confirmed strong plectin downregulation in 
comparison to control clones (Fig. 2-38 B). Plectin downregulation affected keratin networks in 
the same way as described previously for transiently transduced A431 cells. This effect is also 
described in more detail in the next chapter. Integrin β4 patterns resembling HD-like structures 
were mostly absent in shPlectin clones (Fig. 2-38 C). The integrin β4 signal was predominantly 
found in these cells at borders to other cells. In comparison the controls showed patterns 
resembling HD-like structures in most cells and a stronger integrin β4 signal. Interestingly, the 
shPlectin clones formed integrin β5 positive focal adhesions with similar localisation as 
compared to control clones. This was previously not the case for HaCaT cells where plectin was 
transiently downregulated. In general, all previous results for A431 cells in which plectin was 
transiently downregulated were confirmed in the stable shPlectin clones. The downregulation 
efficiency was similar in all cells and plectin downregulation was also additionally confirmed by 
immunoblot analysis. 
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Fig. 2-38: Plectin downregulated clones compared to control clones. 
Scramble control (2112-3, 2112-9), wild type A431, and shPlectin (2108-4, 2108-7) clones were cultivated for 48 
hours on laminin-332-rich matrix. In A the clones were cultivated with, or without FCS, and were tested for 
indicated proteins by immunoblot analysis. In B and C the cells were cultivated with FCS and were 
methanol/acetone fixed for analysis by immunocytochemistry. The images show maximum intensity projections 
from confocal sectioning of complete cells. Plectin* was detected with guinea pig antibodies and plectin** with 
mouse antibodies. The shPlectin clones show reduced plectin levels, altered keratin morphology, and reduced 
integrin β4 positive structures in comparison to control clones. Scale bars are 10 µm. 
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3.7.2. Effect of plectin on keratin network morphology and composition 
The aim in this chapter was to investigate in more detail how keratin networks were affected by 
plectin downregulation. 
The plectin downregulated and scramble control clones were described in the previous chapter. 
For experiments all clones were cultivated on laminin-332-rich matrix and when not otherwise 
indicated in presence of FCS. 
For analysis of keratin network morphology three dimensional projections of complete keratin 
13-EGFP networks were done from living cells. These conditions did not alter the natural 
network morphology as could be the case in fixed cells. The cells were cultivated for 48 hours 
after plating. In Fig. 2-39 A-A’ control clone 2112-3 is compared to plectin downregulated clone 
2108-4 at conditions that favour HD-like structure formation (10% FCS). The control has 
stronger signal outside of thick keratin filaments. This results from a higher number of thin 
keratin filaments that are at or below the resolution limit of the microscope. Another observation 
is that the plectin downregulated clone has more thick filaments that appear more loosely 
organised. 
For statistical analysis of keratin branching images of single cells were taken from recordings 
done for motion analysis in chapter 3.7.4 (the first frame of a recording was always used). Note 
that the images were done with settings optimised for gentle recording conditions and not for 
highest image quality. The keratin 13-EGFP networks in the images were analysed for length 
before branching. This was done with software developed by Dr. Gerlind Herberich as described 
in (Herberich et al., 2011). For statistical analysis results from both shPlectin clones (2108-4, 
2108-7) were merged together and compared to merged results from scramble control clones 
(2112-3, 2112-9) as shown in Fig. 2-39 C. In clones cultivated without FCS the median branch 
length in controls was 639 nm and in shPlectin clones 686 nm. The differences were increased 
when cells were cultivated in presence of FCS. Median filament length before branching was 
then 601 nm in controls and 666 nm in shPlectin clones. The differences were significant for 
cells cultivated without FCS with a p value of 0.003 and for cells cultivated with FCS with a p 
value of 0.0002. 
To investigate if keratin morphology changes were induced by expression of different keratin 
isoforms the clones were cultivated for 48 hours with or without FCS, and then tested by 
immunoblot analysis (Fig. 2-39 B). The total protein levels of keratin 5, 8, 13, and 18 were 
altered in different clones, but this was independent of plectin downregulation. The clones were 
additionally tested for keratin 14 and 17, but surprisingly showed no signal for these keratins 
(data not shown). Another observation that was independent of plectin was that keratin 8 and 18 
protein levels were increased in cells cultivated with FCS. The protein levels of keratin 13-EGFP 
were in general higher than of the endogenous keratin 13. It was also surprising that the 
expression of keratin 13-EGFP showed strong differences in all clones that were based on clone 
AK13-1. 
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Fig. 2-39: Influence of plectin downregulation on keratin network morphology and expression of keratins. 
Scramble control (2112-3, 2112-9) clones, wild type A431 cells, and shPlectin (2108-4, 2108-7) clones were 
cultivated on laminin-332-rich matrix with, or without FCS. In A clone 2112-3, and in A’ clone 2108-4, were 
cultivated in presence of FCS for 48 hours. The images show maximum intensity projections from confocal 
sectioning of complete cells. Plectin downregulation led to decreased number of thin keratin filaments and altered 
network morphology as compared to scramble control. Scale bar is 10 µm. In B the clones were cultivated for 48 
hours and protein levels of different keratins were tested by immunoblot analysis. In C mean keratin length before 
branching was measured in clones cultivated for 48-57 hours. The controls are merged results from clone 2112-3 
and 2112-9, and shPlectin are merged results from clone 2108-4 and 2108-7. Statistical analysis was performed with 
two tailed Mann-Whitney test. The whiskers are minimum and maximum. 
 
3.7.3. Effect of plectin downregulation on two dimensional wound healing 
The aim was to test if plectin downregulation would affect wound closure in cell culture assays. 
Cell culture conditions for plectin downregulated clones (2108-4, 2108-7) and scramble control 
clones (2112-3, 2112-9) were optimised for two dimensional wound healing assays that were 
performed in uncoated 96-well plates. The scratch/wound-width was optimised for an 
observation area of 2.52 x 2.00 mm (4X objective). The scratches were done with a 10 µl pipet 
tip by hand and the complete scratch area was analysed for closure as described in chapter 
2.2.23. Confluent cells cultivated for 24-72 hours were unusable for wound healing assays, 
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because the cell layers were elastic and retracted after scratching. Otherwise, when cells were 
scratched before they formed connections, within 1-3 hours after plating, then they detached and 
reattached inside the scratched area. The optimal time to perform wound healing assays was 
determined for 4 hours after plating and for a concentration of 300,000 cells cm-2 (100,000 cells 
per well). The wound closure was analysed 18 hours afterward as shown in Fig. 2-40 A. At this 
time point the wounds were not closed when they were done symmetrically. The cell 
proliferation was not problematic for the experiments because it was similar in all clones as 
shown in Fig. 2-40 B.  
 
Fig. 2-40: Proliferation and two dimensional wound healing in plectin downregulated clones. 
Control clones (2112-3, 2112-9) and shPlectin clones (2108-4, 2108-7) were cultivated in 96-well plates. In A cells 
were cultivated at a concentration of 300,000 cells cm-2 for 4 hours, before a scratch was performed in middle of 
every well, and medium was replaced. For analysis the cells were recorded directly after scratching and 18 hours 
afterwards. The mean value for wound closure per side was calculated from differences in wound area between time 
point 0 and 18 hours past scratching. In B cell proliferation was measured by MTT-test. The cells were cultivated 
for 24 hours under normal cell culture conditions at a concentration of 150,000 cells cm-1 (50,000 per well). For 
every experiment a mean value from 12 wells was calculated. In C cells were cultivated and analysed in the same 
way as described in A. For every experiment a mean value from 7-12 wells was calculated. In D the cells were 
cultivated in cell medium containing 4 µM mitomycin C before and after scratching. In E the scratch closure was 
calculated for mitomycin C treated cells in the same way as in C. The bars are mean values. Scale bar is 100 µm. 
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Plectin downregulation did not have a significant effect on wound closure (Fig. 2-40 C). The 
wounds generated in control clone 2112-3 closed at a mean range of 222.2 µm per side. In the 
shPlectin clone 2108-7 the wound closure was very similar with 217.7 µm as was the case for the 
other shPlectin clone with 212.7 per side. The control clone 2112-9 showed a faster but not 
significantly different wound closure with 282.1 µm per side.  
Additional experiments were performed under conditions inhibiting cell proliferation. This was 
achieved with mitomycin C at a concentration of 4 µM. As shown in Fig. 2-40 D many 
mitomycin C treated cells were darker (possibly apoptotic) after 22 hours when compared to 
untreated cells in in Fig. 2-40 A. However, the clones closed the wounds, but slower compared 
to mitomycin C untreated cells. The closure was done without any significant differences 
between the clones as shown in Fig. 2-40 E. Control clone 2112-3 closed the wounds at a mean 
range of 94.5 µm per side and clone 2112-9 in a similar range of 102.2 µm. The plectin 
downregulated clones were not significantly different with 110.6 µm for clone 2108-4 and 93.6 
µm for clone 2108-7 per side. 
In general, the wound closure in plectin downregulated clones was not noticeably different in 
comparison to control clones. 
 
3.7.4. Effect of plectin downregulation on keratin dynamics 
The hypothesis was that keratin filament dynamics are affected by plectin. This was tested under 
conditions that disfavour (without FCS) or favour (with FCS) formation of HD-like structure. 
Plectin downregulated clones (2108-4, 2108-7) and scramble control clones (2112-3, 2112-9) 
were cultivated 48-57 hours with or without FCS on laminin-332-rich matrices. The keratin 
motion analysis was performed as described in chapter 3.4.3 with three modifications. The 
scanning area was increased by 30% to record larger cells, which in general show more details of 
the keratin network. The total recording and analysis time was decreased from 15 minutes (30 
frames) to 10 minutes (20 frames). The laser intensity was increased to compensate for laser 
wearing and increased further for better signal to noise ratio. The increased laser intensity did not 
produce noticeable bleaching. 
For statistical analysis, results from both shPlectin clones were merged together and compared to 
merged results from control clones. In all cases the keratin networks were moving toward the 
nucleus independently of plectin and possible HD-like structures (Fig. 2-41 A). The keratin 
movement was fastest in the cell periphery with nearly no movement in cell middle as shown by 
vector fields and heat maps. The keratin bulk flow analysis from motion data shows that keratin 
assembly occurred predominantly in a ring area in the cell periphery and disassembly occurred in 
a smaller ring area around/under the nucleus. Between the assembly and disassembly zones 
another ring in black colour is recognisable, in this area filaments were transported, and no 
assembly or disassembly was detected. In general, the keratin movement in all clones showed the 
same behaviour as in clone AK13-1 in previous experiments. 
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Fig. 2-41: Keratin dynamics in plectin downregulated clones under conditions disfavouring and favouring 
formation of HD-like structures. 
Cells were cultivated on laminin-332-rich matrix without, or with FCS for 48-57 hours. For analysis keratin 13-
EGFP was recorded in single cells for 10 minutes at time intervals of 30 seconds. The results from scramble control 
clones (2112-3, 2112-9) were merged together and compared to merged results from shPlectin clones (2108-4, 
2108-7). In A the keratin 13-EGFP marked networks were normalised before analysis. The images show overlaid 
and averaged results for all experiments that are directly comparable. The vector fields represent the direction of 
keratin movement with increased values for longer vectors. The heat maps indicate the mean keratin speed per pixel 
(the background of 100 AU min-1 was subtracted). The bulk flow maps show keratin sources and sinks that were 
calculated from keratin movement and fluorescence intensity. Scale bar is 5000 AU. In B the mean keratin speed is 
summarised and in C the corresponding mean speed calculated from normalised networks. In D the keratin bulk 
flow is summarised and in E the corresponding bulk flow from normalised networks. Statistical analysis was 
performed with two tailed Mann-Whitney test and p values are only shown for data that was significantly different. 
The whiskers are 5-95 percentiles. 
The results for mean keratin 13 speed calculated from not-normalised networks are shown in Fig. 
2-41 B and for normalised networks in Fig. 2-41 C. The median keratin movement was not 
significantly different in clones cultivated without FCS (control 201.1 nm min-1; shPlectin 199.3 
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nm min-1) resulting in a p value of 0.92. For normalised recordings the median speed was only 
slightly increased by 4.6% in shPlectin clones (control 167.6 AU min-1; shPlectin 175.3 AU min-
1) resulting in a not significant p value of 0.55. The situation changed when cells were cultivated 
in presence of FCS. The median keratin movement calculated from not-normalised networks was 
significantly reduced by 13.0% in control clones compared to plectin downregulated clones 
(control 170.5 nm min-1; shPlectin 196.0 nm min-1). The difference was significant with a p 
value of 0.0065. This was also confirmed for normalised networks with a decrease of 19.0% in 
controls (control 143.2 AU min-1; shPlectin 176.7 AU min-1) with a significant p value of < 
0.0001. 
The results for keratin 13 bulk flow calculated from not-normalised keratin networks are shown 
in Fig. 2-41 D and for normalised networks in Fig. 2-41 E. In clones cultivated without FCS no 
significant differences in median bulk flow were expected and this was the case with a p value 
of 0.54. However, the median bulk flow was decreased by 9.2% (control 2.82 AU min-1; 
shPlectin 2.56 AU min-1) in plectin downregulated clones. Otherwise, bulk flow in plectin 
downregulated clones cultivated with FCS was increased by 11.9% (control 2.68 AU min-1; 
shPlectin 3.00 AU min-1), but surprisingly was not significant with a p value of 0.37. The 
differences in median bulk flow increased after keratin networks were normalised for analysis, 
but the overall differences remained not significant. For clones cultivated without FCS the p 
value was 0.23 (medians: control 1.42 AU min-1, shPlectin 1.22 AU min-1) and for clones 
cultivated in presence of FCS the p value was 0.21 (medians: control 1.33 AU min-1, shPlectin 
1.54 AU min-1). 
In general, plectin downregulation led to significantly increased keratin movement in cells 
cultivated in presence of FCS. This was not the case when the clones were cultivated for two 
days without FCS at conditions that disfavour formation of HD-like structures. 
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4. Discussion 
 
4.1. Keratin cycle of assembly and disassembly 
This work is based on the model that the keratin cytoskeleton assembly occurs through recycling 
of old keratin filaments (Kolsch et al., 2010). In this model recycled keratin intermediate 
filaments nucleate to keratin filament precursors (KFPs) in close vicinity to focal adhesions 
(Windoffer et al., 2006). KFPs elongate by fusion with other KFPs at their ends to short 
filaments (Wöll, 2006). These filaments move toward the keratin network where they are 
integrated (Windoffer et al., 2004). This model was confirmed in SW13, EpH4, PLC, A431, and 
MCF7 cells. It was also shown that the complete keratin network is in motion toward the cell 
center (Windoffer and Leube, 1999). However, the methods for measurement of keratin 
dynamics in these studies were limited to simple observations, kymographs, photoactivation, and 
FRAP experiments.  
To overcome these limitations, methods for analysis of keratin dynamics from fluorescence 
microscopy were developed in cooperation with the Lehrstuhl für Bildverarbeitung of RWTH 
Aachen University. For acquisition of data standard confocal microscopy was chosen because it 
provided the best compromise between low phototoxicity, resolution, elimination of out of focus 
signal, low background noise, and emitted spectrum separation of multiple fluorophores 
(Conchello and Lichtman, 2005). To further reduce phototoxicity the samples were optimised for 
observations in two dimensions in a single scan. Therefore cell culture conditions were adjusted 
for generation of single cells that were strongly spread (flat). This was achieved for A431 cell 
clones by cultivation on laminin-332-rich matrix (3.2.1). Furthermore, the withdrawal of growth 
factors after cell plating led to reduced polarisation. The keratin networks were symmetrically 
and circularly organised around cell center, with increasing keratin thickness towards the 
nucleus. These morphological properties make the comparison of different cells easier and more 
exact. Compared to the previous studies in A431 cells mentioned above, the keratin networks 
investigated here were also less compressed, resulting in better filament separation and therefore 
in better resolution. Interestingly, similar results were archived in HaCaT cells only when they 
were cultivated in presence of FCS. The spreading of single HaCaT cells was increased on 
laminin-332-rich matrix, but the coating was not necessary when cells were cultivated longer 
than two days on uncoated glass surfaces. It is possible that HaCaT cells secrete their own matrix 
with increased time to enhance attachment. These observations are in accordance to a study 
where adhesion of HaCaT cells was increased in conditioned medium from 804G cells, or on the 
same matrix as used in this study (Hormia et al., 1995). Another observation here is that keratin 
5 networks in HaCaT cells are thinner and more compressed (movie_02) than keratin 13 
networks in A431 cells (movie_1). The growing KFPs in HaCaT cells are also smaller and 
integrate faster into the keratin network. 
The increased network symmetry in A431 cells can be explained by strongly reduced number of 
HD-like structures after reduction of growth factors (3.3.5). It is also possible that growth factor 
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withdrawal decreased cell-polarisation in a hemidesmosome independent way. For example for 
multiple cancer cell lines it has been shown that polarity is disturbed by growth factors [for 
review see (Lee and Vasioukhin, 2008; Wodarz and Nathke, 2007)]. 
The keratin dynamics investigated in A431 and HaCaT cells (3.2.2) correspond to the model of 
keratin cycling as described in Fig. 4-1. 
 
Fig. 4-1: Keratin cycle of assembly and disassembly.  
The figure is based on supplementary movie_21. It describes the process of keratin 13-EGFP movement, beginning 
with filament assembly and ending with filament disassembly. Keratin movement was studied in A431 cell clone 
AK13-pax9 that was plated for two days on laminin-332-rich matrix prior to confocal recording. The keratin 
network in the cell middle is directly under the nucleus. Keratin above the bottom plane was not recorded. In the 
first step keratin filament precursors are nucleated (1) in the cell periphery. In the second step keratin precursors 
elongate (2) to larger filaments, this can also happen by fusion with other larger filaments. In the third step single 
keratin filaments are integrated (3) in to the keratin network. In the fourth step the keratin filaments are bundled 
(4) to thicker filaments. In the fifth step keratin filaments are stabilised for longer time periods by maturation (5), 
or they are disassembled (not shown). Especially the keratin cage around the nucleus is composed of keratin 
filaments that are stable for longer time periods. Scale bar is 10 µm. 
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4.1.1. KFP nucleation 
Keratin filament networks are not present in the cell periphery of stationary single cells. In this 
area KFPs are nucleated and elongated (3.2.2). It is not clear if the transport of KFPs is mainly 
responsible for the absence of stable networks in the periphery. When the actin dependent 
transport of KFPs is inhibited KFPs accumulate, but it is not known if they form longer filaments 
(Kolsch et al., 2009). Modelling experiments and in vitro data indicate that vimentin filaments, 
that are similar to keratin filaments, are longitudinally associated from 60-nm-long full-width 
“unit-length” filaments (ULFs) (Kirmse et al., 2007; Portet et al., 2009). In vivo, KFPs or short 
keratin filaments attach to each other forming longer filaments, which are later attached to the 
keratin network (3.2.3). The advantage of such a system could be the control/modification of 
KFPs before integration into the keratin network. Interestingly, cytolinker plectin deficient 
fibroblasts show nearly no vimentin precursors, which are similar to KFPs. Yet, vimentin 
networks are formed in these cells (Burgstaller et al., 2010; Spurny et al., 2008). However, these 
cells have defects in polarisation, which could result from changed vimentin network 
morphology or lacking linkage of unknown proteins to vimentin mediated by plectin. 
In general, in two dimensional cell culture the KFP formation occurs in close vicinity to focal 
adhesions as shown in movie_03 and by (Windoffer et al., 2006). This indicates a possible 
importance of adhesion proteins in the formation of KFPs in cell culture. The same situation 
could be true in tissues where cells attach to extracellular matrix. Keratin networks in A431 cells 
that grow on top of each other show typical keratin movement and turnover. This process is 
shown for multiple cell layers in movie_22 and in zoom for the top layer in movie_23. It is not 
clear if focal adhesions, at which KFPs are formed, are present in upper cell layers. However, 
movie_23 shows dynamic paxillin structures that could be focal adhesions. Further 
investigations in these regions could clarify if focal adhesions are necessary for KFP formation, 
as the data from (Burgstaller et al., 2010) shows for vimentin in a plectin dependent manner. 
 
4.1.2. KFP elongation 
It was previously described that keratin filaments elongate by end to end connection of similar 
filaments (Wöll, 2006). In this work this model is extended to elongations that can occur by 
sideway attachment resulting in y-formed filaments (3.2.3). These y-filaments are not exclusive 
for EGFP-labelled filaments but were also found in wild type cells stained with pan-keratin 
antibodies (Fig. 10-1). The lateral binding could be mediated through cytolinkers such as plectin 
or it could result from unbundling of bundled filaments. 
 
Discussion 
 
  142 
4.1.3. KFP transport in cell periphery 
Small keratin filaments in axon-like extensions of SW-13 cancer cells (Woll et al., 2005) are 
transported in a microtubule dependent way. This was also observed for small keratin particles 
(30-70 nm) in the cell periphery of NEB-1 keratinocytes (Liovic et al., 2003). The movement of 
these structures has the typical microtubule stop and go character and is tenfold faster than the 
actin-dependent movement of keratin filaments in the cell periphery (Kolsch et al., 2009). The 
direction of movement is in general toward the keratin network, but the microtubule dependent 
transport can change the direction for short distances in the opposite direction. The data from 
A431 cells (3.2.6) indicate that small filaments in retraction fibres move (≈ 2.4 µm min-1) with 
the same characteristics as described for microtubule dependent KFP transport. In this context it 
is astonishing that KFPs are formed at the end of retraction fibres that are thinner than 1 µm and 
that can stretch for more than half cell diameter. This gives the additional chance to find KFP 
nucleators by immunocytochemistry, because the number of possible nucleators is possibly 
reduced in retraction fibres. We found that retraction fibres were negative for plectin/HD1 and 
positive for integrin β4. 
 
4.1.4. Keratin network movement 
The manual calculation of keratin movement from fluorescently-tagged filaments can be difficult 
to impossible and heavily time consuming. In most cases the analysis can be done by tracking of 
partially bleached filaments or prominent structures like filament branches. In cases when keratin 
filaments come too close to each other tracking can become impossible. Theoretically tracking of 
photoactivated structures should not have this disadvantage, but it is technically more demanding 
(activation lasers are needed and recording can cause additional activation of the fluorophores). 
These methods were also insufficient for mapping dynamics of entire keratin networks in single 
or multiple cells in previous studies. In the present study such limitations were overcome by 
computational analysis developed by Dr. Gerlind Herberich. The software detected and 
calculated the movement of fluorescently-tagged keratin filaments in entire networks. Not 
included were the few and weakly fluorescent KFPs that were filtered out by denoising. 
Keratin filament movement decreases in A431 cells with increased time after plating (3.4.3). The 
decrease in mean keratin speed from day one to day two is highly significant. This observation 
was not reported before and most likely reflects the transition from a motile to sessile cell 
phenotype. Otherwise, the treatment with EGF that induces the motile phenotype of cells 
enhances keratin movement and turnover (3.5). 
The keratin movement is similar in HaCaT cells cultivated in presence of FCS in comparison to 
A431 cells cultivated without FCS [0.15 vs. 0.11 µm min-1 (3.5.6 and 3.4.3)]. These results are in 
the same range as described by others in different cell lines. In subconfluent PtK2 cells keratin 
tonofibrils move with a mean speed of 0.06 µm min-1 and KFPs with 0.24 µm min-1 (Yoon et al., 
2001). In A431 cells KFP-transport in cell periphery is described with 0.1-0.5 µm min-1  
(Windoffer and Leube, 1999), in PLC cells with 0.1-0.3 µm min-1 (Windoffer et al., 2004), and 
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in EpH4 cells with ≈ 0.5 µm min-1 (Windoffer et al., 2006). Most interestingly, in the SW-13 cell 
line that has no endogenous keratin, the keratin transport in lamellipodia and cell periphery was 
described with 0.23 µm min-1 (Woll et al., 2005).  The transport of keratin 14R125C aggregates in 
MCF-7 cells that don’t form keratin networks occurs with 0.6 µm min-1 (Werner et al., 2004). In 
only one recent study a computational approach was used to determine the complete keratin 
movement. It was done as a feasibility study for a part of a PLC cell that included the periphery 
and nucleus. The keratin movement was determined there to be 0.6 µm min-1 in cell periphery 
decreasing to 0.1 µm min-1 in regions around nucleus with a total mean value of 0.25 µm min-1 
(Kolsch et al., 2010). These independent observations indicate that the process of keratin 
filament transport is very similar across six different human cell lines under different conditions, 
and even in the case of keratin 14R125C aggregates.  
Another advantage of data from computational motion analysis performed here is the ability to 
generate topological maps of keratin motion at subcellular resolution. However, these speed 
maps are not optimal for direct comparison of different cells because of different cell shapes. To 
account for this problem the shapes of keratin networks were transformed into normalised round 
shapes with the same diameter, before motion analysis was performed. This allowed overlaying 
and averaging of speed maps derived from different cells (3.4.3). Most importantly, this method 
can be used for compensation of cell shape changes that occur during the recording process, as 
was the case in experiments where growth factors and drugs were used. However, the 
normalisation of cells is not always beneficial. This is because the normalisation can only be as 
good as the recognised keratin network shape itself, which is detected by the intensity of the 
fluorescently-tagged keratin network. A problem is that the network borders are not reliably 
detected, because KFPs appear at cell borders outside of the network. When such small filaments 
are detected the calculated network shape is extended to their positions. This is the reason why 
normalised recordings sometime appear to jump between frames. The automated recognition of 
cell shape from transmitted light images as an alternative method was not an option, because cell 
shape could not be determined reliably at the low light conditions used for recording in this 
study. Another problem is that normalisation performed here led to cells with a smaller diameter 
with reduced resolution. The transformation itself can also produce new errors. 
The cell shape normalisation is extremely advantageous for averaging of many cells from one 
experiment into a single topological map. Possible artefacts are reduced with increased n-number 
of averaged cells. 
In general, the topological data from normalised cells shows an overall inward flow of keratins 
and no accumulation of keratin filaments in the cell center. This is supported by recording of an 
entire cell in three dimensions for three hours as shown in movie_7. These findings imply that 
keratin filaments are formed predominantly in the cell periphery and that sinks exist in the 
central cytoplasm to eliminate surplus keratin. Based on the filament cycle hypothesis, the results 
from A431 and HaCaT cells suggest that keratin transport, assembly, and disassembly are 
coregulated in a similar way in all cells. 
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4.1.5. Keratin turnover 
Keratin filament sources and sinks were calculated directly from the flux of keratin filaments. 
This was done because keratin assembly and disassembly must be equal or otherwise keratin 
would accumulate in the cell center. The keratin mass was assumed to be proportional to 
fluorescence signal intensity. Gain or loss of fluorescence was then calculated along the vector of 
movement of single filaments. For the analysis the same vector field data was used as was 
described for keratin motion, correspondingly only turnover of moving filaments (bulk flow) was 
detected. The limitation of keratin movement analysis to the bottom plane was not problematic 
because it was assumed that all or most assembly processes occur there (see KFP nucleation). 
Keratin filaments in A431 cells are mostly formed in the cell periphery near the cell border and 
are disassembled inside the cell around the nucleus. Remarkably, when bulk flow maps from 
normalised networks are averaged and overlaid, these zones form a symmetrical ring (Fig. 2-24 
A). The same situation is true for keratin disassembly in such projections, which occurs in a ring 
area close to the nucleus inside the cell. Between the assembly and disassembly zones a third 
area is present where no keratin assembly or disassembly is detected. Movement analysis shows 
that filaments are transported in this zone. A second zone where no keratin assembly or 
disassembly processes are detected is directly under nucleus. The keratin network is also static in 
this zone. This leads to the conclusion that zones of keratin assembly and disassembly are 
spatially separated, and that zones exist where keratin filaments remain stable. 
The keratin bulk flow decreases strongly in A431 cells in a time dependent manner, from day 
one after plating to day two. In the experiments performed the decrease was between 56% for 
not-normalised recordings and 64% for normalised recordings (3.4.4). The corresponding 
amounts of keratin assembly and disassembly balanced each in accordance with the model of 
keratin cycling. The decrease in keratin turnover was also confirmed by FRAP analysis (3.4.2).  
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4.2. Investigation of EGF involvement in keratin filament dynamics 
The treatment of cells with EGF can lead to different results depending on cell culture 
conditions. For example, EGF-induced migration on collagen I was shown to be mediated by 
mitogen-activated protein kinase (MAPK), whereas this was not the case on fibronectin and 
vitronectin (Kawahara et al., 2002). Therefore all experiments were done under highly 
standardised conditions and the comparison with other studies was performed carefully. 
The treatment of A431 cells with EGF increased the nucleation and inward-directed motion of 
keratin filaments (3.5.1). With increased time (> 15 minutes) the keratin network concentrated 
noticeably around the nucleus. Other morphological effects like increased ruffling and retraction 
were described previously in A431 cells cultivated under different conditions (Chinkers et al., 
1981; Lifshitz et al., 1983). These changes in cell morphology were explained by the 
reorganization of the actin cytoskeleton and increased actin polymerisation in response to EGF 
(Peppelenbosch et al., 1993; Rijken et al., 1991). In this context the increased actin 
polymerisation explains the increased inward-directed movement of KFPs that are transported in 
an actin dependent manner (Woll et al., 2005). The earlier studies also showed that the EGFR is 
concentrated at cell borders in regions where KFPs are formed under cell culture conditions. This 
close localisation of EGFR to KFP nucleation centres is possibly beneficial for the control of 
keratin network dynamics in response to EGF. 
The observations of increased keratin movement in response to EGF were confirmed in further 
experiments by quantitative analysis. In A431 cells keratin movement increased by 40 or 31% 
depending on the calculation method used and keratin bulk flow by 36% (3.5.2). The same 
situation was found in HaCaT cells with an increase of 66 or 42% for keratin movement and 142 
or 96% for keratin bulk flow (3.5.6). Despite the differences in calculated speed for not-
normalised and normalised networks, the keratin mean speed was increased significantly in both 
cell lines by at least one third, and bulk flow to a similar or higher degree. The significant 
increase in keratin turnover upon EGF addition was confirmed in independent FRAP 
experiments of complete keratin networks in multiple cells (3.5.3). Furthermore, the role of 
EGFR in regulation of keratin dynamics was confirmed by inhibition of EGFR with Cetuximab 
(3.5.4). Interestingly, the inactivation of EGFR did not affect keratin dynamics, indicating that it 
is only a positive regulator. Another observation was that the changes in keratin dynamics 
occurred without obvious alterations in overall keratin fluorescence intensity (data not shown) 
indicating that keratin translation can be neglected in this scenario. 
The increased keratin turnover in response to EGF was observed together with enhanced 
phosphorylation of keratin 8 on S73 and S431. Phosphorylation of S431 was described 
previously to be induced by EGFR signalling in MAPK dependent pathway (Ku and Omary, 
1997; Omary et al., 1998). In a recent study it was shown that phosphorylation of this site 
induces keratin network reorganisation that enhances migration of epithelial tumour cells (Busch 
et al., 2012). In this case the phosphorylation was induced by the MEK-ERK signalling cascade 
in response to treatment with sphingosylphosphorylcholine (SPC). The effect on cytoskeleton 
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morphology was confirmed in cells transfected with phosphomimetic keratin 8 S431E-mutant. 
Phosphorylation of S73 was described to occur in response to sheer stress in PKC ζ and 14-3-3 
dependent manner in A549 cells (Sivaramakrishnan et al., 2009). The consequence is increased 
bundling of keratin filaments and decrease in soluble keratin (Flitney et al., 2009). Interestingly, 
in this context S73 was described to increase keratin disassembly in the same cell line (Ridge et 
al., 2005). Taken together, the phosphorylation of S73 and S431 in response to EGF possibly 
restructures the keratin network for enhanced cell migration. Additionally, S73 reduces the 
stability of filaments increasing the speed of keratin cycling, which is necessary for the 
restructuration of the network. It can be speculated that not only the network morphology but 
also physical properties of the filaments are changed by phosphorylation in this process. These 
observations are comparable to cytoskeletal remodelling observed during migration in different 
cell lines (Wells et al., 2002). 
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4.3. Investigation of FAK and Src involvement in regulation of keratin 
filament dynamics 
4.3.1. FAK 
The involvement of FAK in the regulation of keratin dynamics was tested by specific 
pharmacological inhibition of its catalytic activity. The hypothesis was that FAK could regulate 
keratin dynamics by control of focal adhesion turnover (1.6.1). To account for possible off-
targeting three structurally different inhibitors were used at low but efficient concentrations 
estimated from serial dilutions (3.6.1). PF-431,396 (0.25 µM) and PF-573,228 (1 µM) inhibited 
the phosphorylation of FAK on Y397 in A431 cells efficiently within one minute. FAK-14 (15 
µM) inhibited Y397 phosphorylation with more than 5 minutes delay after addition. The 
differences in time needed for inhibition can be explained by involvement of the solvent 
dimethyl sulfoxide (DMSO). The first two inhibitors that decreased phosphorylation within one 
minute were dissolved in DMSO, which is known to increase the uptake through cell membranes 
(Gurtovenko and Anwar, 2007). FAK-14 was solved in water, but it was not tested if DMSO 
would speed up its inhibitory effect. Other mechanisms that can be involved in slowed inhibitor 
effect are multi drug transporters, secondary transformations, and chemical structure of the 
inhibitors. An involvement of secondary mechanisms to inhibit FAK by FAK-14 is unlikely 
because the compound was designed specifically to bind directly to FAK (Golubovskaya et al., 
2008). Although FAK-14 was the slowest inhibitor it was the only one that showed significant 
inhibitory effect on keratin movement, assembly, and disassembly. The significant turnover 
decrease was also confirmed by FRAP experiments (3.6.2). PF-431,396 and PF-573,228 did not 
affect keratin dynamics at specific concentrations. When the concentration of PF-431,396 was 
increased by factor two to 500 nM a weak but significant effect only on keratin movement 
calculated from not-normalised recordings was detected. 
The conclusion is that inactivation of the main pool of FAK in A431 cells has no short term 
regulatory effects (within 15 minutes) on keratin dynamics. The decrease of keratin motion and 
turnover by FAK-14 (15 µM) and the decrease of keratin motion by doubled concentration of 
PF-431,396 (0.5 µM) are possibly unspecific side effects. The immunoblot analysis in Fig. 2-32 
C shows that the concentration of 0.5 µM PF-431,396 does not noticeably inhibit 
phosphorylation of Y397 stronger than 0.1 µM indicating off-targeting. These findings do not 
exclude that FAK could be involved together with other factors in regulation of keratin 
dynamics. 
The remaining question is how FAK-14 decreases keratin turnover? Another target inhibited by 
FAK-14 but not by the other FAK inhibitors was Src, which is described below. 
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4.3.2. Src 
Src was of interest because it was inhibited by FAK-14 compound that decreased keratin 
dynamics. The inactivation of Src was reflected in a decrease in phosphorylation of Y418 (Fig. 
2-32 A’) which is necessary for its signalling activity (1.6.2). In accordance, the inhibition of Src 
with SKI-606 (2.5 µM) decreased keratin movement and bulk flow significantly within 5-15 
minutes (calculated from not-normalised recordings) (3.6.3). Topological analysis of overlaid 
and averaged keratin movement and bulk flow calculated from normalised recordings showed 
noticeably lowered keratin dynamics after Src inhibition.  
The negative effect of Src inhibition on keratin movement was further confirmed in a recording 
done for 45 minutes after addition of SKI-606 (movie_19). The keratin movement was decreased 
in a time dependent manner, with noticeable effect 30 minutes after addition of the inhibitor. 
Especially the keratin transport in cell periphery toward cell interior was affected. However, 
these data should be confirmed by a different inhibitor or shRNA because off-targeting of SKI-
606 cannot be excluded. 
The conclusion is that when the inhibition of Src was specific it only had a minor effect on 
keratin dynamics by decreasing it. However, the data indicates that the effect is time dependent 
and could be meaningful for long-term regulation of keratin dynamics. 
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4.4. Involvement of plectin and HD-like structures in regulation of 
keratin filament dynamics 
4.4.1. Assembly of HD-like structures in cell culture 
HD-like structures are formed only in a few cell lines that originate from epithelia including a 
few cancer cell lines (1.4.2). 
In the first experiments (3.3.1) it was tested if available cell lines form HD-like structures on 
glass surfaces. 804G cells formed plectin positive patterns at the bottom membrane that 
resembled HD-like structures as shown by (Riddelle et al., 1992) in the same cell line. These 
structures were well stained by the HD1/plectin antibody that predominantly recognises plectin 
1a (Andra et al., 2003; Hieda et al., 1992; Okumura et al., 1999). In immunocytochemistry with 
the plectin P1 antibody the same structures were recognised but also others. These structures are 
possibly different plectin isoforms that share the antigen on carboxy terminal 6 domain against 
which P1 was raised. Plectin P2 antibody was raised against the same antigen as P1, it 
recognised significantly more structures, the same as HD1/plectin but also filamentous structures 
that did not resemble typical HD-like patterns. This behaviour was described for P2 in muscle 
where muscle fibres were stained only by P2 but not P1 (Schroder et al., 1999). In 804G cells 
such fibres are only keratin filaments that bind different plectin isoforms. However, unspecific 
staining cannot be excluded. Interestingly, the P1 recognised very well rat plectin in 
immunocytochemistry, although it was described previously to be predominantly specific for 
human plectins with low affinity for mouse and bovine plectins in immunoblot analysis 
(Schroder et al., 1999). Another observation in 804G cells was that small circular holes, filled 
with actin, were found in integrin β4 positive patterns that resemble HD-like structures (3.3.6). 
These actin positive structures were also found by (Spinardi et al., 2004) in the same cell line and 
were described as podosome-like. The authors also discovered different cytoskeleton regulators 
in them, for example Arp2/3 and Src. These structures could be involved in the regulation of 
keratin dynamics by the regulation of actin polymerisation. 
In further experiments the focus was changed to human cell lines instead of rat, because integrin 
α6 and β4 antibodies were only available from rat. Human keratinocytes (HaCaT) formed 
plectin/integrin β4 positive rings within two hours after plating, these complexes increased 
strongly in size within three days. In small cell groups of 4-5 cells these complexes formed large 
rings that were continued in all cells in a symmetrical manner as shown in Fig. 2-10. In larger 
cell layers a continuance in neighbouring cells was often noticeable, but the patterns were more 
random and not necessarily circular. Three days after cell plating these patterns were 
keratin/integrin β4 positive as expected from HD-like structures (3.3.2). Similar patterns positive 
for integrin α6 were shown in this cell line by (Ozawa and Tsuruta, 2011). Interestingly, 
hemidesmosomal patterns are continued in cell layers in tissues (Owaribe et al., 1990; Owaribe 
et al., 1991). Such organisation of hemidesmosomes is possibly beneficial for stabilisation of cell 
clusters by adhesion to the extracellular matrix. For example, a line formed of glue is stronger in 
attachment of objects than single dots at larger distances, because small adhesion sites can be 
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easier detached by force. The organisation of hemidesmosomes also has a direct impact on 
morphology of keratin cytoskeleton that connects cells by desmosomes. Stabilisation of keratin 
on both sides of desmosomes in two neighbouring cells would increase the physical stability of 
these connections. 
In A431 cells cultivated on glass surfaces the situation is different. Patterns resembling HD-like 
structures in confluent cell layers are found in less than 1% of cells. In most cells integrin 
β4/plectin positive complexes outline complete cell borders in regions close to other cells (3.3.3). 
The strongly decreased ability to form HD-like structures in confluent A431 cells was described 
by (Mariotti et al., 2001) in consequence to EGFR overexpression, which leads to tyrosine 
phosphorylation of integrin β4 in a Fyn kinase dependent pathway resulting in disassembly of 
these structures. However, by critical observation of Fig. 8 B in the mentioned publication, 
control A431 cells formed integrin β4 patterns that resemble HD-like structures. This is possibly 
a consequence of the laminin-332-rich matrix coating used to cultivate the cells. By another 
group A431 cells were also shown to form at least ring-shaped HD-like structures within 1-2 
hours after plating on laminin-111-rich matrix (Rabinovitz et al., 1999). These findings lead to 
the conclusion that A431 cells unlike 804G and HaCaT cells do not secrete sufficient amounts of 
extracellular matrix necessary for formation of HD-like structures. In further experiments (3.3.3) 
different coatings were tested that are well established. The number of integrin β4/plectin 
positive patterns resembling HD-like structures increase slightly on fibronectin, but in general, it 
is very low. Collagen I and laminin-111 further increase the formation but the total number 
remains low. Collagen IV noticeably increases the formation of HD-like patterns but still more 
than 50% of cells remain without these structures. Extracellular matrix from 804G cells is very 
efficient in induction of HD-like structures in up to 90% of cells. When these cells are 
additionally cultivated in conditioned medium from 804G cells 99% of them can form HD-like 
structures. Interestingly, integrin β4/plectin is not found at cell borders when cells form HD-like 
structures with strong signal in immunocytochemistry. The presence of HD-like structures was 
confirmed by colocalisation of keratins or keratin 13-EGFP with plectin, integrin α6, and 
integrin β4 (3.3.3). The matrix from 804G cells was described to induce formation of HD-like 
structures and the main component was identified as laminin-332 (Langhofer et al., 1993). The 
laminin-332-rich matrix led to formation of HD-like structures in A431 cells within two hours 
after plating in this study. These early structures were circularly shaped as it was the case in 
HaCaT cells. Interestingly, unlike in HaCaT cells these structures were disassembled within 2-12 
hours and were reassembled 12-36 hours later. These new structures were shaped like stripes that 
are directed towards one direction (3.3.4). Between these stripes actin stress fibres are sometimes 
located, which is possibly the reason for their form (data not shown).  
The withdrawal of growth factors from A431 cells led to strongly decreased formation of HD-
like structures within 1-3 days after plating. With increased time the total amount of integrin β4 
was also decreased in this time interval. Interestingly, in these cells a single narrow integrin β4 
ring was formed around the nucleus. At these rings keratins were bundled to rings of similar size 
(3.3.5). These integrin β4/keratin patterns are possibly HD-like structures that could be important 
for keratin bundling around the nucleus. The current data also show that growth factors are 
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involved in the formation of HD-like structures in A431 cells and not only in disassembly of 
them. The involvement of growth factors in HD-like structure formation is not fully understood 
(Litjens et al., 2006). 
 
4.4.2. In vivo detection of HD-like structures 
HD-like structures were detected in living cells by colocalisation of fluorescently-tagged keratins 
and integrin β4 at stable spots. The fluorescence signal of EGFP-tagged integrin β4 was weak in 
patterns resembling HD-like structures, especially in fixed cells. The signal was improved by 
replacement of EGFP with the brighter EYFP. Interestingly, the transfection of A431 cells with 
fluorescently-tagged integrin β4 resulted in labelling of HD-like structures but also of other 
structures. These structures were not found in immunocytochemistry experiments (Fig. 2-12 and 
Fig. 2-13). To improve the yield of integrin β4-EYFP incorporated into HD-like structures a 
sequence encoding for a short α-helix was inserted between integrin β4 and the EYFP-tag. This 
was done to improve the flexibility of the fluorophore in case it should disturb the binding of 
integrin β4 to other hemidesmosome proteins. However, the new construct (plasmid 2105) 
showed the same behaviour as constructs without an additional α-helix (3.3.6). To standardise 
the experiments, stable A431 cell clones with integrin β4-EYFP were generated. Interestingly, 
the clones showed mostly only one phenotype in all cells (3.3.7). The differences in phenotypes 
are possibly a result of different expression levels of integrin β4-EYFP or are resulting from 
other genetic differences that can be acquired by cancer cells. 
 
4.4.3. Influence of HD-like structures on keratin filament dynamics 
Dynamic keratin processes at hemidesmosomes have not been published before. Fluorescently 
labelled integrin β4 and keratin form stable HD-like structures (3.3.8). These structures bind 
keratin and form barriers that stop or decrease keratin movement. This behaviour is similar to the 
concentration of keratin network around the keratin cage that surrounds the nucleus. However, 
the keratin concentration at HD-like structures can be higher, which possibly results from the 
faster keratin movement in the cell periphery and lack of disassembly mechanisms such as 
present in vicinity to cell nucleus. The concentration of keratins at these structures can result in 
the extension of HD-like structures as shown in Fig. 2-20 A by recruitment of integrin β4. 
Otherwise, it is possible that the elastic force generated by keratins at HD-like structures can 
destabilize them. It is also observed that HD-like structures themselves remain stable or 
disassemble within minutes in A431 cells. This was also confirmed previously by other groups 
with single fluorescently-tagged hemidesmosomal components that can be highly dynamic 
(1.4.2). The involvement of keratin in elastic retraction is supported by observations where HD-
like structures are disassembled at the trailing edge during cell migration and in consequence 
large cell parts are retracted as shown in Fig. 2-18 B and movie_14. The investigated HD-like 
structures can move at the bottom plane of the cell (movie_16). This allows the formation of 
larger structures from smaller structures that merge together. The movement is possibly a result 
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of weak adhesion of ECM proteins to glass that anchor HD-like complexes. In this scenario it is 
possible that anchoring matrix proteins are proteolytically degraded by secreted proteases. This 
behaviour can surely decrease the tension of keratins on HD-like structures and decrease the 
stored elastic force in them. Otherwise, it was observed that HD-like structures can be attached 
strongly to ECM preventing the retraction of cells at cell borders, protecting complete cell layers 
from retraction. Small HD-like complexes can also remain behind cells in retraction fibres, as 
was described previously in other cell lines (Geuijen and Sonnenberg, 2002; Kashyap et al., 
2011). 
The investigation of HD-like structures by time lapse confocal microscopy was problematic due 
to extensive bleaching of EGFP- and EYFP-tagged integrin β4. Signal enhancement by 
denoising has proven advantageous in this scenario, but the best signal stability was obtained in 
TIRF microscopy. The disadvantage and advantage of TIRF microscopy was that the keratin 
signal is limited to the bottom plane of the cell. An alternative is to record only HD-like 
structures in TIRF mode and the keratin network in widefield. In this scenario deconvolution of 
keratin filaments further increases the image quality (data not shown). Nevertheless, for 
recording of HD-like structures the focus stabilization has proven most important, because these 
structures are only limited to the plasma membrane at the bottom of the cell. 
 
4.4.4. Influence of plectin on keratin morphology and cell physics 
Plectin can be efficiently downregulated by shRNA in A431 and HaCaT cells and stable cell 
clones can be generated (3.7.1). Plectin downregulation prevents the formation of HD-like 
structures in A431 and HaCaT cells. These cells do not show any integrin β4 patterns that 
resemble HD-like structures indicating that binding of plectin/keratin complexes is necessary for 
the formation of HD-like structures. The lack of plectin leads to downregulation of integrin β4, 
as shown in Fig. 2-38 A, which is plectin’s partner in HD-like structures. Interestingly, in cells 
that are cultivated under conditions that disfavour the formation of HD-like structures this is not 
the case, as integrin β4 levels remain constant regardless of plectin. This indicates that integrin 
β4 quantity is increased in cells that form HD-like structures. Most likely integrin β4 is protected 
from degradation in HD-like structures. Other adhesion proteins that are affected by plectin 
downregulation are integrin α3 and integrin β1. These proteins are unlike integrin β4 also 
downregulated under conditions that disfavour HD-like structures indicating another mechanism 
of plectin in their downregulation. All three proteins were also found in focal adhesions (1.4.1). 
However, integrin β5 positive focal adhesions appear normal in plectin downregulated cells. 
Only the localisation in HaCaT cells was not concentrated in the cell periphery, most likely 
because location of focal adhesions was not restricted by HD-like structures upon plectin 
downregulation in these cells (Fig. 2-38 C). 
In wound closure experiments no usable data was generated for plectin downregulation because 
A431 cells were closing the wounds too slow (3.7.3). The cell migration into the wound was 
mostly mediated by cell growth. Inhibition of cell growth with mitomycin C was not an option 
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because it has been shown toxic for A431 cells. Growth factor induced migration could be an 
alternative for further studies. 
Plectin downregulation in A431 cells resulted in less wavy keratin filaments (fibers) and 
increased their bundling with the consequence that the number of thin keratin fibres was reduced. 
Computational analysis of these networks confirmed that the keratin network mesh size is 
increased in A431 cells upon plectin downregulation as shown in Fig. 2-39 C. These 
morphological changes upon plectin downregulation were described previously for keratinocytes 
that lacked plectin (Osmanagic-Myers et al., 2006). The authors suggested that these phenotypes 
are caused by reduction of cross-linking between keratin filaments mediated by plectin. They did 
not observe changes in expression of keratin isoforms which could also affect the physical 
properties of the networks. This was also confirmed here in Fig. 2-39 B. In another study keratin 
bundling was decreased at the edge of induced wounds upon periplakin downregulation. (Long 
et al., 2006). Periplakin is another plakin family member that can bind IFs like plectin 
(DiColandrea et al., 2000). Interestingly, the periplakin effect on the keratin cytoskeleton is 
dependent on plectin-periplakin interaction in this process (Boczonadi et al., 2007).  
Another observation is that keratin networks are less resilient against osmotic stress without 
plectin in keratinocytes (Osmanagic-Myers et al., 2006). The authors explained this by lack of 
keratin binding to integrin clusters. In another study that was performed in our group it was 
investigated if elasticity of single cells is affected by plectin. Therefore magnetic beads were 
injected in plectin downregulated A431 cell clone 2108-4. The measured displacement of 
magnetic beads in response to a magnetic field was not significantly different than in control 
cells (unpublished data, Raphaela Phol). In other experiments performed in the same cell clone 
by Lena Ramms (Institute of Complex Systems, Forschungszentrum Jülich) the cells were 
characterised for their resilience against external force by atomic force microscopy (AFM). The 
force was measured at cell middle in single cells. The results showed no significant differences 
upon plectin downregulation in comparison to controls (unpublished data). However, the binding 
of keratins to hemidesmosomal structures by plectin is without doubt important for mechanical 
stability of cells. 
In plectin downregulated HaCaT cells (3.7.1) keratin networks were not noticeably changed, 
possibly because in these cells plectin is mostly localised at HD-like structures and not within the 
keratin networks. However, stable clones should be generated for exact quantitative analysis. 
 
4.4.5. Influence of plectin on keratin dynamics 
Keratin dynamics were investigated in plectin downregulated A431 cell clones under conditions 
that favour (with FCS) or disfavour (without FCS) the formation of HD-like structures (3.7.4). 
The movement of keratin filaments was significantly decreased in plectin positive cells when 
compared to plectin deficient cells in cells that tended to form HD-like structures. This behaviour 
is expected because plectin deficient cells have problems to form HD-like structures that anchor 
keratin filaments (3.7.1). An increased keratin movement should lead to increased keratin 
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turnover as predicted by the keratin cycle. The keratin turnover was slightly decreased in cells 
that were likely to form HD-structures but the difference was not significant. However, the 
increased keratin movement in cells with less HD-like structures could be explained by increased 
degree of movement of not anchored keratin filaments. However, this should be tested in further 
studies in more detail. 
The keratin filament precursor-formation in close vicinity to the cell periphery takes place in 
plectin downregulated clones (movie_24). Interestingly, plectin deficient fibroblasts do not form 
typical vimentin squiggle/granule at focal adhesions. Instead fewer but longer vimentin filaments 
are found and the networks are assembled faster (Spurny et al., 2008). The formation of vimentin 
squiggles at focal adhesion was shown to be plectin 1f dependent (Burgstaller et al., 2010). The 
results in this study suggest that in contrast to vimentin formation the formation of keratin 
precursors is not plectin dependent. However, it was not tested if the assembly still occurred in 
vicinity to focal adhesions. 
The role of plectin in keratin movement and turnover in A431 cells without HD-like structures is 
not significant and can be neglected (3.7.4). This is not surprising because plectin deficient 
keratinocytes form intact keratin networks that express only morphological differences 
(Osmanagic-Myers et al., 2006). A keratin connection with actin that could be mediated by 
plectin can be neglected for keratin transport, because plectin mostly colocalises with keratin 
networks in the central parts of the cell and only to a very low degree in the cell periphery, as 
shown in Fig. 2-36. For actin driven keratin transport only the cell periphery is of interest, 
because in central parts of the cell this process is microtubule driven. Keratin interaction with 
microtubules could be mediated by plectin, but also here the analysis has shown no differences 
in keratin movement and disassembly. This indicates that other mechanisms are of higher 
importance or can compensate for plectin. However, in the central parts of the cell it cannot be 
excluded that the remaining plectin in downregulated cells could be sufficient for normal keratin 
transport. 
For keratin assembly the current data and the fact that plectin-deficient keratinocytes form 
keratin networks indicate that plectin is not necessary. A role of plectin could only be detected in 
cells that potentially form HD-like structures, where plectin decreases keratin movement 
obviously by binding them to HD-like structures. 
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4.5. Outlook 
The automated image analysis methods established in this work are essential to further increase 
our understanding of the complexity of dynamic intermediate filament behaviour at the 
subcellular level. Proof-of-principle was provided that these methods are capable to reliably 
detect changes in keratin dynamics that are induced by signalling pathways and will be 
applicable to characterise the specific kinetic and organisational properties of mutant keratins, 
keratin isoforms and to study the relationship of keratin network dynamics to cell mechanics, 
extracellular matrix composition, microbial infections, intoxication, and differentiation. 
Furthermore, the automated analysis of intermediate filament network branching can be 
extended to data from super resolution fluorescence microscopy and scanning electron 
microscopy.  Pilot experiments have already proven their usefulness.  
The identification of EGFR as a modulator of keratin dynamics indicates that proteins 
downstream are responsible for keratin polymerisation. Most likely these are kinases whose 
action on keratins can be examined with specific inhibitors. A possible candidate identified in 
this study is Src which is found at focal adhesions where keratin polymerisation starts.
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6. Abbreviations 
 
A ampere 
APS ammonium persulfate 
µl microliter 
µM micromolar 
2D two dimensional 
3D three dimensional 
ADP adenosine diphosphate 
ATP adenosine-5'-triphosphate 
AU Arbitrary unit 
avi Audio Video Interleaved 
BPAG1 Bullous pemphigoid antigen 1 
BSA bovine serum albumin 
CCD charge-coupled device 
cDNA complementary deoxyribonucleic acid 
cm centimetre 
conc. concentration 
DAPI 4',6-diamidino-2-phenylindole 
ddH2O double-distilled water 
dH2O distilled water 
DMEM Dulbecco's modified Eagle's Medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dNTPs deoxynucleotide triphosphates 
DTT Dithiothreitol 
E.coli Escherichia coli 
ECFP enhanced cyan fluorescent protein 
ECM extracellular matrix  
EDTA Ethylenediaminetetraacetic acid  
EGF epidermal growth factor 
EGFP enhanced green fluorescent protein 
EGFR epidermal growth factor receptor 
EGTA Ethylene glycol tetraacetic acid  
ERK extracellular-signal regulated kinase 
etc. etcetera 
EYFP enhanced yellow fluorescent protein 
FAK focal adhesion kinase 
FAs Focal adhesions 
F-actin filamentous actin  
FCS fetal calf serum 
Fig. figure 
fps frames per second 
FRAP fluorescence recovery after 
photobleaching 
g standard gravity 
G418  geneticin sulfate 
GAPDH Glyceraldehyde 3-phosphate 
dehydrogenase 
GDP guanosine diphosphate 
GTP guanosine-5'-triphosphate 
h hour 
HBSS Hank's buffered salt solution 
HCl hydrochloric acid 
HDs hemidesmosomes 
HEPES 4-2-hydroxyethyl-1-
piperazineethanesulfonic acid 
HRP horseradish peroxidase 
ICC Immunocytochemistry 
IgG immunoglobulin G 
IP3 inositol 1,4,5-trisphosphate 
K keratin 
kb kilo base pairs 
kDa kilo Dalton 
l litre 
LCD liquid crystal display 
LED light-emitting diode 
M molar 
mAb monoclonal antibody 
MAPK mitogen-activated protein kinase 
max. maximum 
min minute 
min. minimum 
MIP maximum intensity projection 
ml millilitre 
MLCK myosin light chain kinase 
mM millimolar 
mm millimetre 
MPEG Moving Picture Experts Group 
mRNA messenger ribonucleic acid 
nM nanomolar 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PFA paraformaldehyde 
pH power of hydrogen 
PI3K phosphoinositide 3-kinase 
PIP2 phosphatidylinositol 4,5-bisphosphate 
PKC protein kinase C 
pM picomolar 
PMT photomultiplier tube 
PVDF polivinylidene difluoride 
px pixel 
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RCF relative centrifugal force 
RGB red, green, and blue (additive colour 
model) 
RNA ribonucleic acid 
rpm rounds per minute 
RT room temperature 
s, sec second (time) 
S1 biosafety level 1 (Germany) 
S2 biosafety level 2 (Germany) 
SD standard deviation 
SDS sodium dodecyl sulfate 
SEM standard error of the mean 
SH2 Src-homology 2 
shRNA short interfering RNA 
Src sarcoma kinase 
sRGB standard RGB 
TEMED Tetramethylethylenediamine 
TIFF Tagged Image File Format 
TIRFM total internal reflection fluorescence 
microscopy  
TNF tumour necrosis factor 
UV ultraviolet light 
V volt 
v/v volume/volume 
W watt 
WB western blot (immune blot) 
wt wild type 
w/v mass/volume
 
 
Tab. 6-1: Amino acids. 
A   alanine (Ala) G   glycine (Gly) M   methionine (Met) S    serine (Ser) 
C   cysteine (Cys) H   histidine (His) N   asparagine (Asn) T    threonine (Thr) 
D   aspartic acid (Asp) I    isoleucine (Ile) P   proline (Pro) V    valine (Val) 
E   glutamic acid (Glu) K   lysine (Lys) Q   glutamine (Gln) W   tryptophan (Trp) 
F   phenylalanine (Phe) L   leucine (Leu) R   arginine (Arg) Y    tyrosine (Tyr) 
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7. List of movies 
 
movie_1: Keratin 13-EGFP motion in a single A431 cell.  
For detail see corresponding Fig. 2-3 A and chapter 3.2.2. 
movie_2: Keratin 5-EYFP motion in a single HaCaT cell. 
For detail see corresponding Fig. 2-3 B and chapter 3.2.2. 
movie_3: Keratin filament precursor (KFP) formation at focal adhesions. 
Keratin 13-EGFP is shown in green and paxillin-dsRed2 positive focal adhesions in red. At time 
point of 10 minutes 50 ng ml-1 EGF were added which resulted in strongly increased formation 
of KFPs at focal adhesions. For detail see corresponding Fig. 2-4 A and chapter 3.2.3.  
movie_4: KFP elongation and fusion to longer filaments. 
The movie shows a different location from cell recorded in movie_03. The region covers Fig. 2-4 
B but shows a larger area. For detail see also chapter 3.2.3. 
movie_05: KFP integration into keratin filament network. 
For detail see corresponding Fig. 2-4 C and chapter 3.2.3. 
movie_06: Keratin network dynamics during cell division. 
For detail see corresponding Fig. 2-5 and chapter 3.2.4. 
movie_07: Keratin network dynamics during cell division. 
A431 cell clone AK13-1 was cultivated for 60 hours (instead for 80 hours as in movie_06) 
without FCS on laminin-332-rich matrix. In the time-lapse images keratin filament network is 
disassembled into aggregates one hour before cell division. After division the keratin network is 
reassembled within 10 minutes. The background was removed by Gaussian filtering. The images 
are maximum intensity projections of keratin 13-EGFP in complete cell from confocal 
sectioning. 
movie_08: Keratin network dynamics during cell division. 
This movie shows a cell division in Hanks-HEPES-solution unlike movie_06 and movie_07 
where cells were cultivated in DMEM. A431 cell clone AK13-1 was cultivated for 24 hours 
without FCS on laminin-332-rich matrix. In the time-lapse images keratin filament network is 
disassembled within 10 minutes before cell division and directly reassembled in the newly 
formed cells. The images are maximum intensity projections of keratin 13-EGFP in complete 
cell from confocal sectioning. 
movie_09: Keratin network dynamics during cell migration. 
For detail see corresponding Fig. 2-6 and chapter 3.2.5. The only difference is that contrast was 
not enhanced to compensate for photobleaching. 
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movie_10: KFP nucleation and transport in retraction fibres. 
For detail see corresponding Fig. 2-7 and chapter 3.2.6. The movie shows only keratin 13-EGFP 
channel. The background was removed in Fiji software by Gaussian filtering (radius: 1.0). 
movie_11: Microtubule movement in A431 cell line. 
For detail see corresponding Fig. 2-8 A-A’’ and chapter 3.2.6. The movie shows the complete 
time lapse sequence of EB3-EGFP marked microtubule ends. 
movie_12: Unknown structures marked by integrin β4-EGFP. 
For detail see corresponding Fig. 2-17 B and chapter 3.3.6.  
movie_13: Live dynamics of HD-like structures in A431 cells. 
For detail see corresponding Fig. 2-18 A and chapter 3.3.8. Integrin β4-EYFP positive HD-like 
structures are shown in blue and keratin 8-mCherry in green. 
movie_14: Live dynamics of HD-like structures and elasticity of keratin networks. 
For detail see corresponding Fig. 2-18 B and chapter 3.3.8. Note that when the integrin β4-EYFP 
positive HD-like structures disassemble the keratin network quickly retracts. 
movie_15: Signal of HD-like structures enhanced by denoising. 
For detail see corresponding Fig. 2-19 A and chapter 3.3.8. 
movie_16: TIRF recordings of HD-like structures that merge together. 
For detail see corresponding Fig. 2-20 A and chapter 3.3.8. 
movie_17: TIRF recordings of keratins moving outside of HD-like structures. 
For detail see corresponding Fig. 2-20 B and chapter 3.3.8. 
movie_18: FAK inhibitor PF-562,271 inhibits the formation and movement of keratin 
granule in MCF-7 cells. 
For detail see corresponding Fig. 2-31. 
movie_19: Src inhibitor SKI-606 decreases keratin movement. 
A431 cell clone AK13-1 was cultivated for 50 hours on laminin-332-rich matrix. SKI-606 (2.5 
µM) was added at time point of 5 minutes.  The confocal images show keratin 13-EGFP at the 
cell bottom. Note that the keratin movement toward cell interior is decreased 30 minutes after 
addition of the inhibitor. 
movie_20: MCF-7 cells forming keratin granule treated with FAK inhibitor PF-573,228. 
For detail see corresponding Fig. 2-35 and chapter 3.6.4. 
movie_21: Keratin cycle of assembly and disassembly. 
For detail see corresponding Fig. 4-1. 
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movie_22: Keratin networks in multiple layers of confluent A431 cells. 
Clone AK13-Pax9 (3.2.3) was cultivated for 100 hours on uncoated glass surfaces. The movie 
shows maximum intensity projections from confocal sectioning. Note that the keratin networks 
show typical keratin movement as is found in cell layers of one cell height or in single cells. The 
gamma grey values were adjusted to make weak keratin signal visible. 
movie_23: Keratin assembly and movement in A431 cells growing on other cells. 
The confocal images show the top layer of movie_22 in a zoom region. Note that paxillin-
dsRed2 forms dynamic complexes that are similar to focal adhesions. The ds-Red2 signal was 
denoised with Gauss filter, Median filter, and background was subtracted with rolling ball 
algorithm in Fiji software. 
movie_24: KFP formation in plectin downregulated cell and control. 
Plectin downregulated A431 cell clone 2108-4 and scramble control clone 2112-3 were 
cultivated for ≈ 50 hours on laminin-332-rich matrix. The confocal recordings show KFP 
formation in cell periphery and transport toward cell interior where the KFPs elongate and merge 
with the keratin network. Weak keratin signal was made visible by changing gamma grey value 
to 0.3 in Image Pro plus software and background noise was removed with Gauss filter in Fiji 
software (radius: 0.7). 
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10. Addendum 
 
10.1. Keratin immunocytochemistry 
 
 
Fig. 10-1: Keratin immunocytochemistry. 
HaCaT cells were cultivated for 68 hours on uncoated glass surfaces. The cells were methanol/acetone fixed and 
stained with pan-keratin antibodies from guinea pig. The image was recorded with confocal microscopy and weak 
keratin signal was made visible by changing gamma grey value to 0.45 in Zen 2011 software. In the zoomed area on 
the right short keratin filaments are marked by arrows that possibly attached to the side of other filaments. 
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10.2. DNA sequence of mApple-actin 
All sequences used in this work are included as digital files in FASTA and clone manager 9 data 
formats. Unlike the other sequences it is not known if this was published previously, therefore it 
is included additionally here. The following sequence from the paper form of the document can 
be digitalised by optical character recognition (OCR) software or copy pasted from the PDF. 
mApple-actin (plasmid 2137) was provided by Prof. James W. Nelson. The following sequence 
was sequenced with primers 00-27, 09-102, 10-39, 11-98, 11-101. At the N-termini (bp 938-
1646, marked in bold black) mApple is encoded, between bp 1646-938 is a linker region, and 
actin is encoded at the C-terminal region (bp 1667-2794, marked in bold blue). The actin 
sequence corresponds to Homo sapiens actin, beta (ACTB), with NCBSequence ID: 
gi|168480144|ref|NM_001101.3|. 
CCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGG
TCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCAC
CTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTT
TTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACC
GTATTACCGCCATGCATTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCG
CGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGT
ATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTG
GCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTA
TGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGA
TGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGAC
GTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCA
AATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTGGTTTAGTGAACCGTCAGATCCGCTAGCGCT
ACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGAATAACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGC
ACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGCCTTTCAG
ACCGCTAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGG
CTCCAAGGTCTACATTAAGCACCCAGCCGACATCCCCGACTACTTCAAGCTGTCCTTCCCCGAGGGCTTCAGGTGGG
AGCGCGTGATGAACTTCGAGGACGGCGGCATTATTCACGTTAACCAGGACTCCTCCCTGCAGGACGGCGTGTTCATC
TACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGC
CTCCGAGGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGAGCGAGATCAAGAAGAGGCTGAAGCTGAAGGACGGCG
GCCACTACGCCGCCGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACATCGTCGAC
ATCAAGTTGGACATCGTGTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTC
CACCGGCGGCATGGACGAGCTGTACAAGTCCGGACTCAGATCTCGAGCTATGGATGATGATATCGCCGCGCTCGTCG
TCGACAACGGCTCCGGCATGTGCAAGGCCGGCTTCGCGGGCGACGATGCCCCCCGGGCCGTCTTCCCCTCCATCGTG
GGGCGCCCCAGGCACCAGGGCGTGATGGTGGGCATGGGTCAGAAGGATTCCTATGTGGGCGACGAGGCCCAGAGCAA
GAGAGGCATCCTCACCCTGAAGTACCCCATCGAGCACGGCATCGTCACCAACTGGGACGACATGGAGAAAATCTGGC
ACCACACCTTCTACAATGAGCTGCGTGTGGCTCCCGAGGAGCACCCCGTGCTGCTGACCGAGGCCCCCCTGAACCCC
AAGGCCAACCGCGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACACCCCAGCCATGTACGTTGCTATCCAGGC
TGTGCTATCCCTGTACGCCTCTGGCCGTACCACTGGCATCGTGATGGACTCCGGTGACGGGGTCACCCACACTGTGC
CCATCTACGAGGGGTATGCCCTCCCCCATGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGACTGACTACCTC
ATGAAGATCCTCACCGAGCGCGGCTACAGCTTCACCACCACGGCCGAGCGGGAAATCGTGCGTGACATTAAGGAGAA
GCTGTGCTACGTCGCCCTGGACTTCGAGCAAGAGATGGCCACGGCTGCTTCCAGCTCCTCCCTGGAGAAGAGCTACG
AGCTGCCTGACGGCCAGGTCATCACCATTGGCAATGAGCGGTTCCGCTGCCCTGAGGCACTCTTCCAGCCTTCCTTC
CTGGGCATGGAGTCCTGTGGCATCCACGAAACTACCTTCAACTCCATCATGAAGTGTGACGTGGACATCCGCAAAGA
CCTGTACGCCAACACAGTGCTGTCTGGCGGCACCACCATGTACCCTGGCATTGCCGACAGGATGCAGAAGGAGATCA
CTGCCCTGGCACCCAGCACAATGAAGATCAAGATCATTGCTCCTCCTGAGCGCAAGTACTCCGTGTGGATCGGCGGC
TCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAGGAGTATGACGAGTCCGGCCCCTCCAT
CGTCCACCGCAAATGCTTCTAGGGATCCACCGGATCTAGATAACTGATCATAATCAGCCATACCACATTTGTAGAGG
TTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAAC
TTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACT
GCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTAACGCGTAAATTGTAAGCGTTAATATTTTGTTAAAA
TTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAA
AGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACG
TCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCG
AGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCCGGCGAACG
TGGCGAGAAAGGAAGG 
Addendum 
  183 
 
10.3. Software settings 
 
Parameters used for KFmotion Analysis 2D v.4.0.4 to detect keratin movement: 
voxel size in x/y = 67 nanometers (pixel size in recorded data) 
maximum sought displacement = 1200 nanometers (movement above is not counted) 
frames used = 1 (with this setting every frame is used) 
smoothness factor = 1,00 
perform noised reduction = yes 
perform rigid preregistration = no 
perform shape normalization: (yes or no depending on experiment) 
save all images = yes 
 
Parameters used for turnover 2D software: 
Radius of turnover region: 25 voxels 
dt between consecutive frames: 20 or 30 sec 
voxel dwell time: 12,60 microsec 
thresh (values above belong only to KFs): 1500 
Acknowledgements 
  184 
Acknowledgements 
Mein besonderer Dank gilt Prof. Dr. Rudolf Leube für die Vergabe des Promotionsthemas, die 
sehr gute Erreichbarkeit, und die ständige Diskussionsbereitschaft. Ich würde auch gerne für die 
gute finanzielle Unterstützung meines Projektes danken und für die Möglichkeit meine Daten auf 
internationalen Kongressen vorzustellen. 
Prof. Dr. Gabriele Pradel danke ich sehr für die Übernahme der Betreuung der Promotionsarbeit 
als zweiter Gutachter.  
Ich würde auch gerne Prof. Dr. Werner Baumgartner, der meine Promotionsarbeit vor 
Universitätswechsel als zweiter Gutachter betreut hat, positiv erwähnen. 
Dr. Reinhard Windoffer danke ich für die Einweisung in Lebendzellmikroskopie, Vermittlung 
von Kooperationspartnern, wissenschaftliche Diskussionen und Hilfe bei Analyse und 
Visualisierung von Daten. Dr. Gerlind Herberich und Prof. Dr. Till Aach danke ich für die gute 
Kooperation und die Entwicklung der Software, die für die Beantwortung der Fragestellungen in 
dieser Arbeit essentiell waren. 
Dr. Nicole Schwarz danke ich für die gute Zusammenarbeit, Anregungen, Einführung in neue 
Methoden, Heilen in MMORPGs und das Korrekturlesen der Arbeit.  
Dr. Anne Kölsch und Ursula Wilhelm danke ich für die Einarbeitung in Zellkultur und 
gentechnische Methoden. Außerdem danke ich Dr. Anne Kölsch, Dr. Claudia Krusche, Prof. Dr. 
Irmgard Classen-Linke und Prof. Dr. Olaf Bossinger für wissenschaftliche Diskussionen.  
Meinem Bürogenossen Sebastian Kant danke ich für die wissenschaftlichen und weniger 
wissenschaftlichen Diskussionen, sowie Freizeitaktivitäten. Dasselbe gilt auch für Dr. Volker 
Buck, Richard Coch, Harald Gerhardus und Dr. Marco Felkl. Ich würde auch gerne Kateryna 
Venger, Mugdha Sawant und Dr. Arne Zoellner für die interessanten Gespräche danken. 
Dem technischen Personal danke ich für die gute Zusammenarbeit: Ursula Wilhelm, Bärbel 
Bonn, Sabina Hennes-Mades, Vanessa Creutz, Sabine Eisner, Christiane Jaeschke, Marina 
Lürkens-Weber, Claudia Schmitz und Diana Seelis. Unserer Verwaltungsfachkraft Elke 
Broekmeulen danke ich für Verwaltungsaufgaben und Organisation. Dem Elektriker Reinhold 
Schweizer danke ich für Hilfe bei technischen Problemen. Den Administratoren Oliver Bantke 
und Felix Meuer danke ich für die Instandhaltung der Server und Datenverfügbarkeit. Unseren 
Putzpersonal, insbesondere Grazina, danke ich für die gute Arbeit. 
Ich danke Prof. Dr. Stefan Uhlig und Prof. Dr. Andreas Ludwig vom Institut für Pharmakologie 
und Toxikologie für Zugang zu S2 Zellkultur und Ultrazentrifuge. Prof. Antonio Sechi vom 
Institute for Biomedical Engineering danke ich für den Zugang zu S1 Zellkultur am TIRF 
Mikroskop und Prof. Dr. Markus Kipp vom Institut für Neuroanatomie für den Zugang zu 
TECAN microplate reader. 
Acknowledgements 
  185 
Unseren wissenschaftlichen Mitarbeitern und medizinischen bzw. zahnmedizinischen 
Doktoranden danke ich für die weniger wissenschaftlichen Gespräche: Raphaela Pohl, Dr. 
Florian Geisler, Dominik Keul, Stephanie Stöcker, Eva Horzowski, Antonia Herzog, Joyce 
Terstegge, Svenja van der Gaag, Dr. Fabia Flensberg, Dr. Philipp Krull, Dr. Julia Camps, 
Alexandra Bach, Theresa Vogt, Lydia Lubowiecki, Oliver Jahnel, Mariam Al Bayat, Muhammed 
und Mustafa Gercek. 
Ich danke natürlich auch allen, die ich vergessen habe. 
I would also thank anyone who provided constructs or antibodies as described in the 
corresponding experiments and material section of this work. 
 
Nachtrag 20.06.2015: 
Ich danke Prof. Dr. Ralph Panstruga (Vorsitzender) und Prof. Dr. Andreas Ludwig (dritter 
Prüfer) für die Teilnahme an der Verteidigung der Doktorarbeit. 
Curriculum Vitae 
  186 
Curriculum Vitae 
 
Due to reasons of data protection, the Curriculum Vitae is not included in this version of the 
document. 
